{"generated": "2026-02-15T22:00:14.430494", "total_unmatched": 176, "total_with_suggestions": 111, "items": [{"id": "gsk_gsk_86eba274", "company": "gsk", "gong_entity": "GSK", "gong_parent": "GSK R&D", "entity_type": "business_unit", "team_size": "70,000", "confidence": "high", "mention_count": 10, "snippet": "Yeah, GSK obviously has something with biorender, you know?", "snippet_date": "2025-12-10", "person_name": "Prashant Waiker", "person_email": "prashant.x.waiker@gsk.com", "internal_name": "Brian Sedlacek; Michael Long", "internal_email": "brian.sedlacek@biorender.com; michael.long@biorender.com", "llm_suggested_match": {"manual_node_id": "gsk-rd", "manual_node_name": "GSK Research & Development", "manual_node_path": "GSK Research & Development", "confidence": "high", "reasoning": "Exact match - GSK is the parent company and the context of biorender licenses suggests this refers to the overall GSK R&D organization"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=f373376430fd71162bc0807224467f46155a47294994371387529a99ddcbf5f0", "call_id": "2025-12-10_f373376430fd", "call_count": 10, "all_snippets": [{"quote": "Yeah, GSK obviously has something with biorender, you know?", "date": "2025-12-10", "callId": "2025-12-10_f373376430fd", "gongUrl": "https://app.gong.io/call?id=f373376430fd71162bc0807224467f46155a47294994371387529a99ddcbf5f0", "speakerId": "5797852991557821441", "customerName": "Prashant Waiker", "internalName": "Brian Sedlacek; Michael Long", "customerEmail": "prashant.x.waiker@gsk.com", "internalEmail": "brian.sedlacek@biorender.com; michael.long@biorender.com", "sizeMentions": []}, {"quote": "I'm Frank joined GSK like five and a half years ago located in heidelberg in Germany", "date": "2025-12-03", "callId": "2025-12-03_67ac234f91fc", "gongUrl": "https://app.gong.io/call?id=67ac234f91fcc4fadc4a30c3ba3679789ce766d217ebe849f24e2e0a23918070", "speakerId": "3499597227668893123", "customerName": "Frank Wippich", "internalName": "Michael Long; Michelle Jang", "customerEmail": "frank.x.wippich@gsk.com", "internalEmail": "michael.long@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}, {"quote": "I'm responsible for the overall commercial relationship between biorender and GSK", "date": "2025-11-27", "callId": "2025-11-27_91052fe989ab", "gongUrl": "https://app.gong.io/call?id=91052fe989ab8156835a1460cbae0befb07a0aebe4036b02f0f72cbae4cfe78b", "speakerId": "3366954264429859350", "customerName": "Sam Rowe; Sam Rowe", "internalName": "Michael Long", "customerEmail": "sam.m.rowe@gsk.com; sam.m.rowe@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}, {"quote": "I know you and I have just briefly spoke over email about the new msa at GSK and getting biorender access for GSK users", "date": "2025-11-24", "callId": "2025-11-24_4785393bd566", "gongUrl": "https://app.gong.io/call?id=4785393bd5669266b6b45f28f8f5f176dd800aec0e3d3e5a371a1dd99bb906f2", "speakerId": "1369761079521554382", "customerName": "Didem Torumkuney; Renuka Kapoor", "internalName": "Michael Long; Michelle Jang", "customerEmail": "didem.x.torumkuney@gsk.com; renuka.x.kapoor@gsk.com", "internalEmail": "michael.long@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}, {"quote": "I'm part of the team that's helped Bing to support our users at GSK", "date": "2025-11-06", "callId": "2025-11-06_afda494ecd0c", "gongUrl": "https://app.gong.io/call?id=afda494ecd0c139472f54cfe3634d3a4d05c6d7d68456ba5e4509023706ba78b", "speakerId": "4596687062783714805", "customerName": "Sam Rowe; Sam Rowe", "internalName": "Michelle Jang", "customerEmail": "sam.m.rowe@gsk.com; sam.m.rowe@gsk.com", "internalEmail": "michelle.jang@biorender.com", "sizeMentions": []}, {"quote": "I joined GSK on the 20 of October", "date": "2025-11-05", "callId": "2025-11-05_b10abe2b7801", "gongUrl": "https://app.gong.io/call?id=b10abe2b780132ee259447ae5da32c1d322441b445dff768e62c9665fbb1a7be", "speakerId": "3786459342286702790", "customerName": "Stefania Zona; Stefania Zona", "internalName": "Brian Sedlacek", "customerEmail": "stefania.x.zona@gsk.com; stefania.x.zona@gsk.com", "internalEmail": "brian.sedlacek@biorender.com", "sizeMentions": []}, {"quote": "I'm the customer success manager that works with all GSK", "date": "2025-10-22", "callId": "2025-10-22_ef9211087dd8", "gongUrl": "https://app.gong.io/call?id=ef9211087dd82819dc45d922c8b985bf717968edd72623179cbc6e502fec8334", "speakerId": "5693836121629020452", "customerName": "Brett Howell; Brett Howell; Mehdi Nikfar; Mehid Nikfar; Mehid Nikfar", "internalName": "Brian Sedlacek", "customerEmail": "brett.a.howell@gsk.com; brett.a.howell@gsk.com; mehdi.x.nikfar@gsk.com; mehdi.x.nikfar@gsk.com; mehdi.x.nikfar@gsk.com", "internalEmail": "brian.sedlacek@biorender.com", "sizeMentions": []}, {"quote": "in my team GSK employees now we are six\u2026 seven eight probably", "date": "2025-10-09", "callId": "2025-10-09_ed7a381cbec1", "gongUrl": "https://app.gong.io/call?id=ed7a381cbec11a0ccf974327d3fb66b8ee70d7061c42ccb1e7c3759d5404a4a1", "speakerId": "4456640047261103480", "customerName": "Matteo Martufi", "internalName": "Brian Sedlacek; Sydney Burniston", "customerEmail": "matteo.x.martufi@gsk.com", "internalEmail": "brian.sedlacek@biorender.com; sydney.b@biorender.com", "sizeMentions": []}, {"quote": "my name is Shane. I'm a scientist in GSK", "date": "2025-10-02", "callId": "2025-10-02_d8834ee1bf4d", "gongUrl": "https://app.gong.io/call?id=d8834ee1bf4dbbcf204921eedf6383a7075ebea2af71b19c14c6a0ce69809cd5", "speakerId": "6962253166522553880", "customerName": "Emily Cook; Michael Bond; Shane O'Brien", "internalName": "Michael Long", "customerEmail": "emily.k.cook@gsk.com; michael.j.bond@gsk.com; shane.w.obrien@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}, {"quote": "you gave me your personal email since GSK kind of blocked some of those external emails", "date": "2025-09-18", "callId": "2025-09-18_0091fb88c764", "gongUrl": "https://app.gong.io/call?id=0091fb88c764cbbb3b4478ee8acee6f8f061a951f17d6b1efe8fdef19a1f7147", "speakerId": "5616591006019231692", "customerName": "Deidre Dalmas", "internalName": "Michelle Jang", "customerEmail": "deidre.a.dalmas@gsk.com", "internalEmail": "michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_vaccines_8190a0b2", "company": "gsk", "gong_entity": "Vaccines", "gong_parent": "GSK", "entity_type": "business_unit", "team_size": "70", "confidence": "high", "mention_count": 10, "snippet": "we were working at consolidating all of the licenses of biorender under vaccines", "snippet_date": "2025-11-24", "person_name": "Didem Torumkuney; Renuka Kapoor", "person_email": "didem.x.torumkuney@gsk.com; renuka.x.kapoor@gsk.com", "internal_name": "Michael Long; Michelle Jang", "internal_email": "michael.long@biorender.com; michelle.jang@biorender.com", "llm_suggested_match": {"manual_node_id": "vaccines-infectious-diseases-research", "manual_node_name": "Vaccines & Infectious Diseases Research", "manual_node_path": "GSK Research & Development > Research > Vaccines & Infectious Diseases Research", "confidence": "medium", "reasoning": "Strong semantic match - entity refers to vaccines business unit, best matches the vaccines research therapeutic area in the org chart"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=4785393bd5669266b6b45f28f8f5f176dd800aec0e3d3e5a371a1dd99bb906f2", "call_id": "2025-11-24_4785393bd566", "call_count": 10, "all_snippets": [{"quote": "we were working at consolidating all of the licenses of biorender under vaccines", "date": "2025-11-24", "callId": "2025-11-24_4785393bd566", "gongUrl": "https://app.gong.io/call?id=4785393bd5669266b6b45f28f8f5f176dd800aec0e3d3e5a371a1dd99bb906f2", "speakerId": "4608526257814388930", "customerName": "Didem Torumkuney; Renuka Kapoor", "internalName": "Michael Long; Michelle Jang", "customerEmail": "didem.x.torumkuney@gsk.com; renuka.x.kapoor@gsk.com", "internalEmail": "michael.long@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}, {"quote": "we have current licenses for example, within vaccines within the ribo group", "date": "2025-10-24", "callId": "2025-10-24_ec055767f572", "gongUrl": "https://app.gong.io/call?id=ec055767f572aba9448a7dee23cec923234e76be145b40af151ba488cad520c7", "speakerId": "4608000112955777667", "customerName": "Kim Reese; Kim Reese", "internalName": "Michael Long", "customerEmail": "kim.x.reese@gsk.com; kim.x.reese@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}, {"quote": "So vaccines had, you know, under maybe 70 researchers using biorender", "date": "2025-10-16", "callId": "2025-10-16_aa822b21b950", "gongUrl": "https://app.gong.io/call?id=aa822b21b950bd1adf88a50373d844c2ffee7df499714e180d14d5e519dea999", "speakerId": "1262197883725469268", "customerName": "Celia Presmanes; Sara Leal", "internalName": "Michael Long", "customerEmail": "celia.x.presmanes@gsk.com; sara.x.leal@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": [{"value": "70", "snippetIndex": 2, "source": {"callDate": "2025-10-16", "customerName": "Celia Presmanes; Sara Leal"}}]}, {"quote": "the entire msa conversation was championed by a VP out of Belgium, Yannick, who leads up vaccines", "date": "2025-10-03", "callId": "2025-10-03_d2bd514f48f5", "gongUrl": "https://app.gong.io/call?id=d2bd514f48f515072d570d5f538c52ae788f6e547a64618266eea85d840cfc8c", "speakerId": "4756729082506714629", "customerName": "Amy Lancaster; Amy Lancaster", "internalName": "Michael Long; Michelle Jang", "customerEmail": "amy.b.lancaster@gsk.com; amy.b.lancaster@gsk.com", "internalEmail": "michael.long@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}, {"quote": "as well as some other major groups within vaccines", "date": "2025-10-02", "callId": "2025-10-02_d8834ee1bf4d", "gongUrl": "https://app.gong.io/call?id=d8834ee1bf4dbbcf204921eedf6383a7075ebea2af71b19c14c6a0ce69809cd5", "speakerId": "688751584058716562", "customerName": "Emily Cook; Michael Bond; Shane O'Brien", "internalName": "Michael Long", "customerEmail": "emily.k.cook@gsk.com; michael.j.bond@gsk.com; shane.w.obrien@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}, {"quote": "It's a vaccines VP out of, Belgium.", "date": "2025-04-15", "callId": "2025-04-15_a4f1ae6fa22d", "gongUrl": "https://app.gong.io/call?id=a4f1ae6fa22dfa3ec50d22e3e991b85fa7d23a9bbec23d4c29b90a64c6db44e6", "speakerId": "6552257046574197027", "customerName": "Jenna Sumey; Jenna Sumey", "internalName": "Adrian Rizos", "customerEmail": "jenna.l.sumey@gsk.com; jenna.l.sumey@gsk.com", "internalEmail": "adrian.rizos@biorender.com", "sizeMentions": []}, {"quote": "So it's under the vaccine umbrella, let's say and the r d department", "date": "2024-12-19", "callId": "2024-12-19_3eab6711ee74", "gongUrl": "https://app.gong.io/call?id=3eab6711ee749bdab92955a7d6f83f6c2b1f967bab5572b3c0e664e32f1ef1a8", "speakerId": "7040791890700399135", "customerName": "Rossella Cuffaro; Rossella Cuffaro", "internalName": "Adrian Rizos", "customerEmail": "rossella.x.cuffaro@gsk.com; rossella.x.cuffaro@gsk.com", "internalEmail": "adrian.rizos@biorender.com", "sizeMentions": []}, {"quote": "because I'm in the vaccine part of the company. And as one became one company one year ago, something like that, before that we are, it was, there was two companies pharmacy and vaccines. And I will also try to because vaccine represent approximately 20,000 people", "date": "2023-08-18", "callId": "2023-08-18_7ac464a150ea", "gongUrl": "https://app.gong.io/call?id=7ac464a150ea06da02589cb4322e052cf56fd3f96fd10d29e29575aac5bcf4d5", "speakerId": "756384962136640331", "customerName": "Carsten Walter; Carsten Walter", "internalName": "Rich Lee; Sydney Burniston", "customerEmail": "carsten.walter@gsk.com; carsten.walter@gsk.com", "internalEmail": "rich@biorender.com; sydney.b@biorender.com", "sizeMentions": [{"value": "20,000", "snippetIndex": 7, "source": {"callDate": "2023-08-18", "customerName": "Carsten Walter; Carsten Walter"}}]}, {"quote": "The, the largest part of vaccines is actually Belgium is recon start that's actually the most people", "date": "2023-07-11", "callId": "2023-07-11_602faffb183e", "gongUrl": "https://app.gong.io/call?id=602faffb183e4e4824d3bf1ab28ee115412c31e230677d7ee034801eb4a6fa8c", "speakerId": "5882762078687495157", "customerName": "Matthew Brecher", "internalName": "Rich Lee", "customerEmail": "matthew.b.brecher@gsk.com", "internalEmail": "rich@biorender.com", "sizeMentions": []}, {"quote": "And so, I'll be able to, at the end of this call, share what that pricing table looks like. And then what I've also been asked to do is our key business stakeholder, Yannick, who's a VP within the vaccines group", "date": "2025-11-25", "callId": "2025-11-25_e303d69d75c7", "gongUrl": "https://app.gong.io/call?id=e303d69d75c74f8e2c50ce723f4aef9ea075ed190e86db41bf07c7e693775d69", "speakerId": "8213524192969324956", "customerName": "Muhmmad Maqbool; Muhmmad Maqbool", "internalName": "Michael Long", "customerEmail": "muhammad.x.maqbool@gsk.com; muhammad.x.maqbool@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}]}, {"id": "gsk_vaccines_r&d_b2ee326b", "company": "gsk", "gong_entity": "Vaccines R&D", "gong_parent": "Vaccines", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "we have one organization called vaccines RD. Yep and, we were hoping to get all vaccines RD together and that's essentially the us cambridge sites and rockville and Belgium. We have two sides and Italy, we have one side.", "snippet_date": "2025-12-10", "person_name": "Prashant Waiker", "person_email": "prashant.x.waiker@gsk.com", "internal_name": "Brian Sedlacek; Michael Long", "internal_email": "brian.sedlacek@biorender.com; michael.long@biorender.com", "llm_suggested_match": {"manual_node_id": "vaccines-development", "manual_node_name": "Vaccines Development", "manual_node_path": "GSK Research & Development > Development > Vaccines Development", "confidence": "medium", "reasoning": "Good semantic match - mentions Cambridge sites, Rockville, Belgium and Italy which align with vaccine R&D sites in the manual chart"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=f373376430fd71162bc0807224467f46155a47294994371387529a99ddcbf5f0", "call_id": "2025-12-10_f373376430fd", "call_count": 1, "all_snippets": [{"quote": "we have one organization called vaccines RD. Yep and, we were hoping to get all vaccines RD together and that's essentially the us cambridge sites and rockville and Belgium. We have two sides and Italy, we have one side.", "date": "2025-12-10", "callId": "2025-12-10_f373376430fd", "gongUrl": "https://app.gong.io/call?id=f373376430fd71162bc0807224467f46155a47294994371387529a99ddcbf5f0", "speakerId": "5797852991557821441", "customerName": "Prashant Waiker", "internalName": "Brian Sedlacek; Michael Long", "customerEmail": "prashant.x.waiker@gsk.com", "internalEmail": "brian.sedlacek@biorender.com; michael.long@biorender.com", "sizeMentions": []}]}, {"id": "gsk_infectious_disease_research_unit_384e52d2", "company": "gsk", "gong_entity": "Infectious Disease Research Unit", "gong_parent": "Vaccines R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 3, "snippet": "We were having kind of these separate conversations with all of the infectious disease research unit teams", "snippet_date": "2025-11-24", "person_name": "Didem Torumkuney; Renuka Kapoor", "person_email": "didem.x.torumkuney@gsk.com; renuka.x.kapoor@gsk.com", "internal_name": "Michael Long; Michelle Jang", "internal_email": "michael.long@biorender.com; michelle.jang@biorender.com", "llm_suggested_match": {"manual_node_id": "vaccines-infectious-diseases-research", "manual_node_name": "Vaccines & Infectious Diseases Research", "manual_node_path": "GSK Research & Development > Research > Vaccines & Infectious Diseases Research", "confidence": "high", "reasoning": "Strong semantic match - infectious disease research unit clearly maps to the Vaccines & Infectious Diseases Research therapeutic area"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=4785393bd5669266b6b45f28f8f5f176dd800aec0e3d3e5a371a1dd99bb906f2", "call_id": "2025-11-24_4785393bd566", "call_count": 3, "all_snippets": [{"quote": "We were having kind of these separate conversations with all of the infectious disease research unit teams", "date": "2025-11-24", "callId": "2025-11-24_4785393bd566", "gongUrl": "https://app.gong.io/call?id=4785393bd5669266b6b45f28f8f5f176dd800aec0e3d3e5a371a1dd99bb906f2", "speakerId": "4608526257814388930", "customerName": "Didem Torumkuney; Renuka Kapoor", "internalName": "Michael Long; Michelle Jang", "customerEmail": "didem.x.torumkuney@gsk.com; renuka.x.kapoor@gsk.com", "internalEmail": "michael.long@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}, {"quote": "I work in the infectious disease research unit", "date": "2025-10-15", "callId": "2025-10-15_04d1807e1dcd", "gongUrl": "https://app.gong.io/call?id=04d1807e1dcda3877d1cb617083a2fa0ecad7a97e6b37e1bc1b322f236c38893", "speakerId": "2855433903326779045", "customerName": "Cory Knudson; Cory Knudson", "internalName": "Michael Long; Michelle Jang", "customerEmail": "cory.j.knudson@gsk.com; cory.j.knudson@gsk.com", "internalEmail": "michael.long@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}, {"quote": "I work in the infectious disease research unit at GSK", "date": "2025-10-01", "callId": "2025-10-01_6366913a986f", "gongUrl": "https://app.gong.io/call?id=6366913a986f577cacf2cc829f6e9906fd9695e2733640759486c40c03f48167", "speakerId": "8516056118991080792", "customerName": "Cory Knudson; Cory Knudson", "internalName": "Michelle Jang", "customerEmail": "cory.j.knudson@gsk.com; cory.j.knudson@gsk.com", "internalEmail": "michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_trd_technical_r&d_a03c9727", "company": "gsk", "gong_entity": "TRD Technical R&D", "gong_parent": "Vaccines R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "And then what happened last this year's? May, there was a big chunk of it's called TRD technical RD within vaccines and RD that moved from vaccines RD into a different organization called medicinal development and supply MDS.", "snippet_date": "2025-12-10", "person_name": "Prashant Waiker", "person_email": "prashant.x.waiker@gsk.com", "internal_name": "Brian Sedlacek; Michael Long", "internal_email": "brian.sedlacek@biorender.com; michael.long@biorender.com", "llm_suggested_match": {"manual_node_id": "cmc-pharmaceutical-sciences", "manual_node_name": "CMC & Pharmaceutical Sciences", "manual_node_path": "GSK Research & Development > CMC & Pharmaceutical Sciences", "confidence": "medium", "reasoning": "Technical R&D within vaccines that moved to medicinal development suggests CMC (Chemistry, Manufacturing, Controls) & Pharmaceutical Sciences division"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=f373376430fd71162bc0807224467f46155a47294994371387529a99ddcbf5f0", "call_id": "2025-12-10_f373376430fd", "call_count": 1, "all_snippets": [{"quote": "And then what happened last this year's? May, there was a big chunk of it's called TRD technical RD within vaccines and RD that moved from vaccines RD into a different organization called medicinal development and supply MDS.", "date": "2025-12-10", "callId": "2025-12-10_f373376430fd", "gongUrl": "https://app.gong.io/call?id=f373376430fd71162bc0807224467f46155a47294994371387529a99ddcbf5f0", "speakerId": "5797852991557821441", "customerName": "Prashant Waiker", "internalName": "Brian Sedlacek; Michael Long", "customerEmail": "prashant.x.waiker@gsk.com", "internalEmail": "brian.sedlacek@biorender.com; michael.long@biorender.com", "sizeMentions": []}]}, {"id": "gsk_vaccines_it_group_456411bf", "company": "gsk", "gong_entity": "Vaccines IT Group", "gong_parent": "Vaccines", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "you would have a conversation with the vaccines it group if you're a part of that division", "snippet_date": "2025-12-11", "person_name": "Sara Porfirio", "person_email": "sara.p.porfirio@gsk.com", "internal_name": "Michael Long", "internal_email": "michael.long@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=efe1b4376fba6df38a4e08d00a739daec4168474cfd5f64eec9f1e3c8d9220b9", "call_id": "2025-12-11_efe1b4376fba", "call_count": 1, "all_snippets": [{"quote": "you would have a conversation with the vaccines it group if you're a part of that division", "date": "2025-12-11", "callId": "2025-12-11_efe1b4376fba", "gongUrl": "https://app.gong.io/call?id=efe1b4376fba6df38a4e08d00a739daec4168474cfd5f64eec9f1e3c8d9220b9", "speakerId": "5015271624001198436", "customerName": "Sara Porfirio", "internalName": "Michael Long", "customerEmail": "sara.p.porfirio@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}]}, {"id": "gsk_vaccines_clap_ecaa62d1", "company": "gsk", "gong_entity": "Vaccines CLAP", "gong_parent": "Vaccines", "entity_type": "team", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "So, for example, you know, one team is called vaccines clap. I think like clinical essay and portfolio something so that we, our team support in us completely.", "snippet_date": "2025-12-10", "person_name": "Prashant Waiker", "person_email": "prashant.x.waiker@gsk.com", "internal_name": "Brian Sedlacek; Michael Long", "internal_email": "brian.sedlacek@biorender.com; michael.long@biorender.com", "llm_suggested_match": {"manual_node_id": "clinical-operations", "manual_node_name": "Clinical Operations", "manual_node_path": "GSK Research & Development > Development > Clinical Operations", "confidence": "medium", "reasoning": "CLAP appears to be 'Clinical Essay and Portfolio' based on context, which best matches Clinical Operations department"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=f373376430fd71162bc0807224467f46155a47294994371387529a99ddcbf5f0", "call_id": "2025-12-10_f373376430fd", "call_count": 1, "all_snippets": [{"quote": "So, for example, you know, one team is called vaccines clap. I think like clinical essay and portfolio something so that we, our team support in us completely.", "date": "2025-12-10", "callId": "2025-12-10_f373376430fd", "gongUrl": "https://app.gong.io/call?id=f373376430fd71162bc0807224467f46155a47294994371387529a99ddcbf5f0", "speakerId": "5797852991557821441", "customerName": "Prashant Waiker", "internalName": "Brian Sedlacek; Michael Long", "customerEmail": "prashant.x.waiker@gsk.com", "internalEmail": "brian.sedlacek@biorender.com; michael.long@biorender.com", "sizeMentions": []}]}, {"id": "gsk_vaccines_lab_ops_4923ca90", "company": "gsk", "gong_entity": "Vaccines Lab Ops", "gong_parent": "Vaccines", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "And our vaccines, lab, ops, lab, operation head, who is based in Italy. He provided a list. He just said like, you know, just support these guys.", "snippet_date": "2025-12-10", "person_name": "Prashant Waiker", "person_email": "prashant.x.waiker@gsk.com", "internal_name": "Brian Sedlacek; Michael Long", "internal_email": "brian.sedlacek@biorender.com; michael.long@biorender.com", "llm_suggested_match": {"manual_node_id": "vaccine-cmc", "manual_node_name": "Vaccine CMC", "manual_node_path": "GSK Research & Development > CMC & Pharmaceutical Sciences > Vaccine CMC", "confidence": "medium", "reasoning": "Lab operations for vaccines likely falls under Vaccine CMC department which handles vaccine manufacturing and development processes"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=f373376430fd71162bc0807224467f46155a47294994371387529a99ddcbf5f0", "call_id": "2025-12-10_f373376430fd", "call_count": 1, "all_snippets": [{"quote": "And our vaccines, lab, ops, lab, operation head, who is based in Italy. He provided a list. He just said like, you know, just support these guys.", "date": "2025-12-10", "callId": "2025-12-10_f373376430fd", "gongUrl": "https://app.gong.io/call?id=f373376430fd71162bc0807224467f46155a47294994371387529a99ddcbf5f0", "speakerId": "5797852991557821441", "customerName": "Prashant Waiker", "internalName": "Brian Sedlacek; Michael Long", "customerEmail": "prashant.x.waiker@gsk.com", "internalEmail": "brian.sedlacek@biorender.com; michael.long@biorender.com", "sizeMentions": []}]}, {"id": "gsk_oncology_87ace7eb", "company": "gsk", "gong_entity": "Oncology", "gong_parent": "GSK", "entity_type": "therapeutic_area", "team_size": null, "confidence": "high", "mention_count": 6, "snippet": "like a few groups within, stevenage office, within oncology", "snippet_date": "2025-11-26", "person_name": "Emma Milford", "person_email": "emma.l.milford@gsk.com", "internal_name": "Michael Long; Michelle Jang", "internal_email": "michael.long@biorender.com; michelle.jang@biorender.com", "llm_suggested_match": {"manual_node_id": "oncology-research", "manual_node_name": "Oncology Research", "manual_node_path": "GSK Research & Development > Research > Oncology Research", "confidence": "high", "reasoning": "Exact match - oncology therapeutic area maps directly to Oncology Research in the manual chart"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=5acc0f3f737c04836e4c0c29df846fecc71ee2db70e6b8a026d6a7554a45fb2d", "call_id": "2025-11-26_5acc0f3f737c", "call_count": 6, "all_snippets": [{"quote": "like a few groups within, stevenage office, within oncology", "date": "2025-11-26", "callId": "2025-11-26_5acc0f3f737c", "gongUrl": "https://app.gong.io/call?id=5acc0f3f737c04836e4c0c29df846fecc71ee2db70e6b8a026d6a7554a45fb2d", "speakerId": "6494269629967001232", "customerName": "Emma Milford", "internalName": "Michael Long; Michelle Jang", "customerEmail": "emma.l.milford@gsk.com", "internalEmail": "michael.long@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}, {"quote": "We have some smaller licenses within oncology", "date": "2025-10-24", "callId": "2025-10-24_ec055767f572", "gongUrl": "https://app.gong.io/call?id=ec055767f572aba9448a7dee23cec923234e76be145b40af151ba488cad520c7", "speakerId": "4608000112955777667", "customerName": "Kim Reese; Kim Reese", "internalName": "Michael Long", "customerEmail": "kim.x.reese@gsk.com; kim.x.reese@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}, {"quote": "if for oncology or for pharma, or for any other department", "date": "2025-10-14", "callId": "2025-10-14_8fa4f3232c29", "gongUrl": "https://app.gong.io/call?id=8fa4f3232c29fb999967ce828dd3d90d405fbb20e3e24fdfafdacac2bed9aee1", "speakerId": "8781652897651607371", "customerName": "Gunasundari Veerapandian; Prashant Waiker; Raffaele Tiezzi", "internalName": "Michael Long", "customerEmail": "gunasundari.x.veerapandian@gsk.com; prashant.x.waiker@gsk.com; raffaele.x.tiezzi@gsk.com; john.x.jonesjr@gsk.com; fabrice.x.godart@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}, {"quote": "yesterday, we spoke to some folks within oncology that have, some folks in cambridge", "date": "2025-10-03", "callId": "2025-10-03_d2bd514f48f5", "gongUrl": "https://app.gong.io/call?id=d2bd514f48f515072d570d5f538c52ae788f6e547a64618266eea85d840cfc8c", "speakerId": "4756729082506714629", "customerName": "Amy Lancaster; Amy Lancaster", "internalName": "Michael Long; Michelle Jang", "customerEmail": "amy.b.lancaster@gsk.com; amy.b.lancaster@gsk.com", "internalEmail": "michael.long@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}, {"quote": "I'm a scientist in GSK, obviously working in oncology", "date": "2025-10-02", "callId": "2025-10-02_d8834ee1bf4d", "gongUrl": "https://app.gong.io/call?id=d8834ee1bf4dbbcf204921eedf6383a7075ebea2af71b19c14c6a0ce69809cd5", "speakerId": "6962253166522553880", "customerName": "Emily Cook; Michael Bond; Shane O'Brien", "internalName": "Michael Long", "customerEmail": "emily.k.cook@gsk.com; michael.j.bond@gsk.com; shane.w.obrien@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}, {"quote": "It was a part of the oncology group.", "date": "2025-12-11", "callId": "2025-12-11_efe1b4376fba", "gongUrl": "https://app.gong.io/call?id=efe1b4376fba6df38a4e08d00a739daec4168474cfd5f64eec9f1e3c8d9220b9", "speakerId": "5015271624001198436", "customerName": "Sara Porfirio", "internalName": "Michael Long", "customerEmail": "sara.p.porfirio@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}]}, {"id": "gsk_oncology_team_d86eae8a", "company": "gsk", "gong_entity": "Oncology Team", "gong_parent": "Oncology", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 2, "snippet": "But what we've been doing is we've had conversations of teams of five or 10 like the oligosciences team or the oncology team in the UK", "snippet_date": "2025-11-25", "person_name": "Muhmmad Maqbool; Muhmmad Maqbool", "person_email": "muhammad.x.maqbool@gsk.com; muhammad.x.maqbool@gsk.com", "internal_name": "Michael Long", "internal_email": "michael.long@biorender.com", "llm_suggested_match": {"manual_node_id": "oncology-research", "manual_node_name": "Oncology Research", "manual_node_path": "GSK Research & Development > Research > Oncology Research", "confidence": "high", "reasoning": "Strong match - oncology team in UK context maps to the Oncology Research therapeutic area, though could refer to any of the specific oncology teams"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=e303d69d75c74f8e2c50ce723f4aef9ea075ed190e86db41bf07c7e693775d69", "call_id": "2025-11-25_e303d69d75c7", "call_count": 2, "all_snippets": [{"quote": "But what we've been doing is we've had conversations of teams of five or 10 like the oligosciences team or the oncology team in the UK", "date": "2025-11-25", "callId": "2025-11-25_e303d69d75c7", "gongUrl": "https://app.gong.io/call?id=e303d69d75c74f8e2c50ce723f4aef9ea075ed190e86db41bf07c7e693775d69", "speakerId": "8213524192969324956", "customerName": "Muhmmad Maqbool; Muhmmad Maqbool", "internalName": "Michael Long", "customerEmail": "muhammad.x.maqbool@gsk.com; muhammad.x.maqbool@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}, {"quote": "Yeah, we do give context and yeah, so we are, I mean, I'm in the oncology team.", "date": "2025-09-15", "callId": "2025-09-15_f3479b8f2585", "gongUrl": "https://app.gong.io/call?id=f3479b8f25850f3b96859ffe9ad38c626cdc729fb5ee10e2bb6a951891bd47f9", "speakerId": "974860769058339397", "customerName": "Natacha Steinckwich-Besancon", "internalName": "Michelle Jang", "customerEmail": "natacha.x.steinckwich-besancon@gsk.com", "internalEmail": "michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_r&d_2c2909a1", "company": "gsk", "gong_entity": "R&D", "gong_parent": "GSK", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 4, "snippet": "That's why I'm and\u2026 it's with it's within in RD, it's in, the part that develops research and development.", "snippet_date": "2025-09-03", "person_name": "Kim Reese; Kim Reese; Kim Reese", "person_email": "kim.x.reese@gsk.com; kim.x.reese@gsk.com; kim.x.reese@gsk.com", "internal_name": "Michelle Jang", "internal_email": "michelle.jang@biorender.com", "llm_suggested_match": {"manual_node_id": "gsk-rd", "manual_node_name": "GSK Research & Development", "manual_node_path": "GSK Research & Development", "confidence": "high", "reasoning": "R&D is a clear acronym for Research & Development, matching the top-level company node exactly"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=765229881bc41cbbe72aa77176d37901c5dc7203ee313002b13587d3b47ff8bb", "call_id": "2025-09-03_765229881bc4", "call_count": 4, "all_snippets": [{"quote": "That's why I'm and\u2026 it's with it's within in RD, it's in, the part that develops research and development.", "date": "2025-09-03", "callId": "2025-09-03_765229881bc4", "gongUrl": "https://app.gong.io/call?id=765229881bc41cbbe72aa77176d37901c5dc7203ee313002b13587d3b47ff8bb", "speakerId": "1217104218013791246", "customerName": "Kim Reese; Kim Reese; Kim Reese", "internalName": "Michelle Jang", "customerEmail": "kim.x.reese@gsk.com; kim.x.reese@gsk.com; kim.x.reese@gsk.com", "internalEmail": "michelle.jang@biorender.com", "sizeMentions": []}, {"quote": "So it's under the vaccine umbrella, let's say and the r d department", "date": "2024-12-19", "callId": "2024-12-19_3eab6711ee74", "gongUrl": "https://app.gong.io/call?id=3eab6711ee749bdab92955a7d6f83f6c2b1f967bab5572b3c0e664e32f1ef1a8", "speakerId": "7040791890700399135", "customerName": "Rossella Cuffaro; Rossella Cuffaro", "internalName": "Adrian Rizos", "customerEmail": "rossella.x.cuffaro@gsk.com; rossella.x.cuffaro@gsk.com", "internalEmail": "adrian.rizos@biorender.com", "sizeMentions": []}, {"quote": "And I've recently, I was in the R&D space, which is how I got brought into this.", "date": "2024-09-10", "callId": "2024-09-10_bdeb980229bf", "gongUrl": "https://app.gong.io/call?id=bdeb980229bf249722cd1e207256e8487e5d4818b79c5748f1e4c66f2572c171", "speakerId": "1018109843767271699", "customerName": "Tessa Lincoln", "internalName": "Derek Fitting; Madison Knock", "customerEmail": "ambertessa.c.lincoln@gsk.com", "internalEmail": "derek.fitting@biorender.com; madison@biorender.com", "sizeMentions": []}, {"quote": "So we, so in the RD department, there are, there is like a bigger department that is called research technologies.", "date": "2025-11-25", "callId": "2025-11-25_e303d69d75c7", "gongUrl": "https://app.gong.io/call?id=e303d69d75c74f8e2c50ce723f4aef9ea075ed190e86db41bf07c7e693775d69", "speakerId": "9151410085682651249", "customerName": "Muhmmad Maqbool; Muhmmad Maqbool", "internalName": "Michael Long", "customerEmail": "muhammad.x.maqbool@gsk.com; muhammad.x.maqbool@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}]}, {"id": "gsk_research_technologies_b2cf2464", "company": "gsk", "gong_entity": "Research Technologies", "gong_parent": "R&D", "entity_type": "business_unit", "team_size": "100", "confidence": "high", "mention_count": 4, "snippet": "I'm part of the lmr department, large molecule discovery, which is part of research tech if you've worked with them.", "snippet_date": "2025-11-05", "person_name": "Paige Fenn", "person_email": "paige.g.fenn@gsk.com", "internal_name": "Michelle Jang", "internal_email": "michelle.jang@biorender.com", "llm_suggested_match": {"manual_node_id": "medicinal-science-technology", "manual_node_name": "Medicinal Science & Technology", "manual_node_path": "GSK Research & Development > Medicinal Science & Technology", "confidence": "medium", "reasoning": "Research Technologies likely refers to the Medicinal Science & Technology division which encompasses research technology functions"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=17f31f16cfe5d1ef54c008abb1f341614523b8aa17670098bc16e866349710f0", "call_id": "2025-11-05_17f31f16cfe5", "call_count": 4, "all_snippets": [{"quote": "I'm part of the lmr department, large molecule discovery, which is part of research tech if you've worked with them.", "date": "2025-11-05", "callId": "2025-11-05_17f31f16cfe5", "gongUrl": "https://app.gong.io/call?id=17f31f16cfe5d1ef54c008abb1f341614523b8aa17670098bc16e866349710f0", "speakerId": "5476356920226236898", "customerName": "Paige Fenn", "internalName": "Michelle Jang", "customerEmail": "paige.g.fenn@gsk.com", "internalEmail": "michelle.jang@biorender.com", "sizeMentions": []}, {"quote": "So overall, we are called the research tech within research tech.", "date": "2025-09-12", "callId": "2025-09-12_15e032aa78b9", "gongUrl": "https://app.gong.io/call?id=15e032aa78b9280b2df0ee2f70cb87273437574fffd29e48ff4d2fa6f3b38ed4", "speakerId": "671417595239033477", "customerName": "Sandeep Talapatra", "internalName": "Michelle Jang", "customerEmail": "sandeep.k.talapatra@gsk.com", "internalEmail": "michelle.jang@biorender.com", "sizeMentions": []}, {"quote": "So we are, we, when I say research technologies, it is really the big department that we are under. So it's not, I'm not talking about one team. It is a lot of people research technologies, I think altogether global manpower. It is something like, you know, like 1,213 100 people.", "date": "2025-11-25", "callId": "2025-11-25_e303d69d75c7", "gongUrl": "https://app.gong.io/call?id=e303d69d75c74f8e2c50ce723f4aef9ea075ed190e86db41bf07c7e693775d69", "speakerId": "9151410085682651249", "customerName": "Muhmmad Maqbool; Muhmmad Maqbool", "internalName": "Michael Long", "customerEmail": "muhammad.x.maqbool@gsk.com; muhammad.x.maqbool@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": [{"value": "100", "snippetIndex": 2, "source": {"callDate": "2025-11-25", "customerName": "Muhmmad Maqbool; Muhmmad Maqbool"}}]}, {"quote": "Our group is under research technologies", "date": "2025-10-03", "callId": "2025-10-03_d2bd514f48f5", "gongUrl": "https://app.gong.io/call?id=d2bd514f48f515072d570d5f538c52ae788f6e547a64618266eea85d840cfc8c", "speakerId": "8622183118565525883", "customerName": "Amy Lancaster; Amy Lancaster", "internalName": "Michael Long; Michelle Jang", "customerEmail": "amy.b.lancaster@gsk.com; amy.b.lancaster@gsk.com", "internalEmail": "michael.long@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_target_discovery_d94cd6ca", "company": "gsk", "gong_entity": "Target Discovery", "gong_parent": "Research Technologies", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 3, "snippet": "And that is part of a department that's called target discovery and that's really where we operate the most in the target discovery space", "snippet_date": "2025-12-03", "person_name": "Frank Wippich", "person_email": "frank.x.wippich@gsk.com", "internal_name": "Michael Long; Michelle Jang", "internal_email": "michael.long@biorender.com; michelle.jang@biorender.com", "llm_suggested_match": {"manual_node_id": "genetics-target-discovery", "manual_node_name": "Genetics-Based Target Discovery", "manual_node_path": "GSK Research & Development > Human Genetics & Genomics > Human Genetics > Genetics-Based Target Discovery", "confidence": "medium", "reasoning": "Target Discovery matches the Genetics-Based Target Discovery team, though the entity may be broader than just genetics-based approaches"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=67ac234f91fcc4fadc4a30c3ba3679789ce766d217ebe849f24e2e0a23918070", "call_id": "2025-12-03_67ac234f91fc", "call_count": 3, "all_snippets": [{"quote": "And that is part of a department that's called target discovery and that's really where we operate the most in the target discovery space", "date": "2025-12-03", "callId": "2025-12-03_67ac234f91fc", "gongUrl": "https://app.gong.io/call?id=67ac234f91fcc4fadc4a30c3ba3679789ce766d217ebe849f24e2e0a23918070", "speakerId": "3499597227668893123", "customerName": "Frank Wippich", "internalName": "Michael Long; Michelle Jang", "customerEmail": "frank.x.wippich@gsk.com", "internalEmail": "michael.long@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}, {"quote": "And then within research technologies, again, there are multiple departments. We are in a department that is called target discovery. Okay? So we are working at as the name says, it is at the level of discovering new targets for like drug design, etc.", "date": "2025-11-25", "callId": "2025-11-25_e303d69d75c7", "gongUrl": "https://app.gong.io/call?id=e303d69d75c74f8e2c50ce723f4aef9ea075ed190e86db41bf07c7e693775d69", "speakerId": "9151410085682651249", "customerName": "Muhmmad Maqbool; Muhmmad Maqbool", "internalName": "Michael Long", "customerEmail": "muhammad.x.maqbool@gsk.com; muhammad.x.maqbool@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}, {"quote": "So we're in target discovery, it's the larger group", "date": "2025-11-06", "callId": "2025-11-06_afda494ecd0c", "gongUrl": "https://app.gong.io/call?id=afda494ecd0c139472f54cfe3634d3a4d05c6d7d68456ba5e4509023706ba78b", "speakerId": "7260657465970454020", "customerName": "Sam Rowe; Sam Rowe", "internalName": "Michelle Jang", "customerEmail": "sam.m.rowe@gsk.com; sam.m.rowe@gsk.com", "internalEmail": "michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_omics_sciences_360d489b", "company": "gsk", "gong_entity": "Omics Sciences", "gong_parent": "Target Discovery", "entity_type": "team", "team_size": "70", "confidence": "high", "mention_count": 3, "snippet": "And within that department, again, there are multiple teams and we are part of the omics sciences. So, omics sciences is, almost like 60 70 people.", "snippet_date": "2025-11-25", "person_name": "Muhmmad Maqbool; Muhmmad Maqbool", "person_email": "muhammad.x.maqbool@gsk.com; muhammad.x.maqbool@gsk.com", "internal_name": "Michael Long", "internal_email": "michael.long@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=e303d69d75c74f8e2c50ce723f4aef9ea075ed190e86db41bf07c7e693775d69", "call_id": "2025-11-25_e303d69d75c7", "call_count": 3, "all_snippets": [{"quote": "And within that department, again, there are multiple teams and we are part of the omics sciences. So, omics sciences is, almost like 60 70 people.", "date": "2025-11-25", "callId": "2025-11-25_e303d69d75c7", "gongUrl": "https://app.gong.io/call?id=e303d69d75c74f8e2c50ce723f4aef9ea075ed190e86db41bf07c7e693775d69", "speakerId": "9151410085682651249", "customerName": "Muhmmad Maqbool; Muhmmad Maqbool", "internalName": "Michael Long", "customerEmail": "muhammad.x.maqbool@gsk.com; muhammad.x.maqbool@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": [{"value": "70", "snippetIndex": 0, "source": {"callDate": "2025-11-25", "customerName": "Muhmmad Maqbool; Muhmmad Maqbool"}}]}, {"quote": "we are called discovery genomics within like omics sciences department", "date": "2025-07-24", "callId": "2025-07-24_9b7e9ddca3aa", "gongUrl": "https://app.gong.io/call?id=9b7e9ddca3aadad1c5f46e2224d385615ab48148c7bba49b34e976b5480e664f", "speakerId": "1933768169700736814", "customerName": "Muhmmad Maqbool", "internalName": "Michael Long; Michelle Jang", "customerEmail": "muhammad.x.maqbool@gsk.com", "internalEmail": "michael.long@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}, {"quote": "And I'm part of a larger team that is so wibbit here, the center of excellence for omics sciences", "date": "2025-12-03", "callId": "2025-12-03_67ac234f91fc", "gongUrl": "https://app.gong.io/call?id=67ac234f91fcc4fadc4a30c3ba3679789ce766d217ebe849f24e2e0a23918070", "speakerId": "3499597227668893123", "customerName": "Frank Wippich", "internalName": "Michael Long; Michelle Jang", "customerEmail": "frank.x.wippich@gsk.com", "internalEmail": "michael.long@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_spatial_omics_6b211098", "company": "gsk", "gong_entity": "Spatial Omics", "gong_parent": "Omics Sciences", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I'm part of a team that is called spatial omics", "snippet_date": "2025-12-03", "person_name": "Frank Wippich", "person_email": "frank.x.wippich@gsk.com", "internal_name": "Michael Long; Michelle Jang", "internal_email": "michael.long@biorender.com; michelle.jang@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=67ac234f91fcc4fadc4a30c3ba3679789ce766d217ebe849f24e2e0a23918070", "call_id": "2025-12-03_67ac234f91fc", "call_count": 1, "all_snippets": [{"quote": "I'm part of a team that is called spatial omics", "date": "2025-12-03", "callId": "2025-12-03_67ac234f91fc", "gongUrl": "https://app.gong.io/call?id=67ac234f91fcc4fadc4a30c3ba3679789ce766d217ebe849f24e2e0a23918070", "speakerId": "3499597227668893123", "customerName": "Frank Wippich", "internalName": "Michael Long; Michelle Jang", "customerEmail": "frank.x.wippich@gsk.com", "internalEmail": "michael.long@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_transcriptomics_line_78fed7d5", "company": "gsk", "gong_entity": "Transcriptomics Line", "gong_parent": "Omics Sciences", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So he's in the transcriptomics line while we're in the spatialomics line", "snippet_date": "2025-12-03", "person_name": "Frank Wippich", "person_email": "frank.x.wippich@gsk.com", "internal_name": "Michael Long; Michelle Jang", "internal_email": "michael.long@biorender.com; michelle.jang@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=67ac234f91fcc4fadc4a30c3ba3679789ce766d217ebe849f24e2e0a23918070", "call_id": "2025-12-03_67ac234f91fc", "call_count": 1, "all_snippets": [{"quote": "So he's in the transcriptomics line while we're in the spatialomics line", "date": "2025-12-03", "callId": "2025-12-03_67ac234f91fc", "gongUrl": "https://app.gong.io/call?id=67ac234f91fcc4fadc4a30c3ba3679789ce766d217ebe849f24e2e0a23918070", "speakerId": "3499597227668893123", "customerName": "Frank Wippich", "internalName": "Michael Long; Michelle Jang", "customerEmail": "frank.x.wippich@gsk.com", "internalEmail": "michael.long@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_omics_and_next_generation_sequencing_team_5eeb898b", "company": "gsk", "gong_entity": "Omics and Next Generation Sequencing Team", "gong_parent": "Omics Sciences", "entity_type": "team", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "We are, so for example, I can speak for myself, we are omix and like next generation sequencing team.", "snippet_date": "2025-11-25", "person_name": "Muhmmad Maqbool; Muhmmad Maqbool", "person_email": "muhammad.x.maqbool@gsk.com; muhammad.x.maqbool@gsk.com", "internal_name": "Michael Long", "internal_email": "michael.long@biorender.com", "llm_suggested_match": {"manual_node_id": "genomic-data-analysis", "manual_node_name": "Genomic Data Analysis", "manual_node_path": "GSK Research & Development > Human Genetics & Genomics > Computational Biology > Genomic Data Analysis", "confidence": "medium", "reasoning": "Next generation sequencing and omics work would likely fall under Genomic Data Analysis team in Computational Biology"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=e303d69d75c74f8e2c50ce723f4aef9ea075ed190e86db41bf07c7e693775d69", "call_id": "2025-11-25_e303d69d75c7", "call_count": 1, "all_snippets": [{"quote": "We are, so for example, I can speak for myself, we are omix and like next generation sequencing team.", "date": "2025-11-25", "callId": "2025-11-25_e303d69d75c7", "gongUrl": "https://app.gong.io/call?id=e303d69d75c74f8e2c50ce723f4aef9ea075ed190e86db41bf07c7e693775d69", "speakerId": "9151410085682651249", "customerName": "Muhmmad Maqbool; Muhmmad Maqbool", "internalName": "Michael Long", "customerEmail": "muhammad.x.maqbool@gsk.com; muhammad.x.maqbool@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}]}, {"id": "gsk_chemical_biology_4a35d10f", "company": "gsk", "gong_entity": "Chemical Biology", "gong_parent": "Research Technologies", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 2, "snippet": "because our chemical biology, we tend to work with all the different research units", "snippet_date": "2025-11-26", "person_name": "Emma Milford", "person_email": "emma.l.milford@gsk.com", "internal_name": "Michael Long; Michelle Jang", "internal_email": "michael.long@biorender.com; michelle.jang@biorender.com", "llm_suggested_match": {"manual_node_id": "medicinal-chemistry", "manual_node_name": "Medicinal Chemistry", "manual_node_path": "GSK Research & Development > Medicinal Science & Technology > Medicinal Chemistry", "confidence": "medium", "reasoning": "Chemical Biology is closely related to Medicinal Chemistry functions, though may be a distinct department not explicitly listed"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=5acc0f3f737c04836e4c0c29df846fecc71ee2db70e6b8a026d6a7554a45fb2d", "call_id": "2025-11-26_5acc0f3f737c", "call_count": 2, "all_snippets": [{"quote": "because our chemical biology, we tend to work with all the different research units", "date": "2025-11-26", "callId": "2025-11-26_5acc0f3f737c", "gongUrl": "https://app.gong.io/call?id=5acc0f3f737c04836e4c0c29df846fecc71ee2db70e6b8a026d6a7554a45fb2d", "speakerId": "1963184571753977811", "customerName": "Emma Milford", "internalName": "Michael Long; Michelle Jang", "customerEmail": "emma.l.milford@gsk.com", "internalEmail": "michael.long@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}, {"quote": "So we work in a group called chemical biology", "date": "2025-09-03", "callId": "2025-09-03_68ce63de1c2c", "gongUrl": "https://app.gong.io/call?id=68ce63de1c2cb9aeaa4f952db53a2934a935386064b7b0142bcebb5e2ca98b52", "speakerId": "2428909520882979792", "customerName": "Chloe Tayler", "internalName": "Michelle Jang", "customerEmail": "chloe.l.tayler@gsk.com", "internalEmail": "michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_large_molecule_discovery_6bd2ee5d", "company": "gsk", "gong_entity": "Large Molecule Discovery", "gong_parent": "Research Technologies", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 2, "snippet": "I'm part of the lmr department, large molecule discovery, which is part of research tech if you've worked with them.", "snippet_date": "2025-11-05", "person_name": "Paige Fenn", "person_email": "paige.g.fenn@gsk.com", "internal_name": "Michelle Jang", "internal_email": "michelle.jang@biorender.com", "llm_suggested_match": {"manual_node_id": "biologics-discovery", "manual_node_name": "Biologics Discovery", "manual_node_path": "GSK Research & Development > Medicinal Science & Technology > Biologics Discovery", "confidence": "high", "reasoning": "Large molecules refer to biologics - exact semantic match between large molecule discovery and biologics discovery"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=17f31f16cfe5d1ef54c008abb1f341614523b8aa17670098bc16e866349710f0", "call_id": "2025-11-05_17f31f16cfe5", "call_count": 2, "all_snippets": [{"quote": "I'm part of the lmr department, large molecule discovery, which is part of research tech if you've worked with them.", "date": "2025-11-05", "callId": "2025-11-05_17f31f16cfe5", "gongUrl": "https://app.gong.io/call?id=17f31f16cfe5d1ef54c008abb1f341614523b8aa17670098bc16e866349710f0", "speakerId": "5476356920226236898", "customerName": "Paige Fenn", "internalName": "Michelle Jang", "customerEmail": "paige.g.fenn@gsk.com", "internalEmail": "michelle.jang@biorender.com", "sizeMentions": []}, {"quote": "We are part of an organization called lmr.", "date": "2025-09-12", "callId": "2025-09-12_15e032aa78b9", "gongUrl": "https://app.gong.io/call?id=15e032aa78b9280b2df0ee2f70cb87273437574fffd29e48ff4d2fa6f3b38ed4", "speakerId": "671417595239033477", "customerName": "Sandeep Talapatra", "internalName": "Michelle Jang", "customerEmail": "sandeep.k.talapatra@gsk.com", "internalEmail": "michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_medicinal_development_and_supply_6ce7def4", "company": "gsk", "gong_entity": "Medicinal Development and Supply", "gong_parent": "GSK", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 3, "snippet": "And as part of that, we're part of the bigger team which is considered MDS or like the medicine delivery and supply team.", "snippet_date": "2025-11-21", "person_name": "Shoumo Chatterjee", "person_email": "shoumo.k.chatterjee@gsk.com", "internal_name": "Michael Long; Michelle Jang", "internal_email": "michael.long@biorender.com; michelle.jang@biorender.com", "llm_suggested_match": {"manual_node_id": "cmc-pharmaceutical-sciences", "manual_node_name": "CMC & Pharmaceutical Sciences", "manual_node_path": "GSK Research & Development > CMC & Pharmaceutical Sciences", "confidence": "medium", "reasoning": "Medicine delivery and supply functions align with CMC (Chemistry, Manufacturing, and Controls) & Pharmaceutical Sciences division"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=cc86ccb27cb0758b2b88458a89f44d2c061f6d2c02fa89ac8ace762930053eea", "call_id": "2025-11-21_cc86ccb27cb0", "call_count": 3, "all_snippets": [{"quote": "And as part of that, we're part of the bigger team which is considered MDS or like the medicine delivery and supply team.", "date": "2025-11-21", "callId": "2025-11-21_cc86ccb27cb0", "gongUrl": "https://app.gong.io/call?id=cc86ccb27cb0758b2b88458a89f44d2c061f6d2c02fa89ac8ace762930053eea", "speakerId": "1842545739947945819", "customerName": "Shoumo Chatterjee", "internalName": "Michael Long; Michelle Jang", "customerEmail": "shoumo.k.chatterjee@gsk.com", "internalEmail": "michael.long@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}, {"quote": "I had notes that BPR was in MDS which is in DSD", "date": "2024-10-16", "callId": "2024-10-16_2ae461fd1f94", "gongUrl": "https://app.gong.io/call?id=2ae461fd1f9435b0e82fa7d983b1b478de404c1408025443966c55b79e250e71", "speakerId": "2670001076495420302", "customerName": "Shoumo Chatterjee", "internalName": "Adrian Rizos; Jacqueline McCoskey", "customerEmail": "shoumo.k.chatterjee@gsk.com; holly.l.corrigall@gsk.com", "internalEmail": "adrian.rizos@biorender.com; jacqueline@biorender.com", "sizeMentions": []}, {"quote": "that moved from vaccines RD into a different organization called medicinal development and supply MDS. Okay? So, which\u2026 so we are still supporting as a lab operation, vaccines RD, lab operations. But MDS is like much bigger organization. They have, you know, sites all over the world, even in Pennsylvania in us and all.", "date": "2025-12-10", "callId": "2025-12-10_f373376430fd", "gongUrl": "https://app.gong.io/call?id=f373376430fd71162bc0807224467f46155a47294994371387529a99ddcbf5f0", "speakerId": "5797852991557821441", "customerName": "Prashant Waiker", "internalName": "Brian Sedlacek; Michael Long", "customerEmail": "prashant.x.waiker@gsk.com", "internalEmail": "brian.sedlacek@biorender.com; michael.long@biorender.com", "sizeMentions": []}]}, {"id": "gsk_dsd_c8d1a4c0", "company": "gsk", "gong_entity": "DSD", "gong_parent": "GSK", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 2, "snippet": "So the MBS team, which is part of DSD", "snippet_date": "2024-10-17", "person_name": "Tessa Lincoln", "person_email": "ambertessa.c.lincoln@gsk.com", "internal_name": "Adrian Rizos; Madison Knock; Mark Erbele", "internal_email": "adrian.rizos@biorender.com; madison@biorender.com; mark@biorender.com", "llm_suggested_match": {"manual_node_id": "drug-substance-development", "manual_node_name": "Drug Substance Development", "manual_node_path": "GSK Research & Development > CMC & Pharmaceutical Sciences > Small Molecule CMC > Drug Substance Development", "confidence": "medium", "reasoning": "DSD likely stands for Drug Substance Development, which is a team in the CMC organization. The context mentions MBS team being part of DSD, which aligns with pharmaceutical development structure."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=64ecd023c8da4c083bfeb99a73c265b3939df52e6a304d60ff5bc20c2c5a8586", "call_id": "2024-10-17_64ecd023c8da", "call_count": 2, "all_snippets": [{"quote": "So the MBS team, which is part of DSD", "date": "2024-10-17", "callId": "2024-10-17_64ecd023c8da", "gongUrl": "https://app.gong.io/call?id=64ecd023c8da4c083bfeb99a73c265b3939df52e6a304d60ff5bc20c2c5a8586", "speakerId": "1742008335089192812", "customerName": "Tessa Lincoln", "internalName": "Adrian Rizos; Madison Knock; Mark Erbele", "customerEmail": "ambertessa.c.lincoln@gsk.com", "internalEmail": "adrian.rizos@biorender.com; madison@biorender.com; mark@biorender.com", "sizeMentions": []}, {"quote": "I had notes that BPR was in MDS which is in DSD", "date": "2024-10-16", "callId": "2024-10-16_2ae461fd1f94", "gongUrl": "https://app.gong.io/call?id=2ae461fd1f9435b0e82fa7d983b1b478de404c1408025443966c55b79e250e71", "speakerId": "2670001076495420302", "customerName": "Shoumo Chatterjee", "internalName": "Adrian Rizos; Jacqueline McCoskey", "customerEmail": "shoumo.k.chatterjee@gsk.com; holly.l.corrigall@gsk.com", "internalEmail": "adrian.rizos@biorender.com; jacqueline@biorender.com", "sizeMentions": []}]}, {"id": "gsk_pharma_95b0d1bf", "company": "gsk", "gong_entity": "Pharma", "gong_parent": "GSK", "entity_type": "business_unit", "team_size": "100,000", "confidence": "high", "mention_count": 2, "snippet": "pharma one, 100,000 people", "snippet_date": "2023-08-18", "person_name": "Carsten Walter; Carsten Walter", "person_email": "carsten.walter@gsk.com; carsten.walter@gsk.com", "internal_name": "Rich Lee; Sydney Burniston", "internal_email": "rich@biorender.com; sydney.b@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=7ac464a150ea06da02589cb4322e052cf56fd3f96fd10d29e29575aac5bcf4d5", "call_id": "2023-08-18_7ac464a150ea", "call_count": 2, "all_snippets": [{"quote": "pharma one, 100,000 people", "date": "2023-08-18", "callId": "2023-08-18_7ac464a150ea", "gongUrl": "https://app.gong.io/call?id=7ac464a150ea06da02589cb4322e052cf56fd3f96fd10d29e29575aac5bcf4d5", "speakerId": "756384962136640331", "customerName": "Carsten Walter; Carsten Walter", "internalName": "Rich Lee; Sydney Burniston", "customerEmail": "carsten.walter@gsk.com; carsten.walter@gsk.com", "internalEmail": "rich@biorender.com; sydney.b@biorender.com", "sizeMentions": [{"value": "100,000", "snippetIndex": 0, "source": {"callDate": "2023-08-18", "customerName": "Carsten Walter; Carsten Walter"}}]}, {"quote": "Yeah, that's up that's pharma", "date": "2023-07-11", "callId": "2023-07-11_602faffb183e", "gongUrl": "https://app.gong.io/call?id=602faffb183e4e4824d3bf1ab28ee115412c31e230677d7ee034801eb4a6fa8c", "speakerId": "5882762078687495157", "customerName": "Matthew Brecher", "internalName": "Rich Lee", "customerEmail": "matthew.b.brecher@gsk.com", "internalEmail": "rich@biorender.com", "sizeMentions": []}]}, {"id": "gsk_viv_healthcare_806ec1f8", "company": "gsk", "gong_entity": "Viv Healthcare", "gong_parent": "GSK", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "we have an active license with Viv healthcare early discovery", "snippet_date": "2025-12-10", "person_name": "Prashant Waiker", "person_email": "prashant.x.waiker@gsk.com", "internal_name": "Michael Long", "internal_email": "michael.long@biorender.com", "llm_suggested_match": {"manual_node_id": "viiv-healthcare-rd", "manual_node_name": "ViiV Healthcare R&D (HIV)", "manual_node_path": "GSK Research & Development > ViiV Healthcare R&D (HIV)", "confidence": "high", "reasoning": "Clear match to ViiV Healthcare R&D division. 'Viv' is a close variant of 'ViiV' and the context about licensing aligns with ViiV's HIV focus."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=ae3f1030fe9cccfb924b5abc51e561dbaef48fa0d6fcc325622f5a7cb34d8013", "call_id": "2025-12-10_ae3f1030fe9c", "call_count": 1, "all_snippets": [{"quote": "we have an active license with Viv healthcare early discovery", "date": "2025-12-10", "callId": "2025-12-10_ae3f1030fe9c", "gongUrl": "https://app.gong.io/call?id=ae3f1030fe9cccfb924b5abc51e561dbaef48fa0d6fcc325622f5a7cb34d8013", "speakerId": "4520796774596570991", "customerName": "Prashant Waiker", "internalName": "Michael Long", "customerEmail": "prashant.x.waiker@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}]}, {"id": "gsk_siena_4a3ba1b8", "company": "gsk", "gong_entity": "Siena", "gong_parent": "GSK R&D", "entity_type": "site", "team_size": null, "confidence": "high", "mention_count": 6, "snippet": "gbga that is vaccine from global health that are in Siena", "snippet_date": "2025-10-16", "person_name": "Celia Presmanes; Sara Leal", "person_email": "celia.x.presmanes@gsk.com; sara.x.leal@gsk.com", "internal_name": "Michael Long", "internal_email": "michael.long@biorender.com", "llm_suggested_match": {"manual_node_id": "siena-italy", "manual_node_name": "Siena, Italy (Vaccines R&D Hub)", "manual_node_path": "GSK Research & Development > Global R&D Sites > Siena, Italy (Vaccines R&D Hub)", "confidence": "high", "reasoning": "Exact match to the Siena, Italy site. Context mentions vaccines and global health, which aligns with Siena being a Vaccines R&D Hub."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=aa822b21b950bd1adf88a50373d844c2ffee7df499714e180d14d5e519dea999", "call_id": "2025-10-16_aa822b21b950", "call_count": 6, "all_snippets": [{"quote": "gbga that is vaccine from global health that are in Siena", "date": "2025-10-16", "callId": "2025-10-16_aa822b21b950", "gongUrl": "https://app.gong.io/call?id=aa822b21b950bd1adf88a50373d844c2ffee7df499714e180d14d5e519dea999", "speakerId": "9221547802177080151", "customerName": "Celia Presmanes; Sara Leal", "internalName": "Michael Long", "customerEmail": "celia.x.presmanes@gsk.com; sara.x.leal@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}, {"quote": "we have sites in Siena, Italy, Belgium and us", "date": "2025-10-14", "callId": "2025-10-14_8fa4f3232c29", "gongUrl": "https://app.gong.io/call?id=8fa4f3232c29fb999967ce828dd3d90d405fbb20e3e24fdfafdacac2bed9aee1", "speakerId": "307459476772530615", "customerName": "Gunasundari Veerapandian; Prashant Waiker; Raffaele Tiezzi", "internalName": "Michael Long", "customerEmail": "gunasundari.x.veerapandian@gsk.com; prashant.x.waiker@gsk.com; raffaele.x.tiezzi@gsk.com; john.x.jonesjr@gsk.com; fabrice.x.godart@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}, {"quote": "Fyi, they do purchasing a little bit differently in Siena.", "date": "2025-04-07", "callId": "2025-04-07_1c3ef51efdf0", "gongUrl": "https://app.gong.io/call?id=1c3ef51efdf0dde1ed6ba5058e8c1e6e9e82525d2d5efb8969b5477bbe679e56", "speakerId": "2506035245485518040", "customerName": "Tessa Lincoln", "internalName": "Adrian Rizos; Adrian Rizos; Madison Knock; Sydney Burniston", "customerEmail": "ambertessa.c.lincoln@gsk.com", "internalEmail": "adrian.rizos@biorender.com; adrian.rizos@biorender.com; madison@biorender.com; sydney.b@biorender.com", "sizeMentions": []}, {"quote": "We are in Siena", "date": "2024-12-19", "callId": "2024-12-19_3eab6711ee74", "gongUrl": "https://app.gong.io/call?id=3eab6711ee749bdab92955a7d6f83f6c2b1f967bab5572b3c0e664e32f1ef1a8", "speakerId": "7040791890700399135", "customerName": "Rossella Cuffaro; Rossella Cuffaro", "internalName": "Adrian Rizos", "customerEmail": "rossella.x.cuffaro@gsk.com; rossella.x.cuffaro@gsk.com", "internalEmail": "adrian.rizos@biorender.com", "sizeMentions": []}, {"quote": "But my understanding is that you already surveyed everybody within, in the different departments within seetta in terms of who wants a runner.", "date": "2023-11-09", "callId": "2023-11-09_b35fc13ea87e", "gongUrl": "https://app.gong.io/call?id=b35fc13ea87e4414b10dbcd88212cee9053ac02917f7331308adf409270911ba", "speakerId": "2114351837945322941", "customerName": "Raffaele Tiezzi", "internalName": "Rich Lee", "customerEmail": "raffaele.x.tiezzi@gsk.com", "internalEmail": "rich@biorender.com", "sizeMentions": []}, {"quote": "Yeah, that's our site in seannaea", "date": "2023-07-11", "callId": "2023-07-11_602faffb183e", "gongUrl": "https://app.gong.io/call?id=602faffb183e4e4824d3bf1ab28ee115412c31e230677d7ee034801eb4a6fa8c", "speakerId": "5882762078687495157", "customerName": "Matthew Brecher", "internalName": "Rich Lee", "customerEmail": "matthew.b.brecher@gsk.com", "internalEmail": "rich@biorender.com", "sizeMentions": []}]}, {"id": "gsk_gsk_belgium_477b0848", "company": "gsk", "gong_entity": "GSK Belgium", "gong_parent": "GSK R&D", "entity_type": "site", "team_size": null, "confidence": "high", "mention_count": 6, "snippet": "He's the one that manages all the licenses in GSK Belgium.", "snippet_date": "2024-02-29", "person_name": "Shoumo Chatterjee", "person_email": "shoumo.k.chatterjee@gsk.com", "internal_name": "Rich Lee", "internal_email": "rich@biorender.com", "llm_suggested_match": {"manual_node_id": "rixensart-belgium", "manual_node_name": "Rixensart & Wavre, Belgium (Vaccines R&D Hub)", "manual_node_path": "GSK Research & Development > Global R&D Sites > Rixensart & Wavre, Belgium (Vaccines R&D Hub)", "confidence": "high", "reasoning": "GSK Belgium refers to the Belgian R&D operations, which are located in Rixensart & Wavre. This is the primary GSK R&D site in Belgium."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=b2583ca4d64004877d02c470a8a2e34d6a4d43940ba602985ab8aa7a3510525a", "call_id": "2024-02-29_b2583ca4d640", "call_count": 6, "all_snippets": [{"quote": "He's the one that manages all the licenses in GSK Belgium.", "date": "2024-02-29", "callId": "2024-02-29_b2583ca4d640", "gongUrl": "https://app.gong.io/call?id=b2583ca4d64004877d02c470a8a2e34d6a4d43940ba602985ab8aa7a3510525a", "speakerId": "7253253695163929270", "customerName": "Shoumo Chatterjee", "internalName": "Rich Lee", "customerEmail": "shoumo.k.chatterjee@gsk.com", "internalEmail": "rich@biorender.com", "sizeMentions": []}, {"quote": "I can actually connect you with Carlston on the GS K, Belgium side", "date": "2023-12-14", "callId": "2023-12-14_b1ffc24e479c", "gongUrl": "https://app.gong.io/call?id=b1ffc24e479ce7233193fda5e74985a0cab248e19b2a7ff75b51c02db505a70b", "speakerId": "532464771571778493", "customerName": "Breda Rogulj; Fabiana Spensieri; Raffaele Tiezzi", "internalName": "Rich Lee; Sydney Burniston", "customerEmail": "breda.x.rogulj@gsk.com; fabiana.x.spensieri@gsk.com; raffaele.x.tiezzi@gsk.com", "internalEmail": "rich@biorender.com; sydney.b@biorender.com", "sizeMentions": []}, {"quote": "they're going to be at GSK Belgium on December eleventh and twelfth", "date": "2023-11-17", "callId": "2023-11-17_3fae6fe14ca4", "gongUrl": "https://app.gong.io/call?id=3fae6fe14ca453066aebe2b820d5d5855be5cbf1a95ce56180783325ef29ee7f", "speakerId": "3356203089684948233", "customerName": "Raffaele Tiezzi", "internalName": "Rich Lee", "customerEmail": "raffaele.x.tiezzi@gsk.com", "internalEmail": "rich@biorender.com", "sizeMentions": []}, {"quote": "And then we also work with GS K, Belgium, right? Just so that, you know, Belgium has, I think about 100 licenses as well.", "date": "2023-11-09", "callId": "2023-11-09_b35fc13ea87e", "gongUrl": "https://app.gong.io/call?id=b35fc13ea87e4414b10dbcd88212cee9053ac02917f7331308adf409270911ba", "speakerId": "2114351837945322941", "customerName": "Raffaele Tiezzi", "internalName": "Rich Lee", "customerEmail": "raffaele.x.tiezzi@gsk.com", "internalEmail": "rich@biorender.com", "sizeMentions": []}, {"quote": "we have sites in Siena, Italy, Belgium and us", "date": "2025-10-14", "callId": "2025-10-14_8fa4f3232c29", "gongUrl": "https://app.gong.io/call?id=8fa4f3232c29fb999967ce828dd3d90d405fbb20e3e24fdfafdacac2bed9aee1", "speakerId": "307459476772530615", "customerName": "Gunasundari Veerapandian; Prashant Waiker; Raffaele Tiezzi", "internalName": "Michael Long", "customerEmail": "gunasundari.x.veerapandian@gsk.com; prashant.x.waiker@gsk.com; raffaele.x.tiezzi@gsk.com; john.x.jonesjr@gsk.com; fabrice.x.godart@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}, {"quote": "another other one is belgium", "date": "2024-07-16", "callId": "2024-07-16_ffeb57b81c8e", "gongUrl": "https://app.gong.io/call?id=ffeb57b81c8e39ea8fde253ea726ecab2169ec61ffaa044a4f35652278e75751", "speakerId": "2425925482248274804", "customerName": "Mark Richardson; Mark Richardson; Mark Richardson; Zakaria Mahmud", "internalName": "Jacqueline McCoskey", "customerEmail": "mark.8.richardson@gsk.com; mark.8.richardson@gsk.com; mark.8.richardson@gsk.com; zakaria.x.mahmud@gsk.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": []}]}, {"id": "gsk_upper_providence_21b7bbfa", "company": "gsk", "gong_entity": "Upper Providence", "gong_parent": "GSK R&D", "entity_type": "site", "team_size": "10", "confidence": "high", "mention_count": 6, "snippet": "maybe a little bit users in upper providence", "snippet_date": "2025-10-14", "person_name": "Gunasundari Veerapandian; Prashant Waiker; Raffaele Tiezzi", "person_email": "gunasundari.x.veerapandian@gsk.com; prashant.x.waiker@gsk.com; raffaele.x.tiezzi@gsk.com; john.x.jonesjr@gsk.com; fabrice.x.godart@gsk.com", "internal_name": "Michael Long", "internal_email": "michael.long@biorender.com", "llm_suggested_match": {"manual_node_id": "upper-providence-pa", "manual_node_name": "Upper Providence, PA, USA (R&D Hub)", "manual_node_path": "GSK Research & Development > Global R&D Sites > Upper Providence, PA, USA (R&D Hub)", "confidence": "high", "reasoning": "Exact match to the Upper Providence, PA site in the manual org chart."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=8fa4f3232c29fb999967ce828dd3d90d405fbb20e3e24fdfafdacac2bed9aee1", "call_id": "2025-10-14_8fa4f3232c29", "call_count": 6, "all_snippets": [{"quote": "maybe a little bit users in upper providence", "date": "2025-10-14", "callId": "2025-10-14_8fa4f3232c29", "gongUrl": "https://app.gong.io/call?id=8fa4f3232c29fb999967ce828dd3d90d405fbb20e3e24fdfafdacac2bed9aee1", "speakerId": "307459476772530615", "customerName": "Gunasundari Veerapandian; Prashant Waiker; Raffaele Tiezzi", "internalName": "Michael Long", "customerEmail": "gunasundari.x.veerapandian@gsk.com; prashant.x.waiker@gsk.com; raffaele.x.tiezzi@gsk.com; john.x.jonesjr@gsk.com; fabrice.x.godart@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}, {"quote": "So our upper providence site is the main RD site in USA", "date": "2025-09-18", "callId": "2025-09-18_cdb277517a69", "gongUrl": "https://app.gong.io/call?id=cdb277517a69d645ec2adf455e162352afec003646a9d73d6f0d037a5a3b991f", "speakerId": "4157251372340494941", "customerName": "Avijit Ray", "internalName": "Michelle Jang; Ross Proudfoot", "customerEmail": "avijit.r.ray@gsk.com", "internalEmail": "michelle.jang@biorender.com; ross@biorender.com", "sizeMentions": []}, {"quote": "So, we have about 10 people in upper providence in us.", "date": "2025-07-24", "callId": "2025-07-24_9b7e9ddca3aa", "gongUrl": "https://app.gong.io/call?id=9b7e9ddca3aadad1c5f46e2224d385615ab48148c7bba49b34e976b5480e664f", "speakerId": "1933768169700736814", "customerName": "Muhmmad Maqbool", "internalName": "Michael Long; Michelle Jang", "customerEmail": "muhammad.x.maqbool@gsk.com", "internalEmail": "michael.long@biorender.com; michelle.jang@biorender.com", "sizeMentions": [{"value": "10", "snippetIndex": 2, "source": {"callDate": "2025-07-24", "customerName": "Muhmmad Maqbool"}}]}, {"quote": "I'm in the upper providence site", "date": "2025-10-02", "callId": "2025-10-02_d8834ee1bf4d", "gongUrl": "https://app.gong.io/call?id=d8834ee1bf4dbbcf204921eedf6383a7075ebea2af71b19c14c6a0ce69809cd5", "speakerId": "6962253166522553880", "customerName": "Emily Cook; Michael Bond; Shane O'Brien", "internalName": "Michael Long", "customerEmail": "emily.k.cook@gsk.com; michael.j.bond@gsk.com; shane.w.obrien@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}, {"quote": "I was actually on site there at the upper providence site for two days", "date": "2023-11-08", "callId": "2023-11-08_32901e504b4b", "gongUrl": "https://app.gong.io/call?id=32901e504b4b4280296134091d8a2c98e4d720452805d63826edfbbaef8f402c", "speakerId": "5258701633084091090", "customerName": "Kashappa-Goud Desai", "internalName": "Rich Lee", "customerEmail": "kashappa-goud.x.desai@gsk.com", "internalEmail": "rich@biorender.com", "sizeMentions": []}, {"quote": "So he's an upper providence site just like you.", "date": "2023-07-21", "callId": "2023-07-21_909f63b4232d", "gongUrl": "https://app.gong.io/call?id=909f63b4232d6cedca4a8bbfdb3ec14d40dd8cc1280e0ede31a30e9de745ddbd", "speakerId": "1782946702512217361", "customerName": "Sissy Easo-Joseph; Sissy Easo-Joseph", "internalName": "Hayley Lau; Richard Lee", "customerEmail": "sissy.x.easo-joseph@gsk.com; sissy.x.easo-joseph@gsk.com", "internalEmail": "hayley@biorender.com; rich@biorender.com", "sizeMentions": []}]}, {"id": "gsk_stevenage_15671df5", "company": "gsk", "gong_entity": "Stevenage", "gong_parent": "GSK R&D", "entity_type": "site", "team_size": null, "confidence": "high", "mention_count": 3, "snippet": "I'm at the stevenage location now, stevenage?", "snippet_date": "2025-11-21", "person_name": "Shoumo Chatterjee", "person_email": "shoumo.k.chatterjee@gsk.com", "internal_name": "Michael Long; Michelle Jang", "internal_email": "michael.long@biorender.com; michelle.jang@biorender.com", "llm_suggested_match": {"manual_node_id": "stevenage-uk", "manual_node_name": "Stevenage, UK (Global R&D Hub)", "manual_node_path": "GSK Research & Development > Global R&D Sites > Stevenage, UK (Global R&D Hub)", "confidence": "high", "reasoning": "Exact match to the Stevenage, UK site, which is GSK's Global R&D Hub."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=cc86ccb27cb0758b2b88458a89f44d2c061f6d2c02fa89ac8ace762930053eea", "call_id": "2025-11-21_cc86ccb27cb0", "call_count": 3, "all_snippets": [{"quote": "I'm at the stevenage location now, stevenage?", "date": "2025-11-21", "callId": "2025-11-21_cc86ccb27cb0", "gongUrl": "https://app.gong.io/call?id=cc86ccb27cb0758b2b88458a89f44d2c061f6d2c02fa89ac8ace762930053eea", "speakerId": "1842545739947945819", "customerName": "Shoumo Chatterjee", "internalName": "Michael Long; Michelle Jang", "customerEmail": "shoumo.k.chatterjee@gsk.com", "internalEmail": "michael.long@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}, {"quote": "So, I'm based in stevenage in the UK. It's a GSK RD site.", "date": "2025-09-17", "callId": "2025-09-17_236090118564", "gongUrl": "https://app.gong.io/call?id=2360901185648fdba0e5a4273010b74cec0ad73754ddd7100e4791cf2a9be46b", "speakerId": "7124197286904339622", "customerName": "Rajesh Sundaresan; Rajesh Sundaresan", "internalName": "Jacqueline McCoskey; Michelle Jang", "customerEmail": "rajesh.a.sundaresan@gsk.com; rajesh.a.sundaresan@gsk.com", "internalEmail": "jacqueline@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}, {"quote": "So, upper providence, stevenage and heidelberg, there are some smaller like more specific RD sites", "date": "2025-07-24", "callId": "2025-07-24_9b7e9ddca3aa", "gongUrl": "https://app.gong.io/call?id=9b7e9ddca3aadad1c5f46e2224d385615ab48148c7bba49b34e976b5480e664f", "speakerId": "1933768169700736814", "customerName": "Muhmmad Maqbool", "internalName": "Michael Long; Michelle Jang", "customerEmail": "muhammad.x.maqbool@gsk.com", "internalEmail": "michael.long@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_rockville_1a08b156", "company": "gsk", "gong_entity": "Rockville", "gong_parent": "GSK R&D", "entity_type": "site", "team_size": null, "confidence": "high", "mention_count": 3, "snippet": "rockville, three sites up in Boston", "snippet_date": "2025-10-14", "person_name": "Gunasundari Veerapandian; Prashant Waiker; Raffaele Tiezzi", "person_email": "gunasundari.x.veerapandian@gsk.com; prashant.x.waiker@gsk.com; raffaele.x.tiezzi@gsk.com; john.x.jonesjr@gsk.com; fabrice.x.godart@gsk.com", "internal_name": "Michael Long", "internal_email": "michael.long@biorender.com", "llm_suggested_match": {"manual_node_id": "rockville-md", "manual_node_name": "Rockville, MD, USA (Vaccines R&D Center)", "manual_node_path": "GSK Research & Development > Global R&D Sites > Rockville, MD, USA (Vaccines R&D Center)", "confidence": "high", "reasoning": "Exact match to the Rockville, MD site in the manual org chart."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=8fa4f3232c29fb999967ce828dd3d90d405fbb20e3e24fdfafdacac2bed9aee1", "call_id": "2025-10-14_8fa4f3232c29", "call_count": 3, "all_snippets": [{"quote": "rockville, three sites up in Boston", "date": "2025-10-14", "callId": "2025-10-14_8fa4f3232c29", "gongUrl": "https://app.gong.io/call?id=8fa4f3232c29fb999967ce828dd3d90d405fbb20e3e24fdfafdacac2bed9aee1", "speakerId": "307459476772530615", "customerName": "Gunasundari Veerapandian; Prashant Waiker; Raffaele Tiezzi", "internalName": "Michael Long", "customerEmail": "gunasundari.x.veerapandian@gsk.com; prashant.x.waiker@gsk.com; raffaele.x.tiezzi@gsk.com; john.x.jonesjr@gsk.com; fabrice.x.godart@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}, {"quote": "One is in rockville, Maryland", "date": "2024-07-16", "callId": "2024-07-16_ffeb57b81c8e", "gongUrl": "https://app.gong.io/call?id=ffeb57b81c8e39ea8fde253ea726ecab2169ec61ffaa044a4f35652278e75751", "speakerId": "2425925482248274804", "customerName": "Mark Richardson; Mark Richardson; Mark Richardson; Zakaria Mahmud", "internalName": "Jacqueline McCoskey", "customerEmail": "mark.8.richardson@gsk.com; mark.8.richardson@gsk.com; mark.8.richardson@gsk.com; zakaria.x.mahmud@gsk.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": []}, {"quote": "last year, for example, I helped rockville and site with 30 or so licenses.", "date": "2023-07-21", "callId": "2023-07-21_909f63b4232d", "gongUrl": "https://app.gong.io/call?id=909f63b4232d6cedca4a8bbfdb3ec14d40dd8cc1280e0ede31a30e9de745ddbd", "speakerId": "1782946702512217361", "customerName": "Sissy Easo-Joseph; Sissy Easo-Joseph", "internalName": "Hayley Lau; Richard Lee", "customerEmail": "sissy.x.easo-joseph@gsk.com; sissy.x.easo-joseph@gsk.com", "internalEmail": "hayley@biorender.com; rich@biorender.com", "sizeMentions": []}]}, {"id": "gsk_oligosciences_team_e344deed", "company": "gsk", "gong_entity": "Oligosciences Team", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": "10", "confidence": "high", "mention_count": 3, "snippet": "teams of five within the oligosciences team in the cambridge area, in the Boston area.", "snippet_date": "2025-12-11", "person_name": "Sara Porfirio", "person_email": "sara.p.porfirio@gsk.com", "internal_name": "Michael Long", "internal_email": "michael.long@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=efe1b4376fba6df38a4e08d00a739daec4168474cfd5f64eec9f1e3c8d9220b9", "call_id": "2025-12-11_efe1b4376fba", "call_count": 3, "all_snippets": [{"quote": "teams of five within the oligosciences team in the cambridge area, in the Boston area.", "date": "2025-12-11", "callId": "2025-12-11_efe1b4376fba", "gongUrl": "https://app.gong.io/call?id=efe1b4376fba6df38a4e08d00a739daec4168474cfd5f64eec9f1e3c8d9220b9", "speakerId": "5015271624001198436", "customerName": "Sara Porfirio", "internalName": "Michael Long", "customerEmail": "sara.p.porfirio@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}, {"quote": "But what we've been doing is we've had conversations of teams of five or 10 like the oligosciences team or the oncology team in the UK", "date": "2025-11-25", "callId": "2025-11-25_e303d69d75c7", "gongUrl": "https://app.gong.io/call?id=e303d69d75c74f8e2c50ce723f4aef9ea075ed190e86db41bf07c7e693775d69", "speakerId": "8213524192969324956", "customerName": "Muhmmad Maqbool; Muhmmad Maqbool", "internalName": "Michael Long", "customerEmail": "muhammad.x.maqbool@gsk.com; muhammad.x.maqbool@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}, {"quote": "we're part of an oligosciences team that has biology, chemistry, and bioinformatics", "date": "2025-10-03", "callId": "2025-10-03_d2bd514f48f5", "gongUrl": "https://app.gong.io/call?id=d2bd514f48f515072d570d5f538c52ae788f6e547a64618266eea85d840cfc8c", "speakerId": "8622183118565525883", "customerName": "Amy Lancaster; Amy Lancaster", "internalName": "Michael Long; Michelle Jang", "customerEmail": "amy.b.lancaster@gsk.com; amy.b.lancaster@gsk.com", "internalEmail": "michael.long@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_immunology_66cd4f8d", "company": "gsk", "gong_entity": "Immunology", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 2, "snippet": "I know that the, some people in like immunology, I believe that have some current licenses.", "snippet_date": "2024-07-23", "person_name": "Jenna Sumey; Jenna Sumey", "person_email": "jenna.l.sumey@gsk.com; jenna.l.sumey@gsk.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": {"manual_node_id": "respiratory-immunology-research", "manual_node_name": "Respiratory, Immunology & Inflammation Research", "manual_node_path": "GSK Research & Development > Research > Respiratory, Immunology & Inflammation Research", "confidence": "medium", "reasoning": "Partial match - Immunology is part of the Respiratory, Immunology & Inflammation Research therapeutic area. The entity likely refers to immunology work within this broader organization."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=03bd29b420ab75e49adf9c37efc4d105d224830df1fd2436eeb67477983e4b0c", "call_id": "2024-07-23_03bd29b420ab", "call_count": 2, "all_snippets": [{"quote": "I know that the, some people in like immunology, I believe that have some current licenses.", "date": "2024-07-23", "callId": "2024-07-23_03bd29b420ab", "gongUrl": "https://app.gong.io/call?id=03bd29b420ab75e49adf9c37efc4d105d224830df1fd2436eeb67477983e4b0c", "speakerId": "1661437798478689558", "customerName": "Jenna Sumey; Jenna Sumey", "internalName": "Jacqueline McCoskey", "customerEmail": "jenna.l.sumey@gsk.com; jenna.l.sumey@gsk.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": []}, {"quote": "So you let me know because I know eminology has a number of licenses within collegeville as well.", "date": "2024-04-25", "callId": "2024-04-25_6a30c2eefde4", "gongUrl": "https://app.gong.io/call?id=6a30c2eefde4003f77491275439af7a786bf89d9610dd3927df21960c84de9e6", "speakerId": "4150910960750169108", "customerName": "David Tattersall", "internalName": "Rich Lee", "customerEmail": "david.d.tattersall@gsk.com", "internalEmail": "rich@biorender.com", "sizeMentions": []}]}, {"id": "gsk_discovery_medicine_a0470d11", "company": "gsk", "gong_entity": "Discovery Medicine", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "medium", "mention_count": 2, "snippet": "And then I think he's going to speak to his SVP of like discovery medicine to see if they're interested as well.", "snippet_date": "2023-06-29", "person_name": "Karanbir Pahil", "person_email": "karanbir.s.pahil@gsk.com", "internal_name": "Hayley Lau; Richard Lee", "internal_email": "hayley@biorender.com; rich@biorender.com", "llm_suggested_match": {"manual_node_id": "translational-medicine", "manual_node_name": "Translational Medicine", "manual_node_path": "GSK Research & Development > Development > Translational Medicine", "confidence": "medium", "reasoning": "Discovery Medicine likely refers to translational medicine activities that bridge discovery and development phases"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=c53828a1ea9ea13b52e16a4647afb62d5db5a4268832101b27b731c8fdfb8c1d", "call_id": "2023-06-29_c53828a1ea9e", "call_count": 2, "all_snippets": [{"quote": "And then I think he's going to speak to his SVP of like discovery medicine to see if they're interested as well.", "date": "2023-06-29", "callId": "2023-06-29_c53828a1ea9e", "gongUrl": "https://app.gong.io/call?id=c53828a1ea9ea13b52e16a4647afb62d5db5a4268832101b27b731c8fdfb8c1d", "speakerId": "6566323918198523305", "customerName": "Karanbir Pahil", "internalName": "Hayley Lau; Richard Lee", "customerEmail": "karanbir.s.pahil@gsk.com", "internalEmail": "hayley@biorender.com; rich@biorender.com", "sizeMentions": []}, {"quote": "The, the discovery medicine, the person is on the senior VP of discovery medicine or clinical bio market group.", "date": "2023-06-27", "callId": "2023-06-27_f8c29de04cc3", "gongUrl": "https://app.gong.io/call?id=f8c29de04cc378bc43bcbcb80fe22c6db16637f3f6a2a97dac990864f2b61df2", "speakerId": "3217337874125958899", "customerName": "Sunil Nagpal", "internalName": "Richard Lee", "customerEmail": "sunil.x.nagpal@gsk.com", "internalEmail": "rich@biorender.com", "sizeMentions": []}]}, {"id": "gsk_bdsd_team_48d5fe84", "company": "gsk", "gong_entity": "BDSD Team", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": "150", "confidence": "high", "mention_count": 2, "snippet": "Or for example, for this bdsd team, they are, I think about 150 scientists.", "snippet_date": "2025-12-10", "person_name": "Prashant Waiker", "person_email": "prashant.x.waiker@gsk.com", "internal_name": "Brian Sedlacek; Michael Long", "internal_email": "brian.sedlacek@biorender.com; michael.long@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=f373376430fd71162bc0807224467f46155a47294994371387529a99ddcbf5f0", "call_id": "2025-12-10_f373376430fd", "call_count": 2, "all_snippets": [{"quote": "Or for example, for this bdsd team, they are, I think about 150 scientists.", "date": "2025-12-10", "callId": "2025-12-10_f373376430fd", "gongUrl": "https://app.gong.io/call?id=f373376430fd71162bc0807224467f46155a47294994371387529a99ddcbf5f0", "speakerId": "1045073310794266187", "customerName": "Prashant Waiker", "internalName": "Brian Sedlacek; Michael Long", "customerEmail": "prashant.x.waiker@gsk.com", "internalEmail": "brian.sedlacek@biorender.com; michael.long@biorender.com", "sizeMentions": [{"value": "150", "snippetIndex": 0, "source": {"callDate": "2025-12-10", "customerName": "Prashant Waiker"}}]}, {"quote": "The other option that we have is we've been working with like the bdsd team who's about a group of 150.", "date": "2025-11-25", "callId": "2025-11-25_e303d69d75c7", "gongUrl": "https://app.gong.io/call?id=e303d69d75c74f8e2c50ce723f4aef9ea075ed190e86db41bf07c7e693775d69", "speakerId": "8213524192969324956", "customerName": "Muhmmad Maqbool; Muhmmad Maqbool", "internalName": "Michael Long", "customerEmail": "muhammad.x.maqbool@gsk.com; muhammad.x.maqbool@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": [{"value": "150", "snippetIndex": 1, "source": {"callDate": "2025-11-25", "customerName": "Muhmmad Maqbool; Muhmmad Maqbool"}}]}]}, {"id": "gsk_lsa_team_0089bd34", "company": "gsk", "gong_entity": "LSA Team", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 2, "snippet": "you didn't purchase anything through the lsa team, right?", "snippet_date": "2025-11-06", "person_name": "Cory Knudson", "person_email": "cory.j.knudson@gsk.com", "internal_name": "Michael Long", "internal_email": "michael.long@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=01d59ee11ca984be9b6180324e480038d1634ae2dbbfd8679ed606b2e37944d0", "call_id": "2025-11-06_01d59ee11ca9", "call_count": 2, "all_snippets": [{"quote": "you didn't purchase anything through the lsa team, right?", "date": "2025-11-06", "callId": "2025-11-06_01d59ee11ca9", "gongUrl": "https://app.gong.io/call?id=01d59ee11ca984be9b6180324e480038d1634ae2dbbfd8679ed606b2e37944d0", "speakerId": "9139491820263027725", "customerName": "Cory Knudson", "internalName": "Michael Long", "customerEmail": "cory.j.knudson@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}, {"quote": "I know the lsa team is one of them that have had access for a couple years at this point", "date": "2025-11-06", "callId": "2025-11-06_afda494ecd0c", "gongUrl": "https://app.gong.io/call?id=afda494ecd0c139472f54cfe3634d3a4d05c6d7d68456ba5e4509023706ba78b", "speakerId": "4596687062783714805", "customerName": "Sam Rowe; Sam Rowe", "internalName": "Michelle Jang", "customerEmail": "sam.m.rowe@gsk.com; sam.m.rowe@gsk.com", "internalEmail": "michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_preclinical_imaging_9b5ad8fb", "company": "gsk", "gong_entity": "Preclinical Imaging", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "Now, pre, clinical imaging, bioimaging kind of thing.", "snippet_date": "2025-09-16", "person_name": "Bhasker Radaram", "person_email": "bhasker.x.radaram@gsk.com", "internal_name": "Michelle Jang", "internal_email": "michelle.jang@biorender.com", "llm_suggested_match": {"manual_node_id": "imaging-analysis-ai", "manual_node_name": "Medical Imaging Analysis", "manual_node_path": "GSK Research & Development > Artificial Intelligence & Machine Learning > Clinical Development AI > Medical Imaging Analysis", "confidence": "medium", "reasoning": "Preclinical imaging activities would likely involve medical imaging analysis capabilities, though the manual node focuses on clinical rather than preclinical applications"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=1366b7cc0516b72ec6d90dc4e01493ccdd6036eb21b68bf9b1e2932bf6653086", "call_id": "2025-09-16_1366b7cc0516", "call_count": 1, "all_snippets": [{"quote": "Now, pre, clinical imaging, bioimaging kind of thing.", "date": "2025-09-16", "callId": "2025-09-16_1366b7cc0516", "gongUrl": "https://app.gong.io/call?id=1366b7cc0516b72ec6d90dc4e01493ccdd6036eb21b68bf9b1e2932bf6653086", "speakerId": "6359003338091271041", "customerName": "Bhasker Radaram", "internalName": "Michelle Jang", "customerEmail": "bhasker.x.radaram@gsk.com", "internalEmail": "michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_global_oncology_c0412602", "company": "gsk", "gong_entity": "Global Oncology", "gong_parent": "GSK R&D", "entity_type": "therapeutic_area", "team_size": null, "confidence": "high", "mention_count": 2, "snippet": "It should be under like oncology, like\u2026 global oncology, honestly?", "snippet_date": "2025-09-10", "person_name": "Prajna Behera", "person_email": "prajna.x.behera@gsk.com", "internal_name": "Michelle Jang", "internal_email": "michelle.jang@biorender.com", "llm_suggested_match": {"manual_node_id": "oncology-research", "manual_node_name": "Oncology Research", "manual_node_path": "GSK Research & Development > Research > Oncology Research", "confidence": "high", "reasoning": "Direct match for oncology therapeutic area, though entity specifies 'Global' which suggests broader scope than just research"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=530ae118a98960354a5e3c5b9f6d7f7c5bd3c01b80cfc9e1d437ffde1d3c3f8c", "call_id": "2025-09-10_530ae118a989", "call_count": 2, "all_snippets": [{"quote": "It should be under like oncology, like\u2026 global oncology, honestly?", "date": "2025-09-10", "callId": "2025-09-10_530ae118a989", "gongUrl": "https://app.gong.io/call?id=530ae118a98960354a5e3c5b9f6d7f7c5bd3c01b80cfc9e1d437ffde1d3c3f8c", "speakerId": "2590160092166618127", "customerName": "Prajna Behera", "internalName": "Michelle Jang", "customerEmail": "prajna.x.behera@gsk.com", "internalEmail": "michelle.jang@biorender.com", "sizeMentions": []}, {"quote": "although we're talking about sort of part of the oncology groups, we are still one GSK", "date": "2025-08-06", "callId": "2025-08-06_11af0262f179", "gongUrl": "https://app.gong.io/call?id=11af0262f179c9ac8387e6625b64d00ff94c4535d86edaa188ce22b99db6b978", "speakerId": "920261568244958462", "customerName": "Neil Garton", "internalName": "Michael Long", "customerEmail": "neil.s.garton@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}]}, {"id": "gsk_medicine_development_and_supply_team_472ddd95", "company": "gsk", "gong_entity": "Medicine Development and Supply Team", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "they're part of the medicine development and supply team. So the MBS team, which is part of DSD", "snippet_date": "2024-10-17", "person_name": "Tessa Lincoln", "person_email": "ambertessa.c.lincoln@gsk.com", "internal_name": "Adrian Rizos; Madison Knock; Mark Erbele", "internal_email": "adrian.rizos@biorender.com; madison@biorender.com; mark@biorender.com", "llm_suggested_match": {"manual_node_id": "development", "manual_node_name": "Development", "manual_node_path": "GSK Research & Development > Development", "confidence": "medium", "reasoning": "Medicine development and supply activities would fall under the broader Development division, though no exact match for the combined development/supply function"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=64ecd023c8da4c083bfeb99a73c265b3939df52e6a304d60ff5bc20c2c5a8586", "call_id": "2024-10-17_64ecd023c8da", "call_count": 1, "all_snippets": [{"quote": "they're part of the medicine development and supply team. So the MBS team, which is part of DSD", "date": "2024-10-17", "callId": "2024-10-17_64ecd023c8da", "gongUrl": "https://app.gong.io/call?id=64ecd023c8da4c083bfeb99a73c265b3939df52e6a304d60ff5bc20c2c5a8586", "speakerId": "1742008335089192812", "customerName": "Tessa Lincoln", "internalName": "Adrian Rizos; Madison Knock; Mark Erbele", "customerEmail": "ambertessa.c.lincoln@gsk.com", "internalEmail": "adrian.rizos@biorender.com; madison@biorender.com; mark@biorender.com", "sizeMentions": []}]}, {"id": "gsk_biopharm_process_research_d6d43f07", "company": "gsk", "gong_entity": "Biopharm Process Research", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": "60", "confidence": "high", "mention_count": 2, "snippet": "I wouldn't say BPR is a small team it's about like 60 60 okay so I think BPR is like more is the BPR is our department", "snippet_date": "2024-10-16", "person_name": "Shoumo Chatterjee", "person_email": "shoumo.k.chatterjee@gsk.com; holly.l.corrigall@gsk.com", "internal_name": "Adrian Rizos; Jacqueline McCoskey", "internal_email": "adrian.rizos@biorender.com; jacqueline@biorender.com", "llm_suggested_match": {"manual_node_id": "biologics-cmc", "manual_node_name": "Biologics CMC", "manual_node_path": "GSK Research & Development > CMC & Pharmaceutical Sciences > Biologics CMC", "confidence": "medium", "reasoning": "Biopharm process research activities align with biologics CMC functions including process development and manufacturing science"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=2ae461fd1f9435b0e82fa7d983b1b478de404c1408025443966c55b79e250e71", "call_id": "2024-10-16_2ae461fd1f94", "call_count": 2, "all_snippets": [{"quote": "I wouldn't say BPR is a small team it's about like 60 60 okay so I think BPR is like more is the BPR is our department", "date": "2024-10-16", "callId": "2024-10-16_2ae461fd1f94", "gongUrl": "https://app.gong.io/call?id=2ae461fd1f9435b0e82fa7d983b1b478de404c1408025443966c55b79e250e71", "speakerId": "762857497320675935", "customerName": "Shoumo Chatterjee", "internalName": "Adrian Rizos; Jacqueline McCoskey", "customerEmail": "shoumo.k.chatterjee@gsk.com; holly.l.corrigall@gsk.com", "internalEmail": "adrian.rizos@biorender.com; jacqueline@biorender.com", "sizeMentions": []}, {"quote": "So the department, I believe, is under what's known as Biopharm Process Research.", "date": "2024-08-14", "callId": "2024-08-14_198127ea8843", "gongUrl": "https://app.gong.io/call?id=198127ea884392e62e06166535fd4bf000fc814f59d6279c6db0fe29b71aae23", "speakerId": "4627793280013784240", "customerName": "Holly Corrigall; Shoumo Chatterjee", "internalName": "Jacqueline McCoskey; Madison Knock", "customerEmail": "holly.l.corrigall@gsk.com; shoumo.k.chatterjee@gsk.com", "internalEmail": "jacqueline@biorender.com; madison@biorender.com", "sizeMentions": []}]}, {"id": "gsk_biopharm_processing_research_team_170308e9", "company": "gsk", "gong_entity": "BioPharm Processing Research Team", "gong_parent": "Biopharm Process Research", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "The feedback call with the BioPharm processing research team", "snippet_date": "2024-10-17", "person_name": "Tessa Lincoln", "person_email": "ambertessa.c.lincoln@gsk.com", "internal_name": "Adrian Rizos; Madison Knock; Mark Erbele", "internal_email": "adrian.rizos@biorender.com; madison@biorender.com; mark@biorender.com", "llm_suggested_match": {"manual_node_id": "upstream-downstream", "manual_node_name": "Upstream & Downstream Processing", "manual_node_path": "GSK Research & Development > CMC & Pharmaceutical Sciences > Biologics CMC > Upstream & Downstream Processing", "confidence": "high", "reasoning": "BioPharm processing research directly matches upstream and downstream processing activities for biologics manufacturing"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=64ecd023c8da4c083bfeb99a73c265b3939df52e6a304d60ff5bc20c2c5a8586", "call_id": "2024-10-17_64ecd023c8da", "call_count": 1, "all_snippets": [{"quote": "The feedback call with the BioPharm processing research team", "date": "2024-10-17", "callId": "2024-10-17_64ecd023c8da", "gongUrl": "https://app.gong.io/call?id=64ecd023c8da4c083bfeb99a73c265b3939df52e6a304d60ff5bc20c2c5a8586", "speakerId": "1742008335089192812", "customerName": "Tessa Lincoln", "internalName": "Adrian Rizos; Madison Knock; Mark Erbele", "customerEmail": "ambertessa.c.lincoln@gsk.com", "internalEmail": "adrian.rizos@biorender.com; madison@biorender.com; mark@biorender.com", "sizeMentions": []}]}, {"id": "gsk_pre_clinical_sciences_31f2f667", "company": "gsk", "gong_entity": "Pre Clinical Sciences", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So I think the bigger team would be pre clinical sciences.", "snippet_date": "2024-06-20", "person_name": "Prabhas Jagdale; Prabhas Jagdale", "person_email": "prabhas.b.jagdale@gsk.com; prabhas.b.jagdale@gsk.com", "internal_name": "Jaden Dankevy; Rich Lee", "internal_email": "jaden.dankevy@biorender.com; rich@biorender.com", "llm_suggested_match": {"manual_node_id": "medicinal-science-technology", "manual_node_name": "Medicinal Science & Technology", "manual_node_path": "GSK Research & Development > Medicinal Science & Technology", "confidence": "medium", "reasoning": "Preclinical sciences activities would encompass medicinal science and technology functions including pharmacology, medicinal chemistry, and structural biology"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=42828fef14782737e36a3163a296840a67a615fd62a988441b6efbbe01df1434", "call_id": "2024-06-20_42828fef1478", "call_count": 1, "all_snippets": [{"quote": "So I think the bigger team would be pre clinical sciences.", "date": "2024-06-20", "callId": "2024-06-20_42828fef1478", "gongUrl": "https://app.gong.io/call?id=42828fef14782737e36a3163a296840a67a615fd62a988441b6efbbe01df1434", "speakerId": "2219511385709321541", "customerName": "Prabhas Jagdale; Prabhas Jagdale", "internalName": "Jaden Dankevy; Rich Lee", "customerEmail": "prabhas.b.jagdale@gsk.com; prabhas.b.jagdale@gsk.com", "internalEmail": "jaden.dankevy@biorender.com; rich@biorender.com", "sizeMentions": []}]}, {"id": "gsk_tmpk_drug_metabolism_d8de172d", "company": "gsk", "gong_entity": "TMPK Drug Metabolism", "gong_parent": "Pre Clinical Sciences", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "And then I'm sit with an ivivt in a team called as tmpk drug metabolism.", "snippet_date": "2024-06-20", "person_name": "Prabhas Jagdale; Prabhas Jagdale", "person_email": "prabhas.b.jagdale@gsk.com; prabhas.b.jagdale@gsk.com", "internal_name": "Jaden Dankevy; Rich Lee", "internal_email": "jaden.dankevy@biorender.com; rich@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=42828fef14782737e36a3163a296840a67a615fd62a988441b6efbbe01df1434", "call_id": "2024-06-20_42828fef1478", "call_count": 1, "all_snippets": [{"quote": "And then I'm sit with an ivivt in a team called as tmpk drug metabolism.", "date": "2024-06-20", "callId": "2024-06-20_42828fef1478", "gongUrl": "https://app.gong.io/call?id=42828fef14782737e36a3163a296840a67a615fd62a988441b6efbbe01df1434", "speakerId": "2219511385709321541", "customerName": "Prabhas Jagdale; Prabhas Jagdale", "internalName": "Jaden Dankevy; Rich Lee", "customerEmail": "prabhas.b.jagdale@gsk.com; prabhas.b.jagdale@gsk.com", "internalEmail": "jaden.dankevy@biorender.com; rich@biorender.com", "sizeMentions": []}]}, {"id": "gsk_med_cam_b31726af", "company": "gsk", "gong_entity": "Med Cam", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "medium", "mention_count": 2, "snippet": "Med Cam and complex in vitro models were not the other departments that you're referring to or?", "snippet_date": "2024-04-25", "person_name": "David Tattersall", "person_email": "david.d.tattersall@gsk.com", "internal_name": "Rich Lee", "internal_email": "rich@biorender.com", "llm_suggested_match": {"manual_node_id": "medical-communications", "manual_node_name": "Medical Communications", "manual_node_path": "GSK Research & Development > Medical, Regulatory & Quality > Medical Affairs > Medical Communications", "confidence": "high", "reasoning": "Med Cam is a clear acronym for Medical Communications, which exists as a team in the Medical Affairs department."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=6a30c2eefde4003f77491275439af7a786bf89d9610dd3927df21960c84de9e6", "call_id": "2024-04-25_6a30c2eefde4", "call_count": 2, "all_snippets": [{"quote": "Med Cam and complex in vitro models were not the other departments that you're referring to or?", "date": "2024-04-25", "callId": "2024-04-25_6a30c2eefde4", "gongUrl": "https://app.gong.io/call?id=6a30c2eefde4003f77491275439af7a786bf89d9610dd3927df21960c84de9e6", "speakerId": "4150910960750169108", "customerName": "David Tattersall", "internalName": "Rich Lee", "customerEmail": "david.d.tattersall@gsk.com", "internalEmail": "rich@biorender.com", "sizeMentions": []}, {"quote": "we're actually running trials in complex in vitro med, Cam, monology, novel human genetics, new chemical entity at the upper providence site", "date": "2023-11-08", "callId": "2023-11-08_32901e504b4b", "gongUrl": "https://app.gong.io/call?id=32901e504b4b4280296134091d8a2c98e4d720452805d63826edfbbaef8f402c", "speakerId": "5258701633084091090", "customerName": "Kashappa-Goud Desai", "internalName": "Rich Lee", "customerEmail": "kashappa-goud.x.desai@gsk.com", "internalEmail": "rich@biorender.com", "sizeMentions": []}]}, {"id": "gsk_complex_in_vitro_models_e08ce5ae", "company": "gsk", "gong_entity": "Complex In Vitro Models", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 2, "snippet": "Not me, but it could be complex in vitro models definitely.", "snippet_date": "2024-04-25", "person_name": "David Tattersall", "person_email": "david.d.tattersall@gsk.com", "internal_name": "Rich Lee", "internal_email": "rich@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=6a30c2eefde4003f77491275439af7a786bf89d9610dd3927df21960c84de9e6", "call_id": "2024-04-25_6a30c2eefde4", "call_count": 2, "all_snippets": [{"quote": "Not me, but it could be complex in vitro models definitely.", "date": "2024-04-25", "callId": "2024-04-25_6a30c2eefde4", "gongUrl": "https://app.gong.io/call?id=6a30c2eefde4003f77491275439af7a786bf89d9610dd3927df21960c84de9e6", "speakerId": "5628648247018030491", "customerName": "David Tattersall", "internalName": "Rich Lee", "customerEmail": "david.d.tattersall@gsk.com", "internalEmail": "rich@biorender.com", "sizeMentions": []}, {"quote": "we're actually running trials in complex in vitro med, Cam, monology, novel human genetics, new chemical entity at the upper providence site", "date": "2023-11-08", "callId": "2023-11-08_32901e504b4b", "gongUrl": "https://app.gong.io/call?id=32901e504b4b4280296134091d8a2c98e4d720452805d63826edfbbaef8f402c", "speakerId": "5258701633084091090", "customerName": "Kashappa-Goud Desai", "internalName": "Rich Lee", "customerEmail": "kashappa-goud.x.desai@gsk.com", "internalEmail": "rich@biorender.com", "sizeMentions": []}]}, {"id": "gsk_global_gsk_c9b5bc47", "company": "gsk", "gong_entity": "Global GSK", "gong_parent": "GSK R&D", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 2, "snippet": "This will be probably an agreement for all the Europe GSK Europe or potentially also for the global GSK.", "snippet_date": "2023-11-09", "person_name": "Raffaele Tiezzi", "person_email": "raffaele.x.tiezzi@gsk.com", "internal_name": "Rich Lee", "internal_email": "rich@biorender.com", "llm_suggested_match": {"manual_node_id": "gsk-rd", "manual_node_name": "GSK Research & Development", "manual_node_path": "GSK Research & Development", "confidence": "medium", "reasoning": "Global GSK likely refers to the overall GSK organization. Matching to the top-level R&D entity as the closest representation in this org chart."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=b35fc13ea87e4414b10dbcd88212cee9053ac02917f7331308adf409270911ba", "call_id": "2023-11-09_b35fc13ea87e", "call_count": 2, "all_snippets": [{"quote": "This will be probably an agreement for all the Europe GSK Europe or potentially also for the global GSK.", "date": "2023-11-09", "callId": "2023-11-09_b35fc13ea87e", "gongUrl": "https://app.gong.io/call?id=b35fc13ea87e4414b10dbcd88212cee9053ac02917f7331308adf409270911ba", "speakerId": "6886108149542803438", "customerName": "Raffaele Tiezzi", "internalName": "Rich Lee", "customerEmail": "raffaele.x.tiezzi@gsk.com", "internalEmail": "rich@biorender.com", "sizeMentions": []}, {"quote": "There's. Quite a bit of momentum at GS K right now", "date": "2023-08-16", "callId": "2023-08-16_f2a159c8c72b", "gongUrl": "https://app.gong.io/call?id=f2a159c8c72bc4cc6c6e9c3db227cea9d6042357f9568d43b5405e0033990213", "speakerId": "1910160836855994154", "customerName": "John Lich", "internalName": "Rich Lee; Sydney Burniston", "customerEmail": "john.d.lich@gsk.com", "internalEmail": "rich@biorender.com; sydney.b@biorender.com", "sizeMentions": []}]}, {"id": "gsk_gsk_europe_842e84bd", "company": "gsk", "gong_entity": "GSK Europe", "gong_parent": "Global GSK", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "This will be probably an agreement for all the Europe GSK Europe or potentially also for the global GSK.", "snippet_date": "2023-11-09", "person_name": "Raffaele Tiezzi", "person_email": "raffaele.x.tiezzi@gsk.com", "internal_name": "Rich Lee", "internal_email": "rich@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=b35fc13ea87e4414b10dbcd88212cee9053ac02917f7331308adf409270911ba", "call_id": "2023-11-09_b35fc13ea87e", "call_count": 1, "all_snippets": [{"quote": "This will be probably an agreement for all the Europe GSK Europe or potentially also for the global GSK.", "date": "2023-11-09", "callId": "2023-11-09_b35fc13ea87e", "gongUrl": "https://app.gong.io/call?id=b35fc13ea87e4414b10dbcd88212cee9053ac02917f7331308adf409270911ba", "speakerId": "6886108149542803438", "customerName": "Raffaele Tiezzi", "internalName": "Rich Lee", "customerEmail": "raffaele.x.tiezzi@gsk.com", "internalEmail": "rich@biorender.com", "sizeMentions": []}]}, {"id": "gsk_monology_group_c9edda54", "company": "gsk", "gong_entity": "Monology Group", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I was mainly working with the monology group", "snippet_date": "2023-11-08", "person_name": "Kashappa-Goud Desai", "person_email": "kashappa-goud.x.desai@gsk.com", "internal_name": "Rich Lee", "internal_email": "rich@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=32901e504b4b4280296134091d8a2c98e4d720452805d63826edfbbaef8f402c", "call_id": "2023-11-08_32901e504b4b", "call_count": 1, "all_snippets": [{"quote": "I was mainly working with the monology group", "date": "2023-11-08", "callId": "2023-11-08_32901e504b4b", "gongUrl": "https://app.gong.io/call?id=32901e504b4b4280296134091d8a2c98e4d720452805d63826edfbbaef8f402c", "speakerId": "5258701633084091090", "customerName": "Kashappa-Goud Desai", "internalName": "Rich Lee", "customerEmail": "kashappa-goud.x.desai@gsk.com", "internalEmail": "rich@biorender.com", "sizeMentions": []}]}, {"id": "gsk_discovery_biology_4222e98f", "company": "gsk", "gong_entity": "Discovery Biology", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "He's a part of discovery biology, biological, max spectrometry", "snippet_date": "2025-12-10", "person_name": "Prashant Waiker", "person_email": "prashant.x.waiker@gsk.com", "internal_name": "Michael Long", "internal_email": "michael.long@biorender.com", "llm_suggested_match": {"manual_node_id": "biologics-discovery", "manual_node_name": "Biologics Discovery", "manual_node_path": "GSK Research & Development > Medicinal Science & Technology > Biologics Discovery", "confidence": "medium", "reasoning": "Discovery Biology likely refers to biological discovery activities. Biologics Discovery is the closest match, though it may be more specific than the entity suggests."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=ae3f1030fe9cccfb924b5abc51e561dbaef48fa0d6fcc325622f5a7cb34d8013", "call_id": "2025-12-10_ae3f1030fe9c", "call_count": 1, "all_snippets": [{"quote": "He's a part of discovery biology, biological, max spectrometry", "date": "2025-12-10", "callId": "2025-12-10_ae3f1030fe9c", "gongUrl": "https://app.gong.io/call?id=ae3f1030fe9cccfb924b5abc51e561dbaef48fa0d6fcc325622f5a7cb34d8013", "speakerId": "4520796774596570991", "customerName": "Prashant Waiker", "internalName": "Michael Long", "customerEmail": "prashant.x.waiker@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}]}, {"id": "gsk_cmc_team_9736c31f", "company": "gsk", "gong_entity": "CMC Team", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": null, "confidence": "low", "mention_count": 1, "snippet": "I think I met with someone from the CMC team, but I could be totally misremembering", "snippet_date": "2025-12-11", "person_name": "Sara Porfirio", "person_email": "sara.p.porfirio@gsk.com", "internal_name": "Michael Long", "internal_email": "michael.long@biorender.com", "llm_suggested_match": {"manual_node_id": "cmc-pharmaceutical-sciences", "manual_node_name": "CMC & Pharmaceutical Sciences", "manual_node_path": "GSK Research & Development > CMC & Pharmaceutical Sciences", "confidence": "high", "reasoning": "CMC Team clearly refers to Chemistry, Manufacturing, and Controls. Matching to the CMC & Pharmaceutical Sciences division which encompasses CMC activities."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=efe1b4376fba6df38a4e08d00a739daec4168474cfd5f64eec9f1e3c8d9220b9", "call_id": "2025-12-11_efe1b4376fba", "call_count": 1, "all_snippets": [{"quote": "I think I met with someone from the CMC team, but I could be totally misremembering", "date": "2025-12-11", "callId": "2025-12-11_efe1b4376fba", "gongUrl": "https://app.gong.io/call?id=efe1b4376fba6df38a4e08d00a739daec4168474cfd5f64eec9f1e3c8d9220b9", "speakerId": "5015271624001198436", "customerName": "Sara Porfirio", "internalName": "Michael Long", "customerEmail": "sara.p.porfirio@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}]}, {"id": "gsk_lab_systems_and_automation_a67d0a61", "company": "gsk", "gong_entity": "Lab Systems and Automation", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "But our team like, you know, it's called lab or systems and automation in us.", "snippet_date": "2025-12-10", "person_name": "Prashant Waiker", "person_email": "prashant.x.waiker@gsk.com", "internal_name": "Brian Sedlacek; Michael Long", "internal_email": "brian.sedlacek@biorender.com; michael.long@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=f373376430fd71162bc0807224467f46155a47294994371387529a99ddcbf5f0", "call_id": "2025-12-10_f373376430fd", "call_count": 1, "all_snippets": [{"quote": "But our team like, you know, it's called lab or systems and automation in us.", "date": "2025-12-10", "callId": "2025-12-10_f373376430fd", "gongUrl": "https://app.gong.io/call?id=f373376430fd71162bc0807224467f46155a47294994371387529a99ddcbf5f0", "speakerId": "5797852991557821441", "customerName": "Prashant Waiker", "internalName": "Brian Sedlacek; Michael Long", "customerEmail": "prashant.x.waiker@gsk.com", "internalEmail": "brian.sedlacek@biorender.com; michael.long@biorender.com", "sizeMentions": []}]}, {"id": "gsk_lab_systems_automation_team_87ff8044", "company": "gsk", "gong_entity": "Lab Systems Automation Team", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "Term lsa, it's like the lab systems automation team", "snippet_date": "2025-11-24", "person_name": "Didem Torumkuney; Renuka Kapoor", "person_email": "didem.x.torumkuney@gsk.com; renuka.x.kapoor@gsk.com", "internal_name": "Michael Long; Michelle Jang", "internal_email": "michael.long@biorender.com; michelle.jang@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=4785393bd5669266b6b45f28f8f5f176dd800aec0e3d3e5a371a1dd99bb906f2", "call_id": "2025-11-24_4785393bd566", "call_count": 1, "all_snippets": [{"quote": "Term lsa, it's like the lab systems automation team", "date": "2025-11-24", "callId": "2025-11-24_4785393bd566", "gongUrl": "https://app.gong.io/call?id=4785393bd5669266b6b45f28f8f5f176dd800aec0e3d3e5a371a1dd99bb906f2", "speakerId": "4608526257814388930", "customerName": "Didem Torumkuney; Renuka Kapoor", "internalName": "Michael Long; Michelle Jang", "customerEmail": "didem.x.torumkuney@gsk.com; renuka.x.kapoor@gsk.com", "internalEmail": "michael.long@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_biopharm_process_research_division_65439a17", "company": "gsk", "gong_entity": "Biopharm Process Research Division", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So, well, I'm a scientist working over in the, well, the biopharm process research division here at GSK in stevenage in the UK.", "snippet_date": "2025-11-21", "person_name": "Shoumo Chatterjee", "person_email": "shoumo.k.chatterjee@gsk.com", "internal_name": "Michael Long; Michelle Jang", "internal_email": "michael.long@biorender.com; michelle.jang@biorender.com", "llm_suggested_match": {"manual_node_id": "upper-merion-pa", "manual_node_name": "Upper Merion, PA, USA (Biopharm Center of Excellence)", "manual_node_path": "GSK Research & Development > Global R&D Sites > Upper Merion, PA, USA (Biopharm Center of Excellence)", "confidence": "medium", "reasoning": "Entity mentions biopharm process research and the manual chart has a Biopharm Center of Excellence, though the entity appears to be at Stevenage UK rather than Upper Merion PA"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=cc86ccb27cb0758b2b88458a89f44d2c061f6d2c02fa89ac8ace762930053eea", "call_id": "2025-11-21_cc86ccb27cb0", "call_count": 1, "all_snippets": [{"quote": "So, well, I'm a scientist working over in the, well, the biopharm process research division here at GSK in stevenage in the UK.", "date": "2025-11-21", "callId": "2025-11-21_cc86ccb27cb0", "gongUrl": "https://app.gong.io/call?id=cc86ccb27cb0758b2b88458a89f44d2c061f6d2c02fa89ac8ace762930053eea", "speakerId": "1842545739947945819", "customerName": "Shoumo Chatterjee", "internalName": "Michael Long; Michelle Jang", "customerEmail": "shoumo.k.chatterjee@gsk.com", "internalEmail": "michael.long@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_drug_substance_development_team_3a4288b1", "company": "gsk", "gong_entity": "Drug Substance Development Team", "gong_parent": "Biopharm Process Research Division", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So, we're part of the, what's known as the bdst team or the drug substance development team?", "snippet_date": "2025-11-21", "person_name": "Shoumo Chatterjee", "person_email": "shoumo.k.chatterjee@gsk.com", "internal_name": "Michael Long; Michelle Jang", "internal_email": "michael.long@biorender.com; michelle.jang@biorender.com", "llm_suggested_match": {"manual_node_id": "drug-substance-development", "manual_node_name": "Drug Substance Development", "manual_node_path": "GSK Research & Development > CMC & Pharmaceutical Sciences > Small Molecule CMC > Drug Substance Development", "confidence": "high", "reasoning": "Exact match - entity name matches manual node name exactly, and the acronym 'bdst' aligns with this function"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=cc86ccb27cb0758b2b88458a89f44d2c061f6d2c02fa89ac8ace762930053eea", "call_id": "2025-11-21_cc86ccb27cb0", "call_count": 1, "all_snippets": [{"quote": "So, we're part of the, what's known as the bdst team or the drug substance development team?", "date": "2025-11-21", "callId": "2025-11-21_cc86ccb27cb0", "gongUrl": "https://app.gong.io/call?id=cc86ccb27cb0758b2b88458a89f44d2c061f6d2c02fa89ac8ace762930053eea", "speakerId": "1842545739947945819", "customerName": "Shoumo Chatterjee", "internalName": "Michael Long; Michelle Jang", "customerEmail": "shoumo.k.chatterjee@gsk.com", "internalEmail": "michael.long@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_medicine_delivery_and_supply_team_f2f10a02", "company": "gsk", "gong_entity": "Medicine Delivery and Supply Team", "gong_parent": "GSK R&D", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "And as part of that, we're part of the bigger team which is considered MDS or like the medicine delivery and supply team.", "snippet_date": "2025-11-21", "person_name": "Shoumo Chatterjee", "person_email": "shoumo.k.chatterjee@gsk.com", "internal_name": "Michael Long; Michelle Jang", "internal_email": "michael.long@biorender.com; michelle.jang@biorender.com", "llm_suggested_match": {"manual_node_id": "cmc-pharmaceutical-sciences", "manual_node_name": "CMC & Pharmaceutical Sciences", "manual_node_path": "GSK Research & Development > CMC & Pharmaceutical Sciences", "confidence": "medium", "reasoning": "MDS (Medicine Delivery and Supply) semantically aligns with CMC & Pharmaceutical Sciences division which handles drug development and manufacturing"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=cc86ccb27cb0758b2b88458a89f44d2c061f6d2c02fa89ac8ace762930053eea", "call_id": "2025-11-21_cc86ccb27cb0", "call_count": 1, "all_snippets": [{"quote": "And as part of that, we're part of the bigger team which is considered MDS or like the medicine delivery and supply team.", "date": "2025-11-21", "callId": "2025-11-21_cc86ccb27cb0", "gongUrl": "https://app.gong.io/call?id=cc86ccb27cb0758b2b88458a89f44d2c061f6d2c02fa89ac8ace762930053eea", "speakerId": "1842545739947945819", "customerName": "Shoumo Chatterjee", "internalName": "Michael Long; Michelle Jang", "customerEmail": "shoumo.k.chatterjee@gsk.com", "internalEmail": "michael.long@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_idiu_group_a6d0e905", "company": "gsk", "gong_entity": "IDIU Group", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "there's another person within the, idiu group, Steve, Stephen Kramer", "snippet_date": "2025-11-06", "person_name": "Cory Knudson", "person_email": "cory.j.knudson@gsk.com", "internal_name": "Michael Long", "internal_email": "michael.long@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=01d59ee11ca984be9b6180324e480038d1634ae2dbbfd8679ed606b2e37944d0", "call_id": "2025-11-06_01d59ee11ca9", "call_count": 1, "all_snippets": [{"quote": "there's another person within the, idiu group, Steve, Stephen Kramer", "date": "2025-11-06", "callId": "2025-11-06_01d59ee11ca9", "gongUrl": "https://app.gong.io/call?id=01d59ee11ca984be9b6180324e480038d1634ae2dbbfd8679ed606b2e37944d0", "speakerId": "9139491820263027725", "customerName": "Cory Knudson", "internalName": "Michael Long", "customerEmail": "cory.j.knudson@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}]}, {"id": "gsk_chemical_biology_group_09042b5c", "company": "gsk", "gong_entity": "Chemical Biology Group", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "you're in the medicinal chemistry or not, medicinal chemistry, chemical biology group at GSK", "snippet_date": "2025-11-06", "person_name": "Sam Rowe; Sam Rowe", "person_email": "sam.m.rowe@gsk.com; sam.m.rowe@gsk.com", "internal_name": "Michelle Jang", "internal_email": "michelle.jang@biorender.com", "llm_suggested_match": {"manual_node_id": "medicinal-chemistry", "manual_node_name": "Medicinal Chemistry", "manual_node_path": "GSK Research & Development > Medicinal Science & Technology > Medicinal Chemistry", "confidence": "medium", "reasoning": "Chemical biology is closely related to medicinal chemistry - both involve chemical approaches to biological problems"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=afda494ecd0c139472f54cfe3634d3a4d05c6d7d68456ba5e4509023706ba78b", "call_id": "2025-11-06_afda494ecd0c", "call_count": 1, "all_snippets": [{"quote": "you're in the medicinal chemistry or not, medicinal chemistry, chemical biology group at GSK", "date": "2025-11-06", "callId": "2025-11-06_afda494ecd0c", "gongUrl": "https://app.gong.io/call?id=afda494ecd0c139472f54cfe3634d3a4d05c6d7d68456ba5e4509023706ba78b", "speakerId": "4596687062783714805", "customerName": "Sam Rowe; Sam Rowe", "internalName": "Michelle Jang", "customerEmail": "sam.m.rowe@gsk.com; sam.m.rowe@gsk.com", "internalEmail": "michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_biological_mass_spec_661d8331", "company": "gsk", "gong_entity": "Biological Mass Spec", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "you mentioned Tim hammerly, who sounds like he's in biological mass spec", "snippet_date": "2025-11-06", "person_name": "Sam Rowe; Sam Rowe", "person_email": "sam.m.rowe@gsk.com; sam.m.rowe@gsk.com", "internal_name": "Michelle Jang", "internal_email": "michelle.jang@biorender.com", "llm_suggested_match": {"manual_node_id": "analytical-development-bio", "manual_node_name": "Analytical Development", "manual_node_path": "GSK Research & Development > CMC & Pharmaceutical Sciences > Biologics CMC > Analytical Development", "confidence": "medium", "reasoning": "Biological mass spectrometry is an analytical technique that would fall under analytical development for biologics"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=afda494ecd0c139472f54cfe3634d3a4d05c6d7d68456ba5e4509023706ba78b", "call_id": "2025-11-06_afda494ecd0c", "call_count": 1, "all_snippets": [{"quote": "you mentioned Tim hammerly, who sounds like he's in biological mass spec", "date": "2025-11-06", "callId": "2025-11-06_afda494ecd0c", "gongUrl": "https://app.gong.io/call?id=afda494ecd0c139472f54cfe3634d3a4d05c6d7d68456ba5e4509023706ba78b", "speakerId": "7260657465970454020", "customerName": "Sam Rowe; Sam Rowe", "internalName": "Michelle Jang", "customerEmail": "sam.m.rowe@gsk.com; sam.m.rowe@gsk.com", "internalEmail": "michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_large_molecule_discovery_20e1e41a", "company": "gsk", "gong_entity": "Large Molecule Discovery", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I'm part of the lmr department, large molecule discovery, which is part of research tech if you've worked with them.", "snippet_date": "2025-11-05", "person_name": "Paige Fenn", "person_email": "paige.g.fenn@gsk.com", "internal_name": "Michelle Jang", "internal_email": "michelle.jang@biorender.com", "llm_suggested_match": {"manual_node_id": "biologics-discovery", "manual_node_name": "Biologics Discovery", "manual_node_path": "GSK Research & Development > Medicinal Science & Technology > Biologics Discovery", "confidence": "high", "reasoning": "Large molecules refer to biologics - exact semantic match between large molecule discovery and biologics discovery"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=17f31f16cfe5d1ef54c008abb1f341614523b8aa17670098bc16e866349710f0", "call_id": "2025-11-05_17f31f16cfe5", "call_count": 1, "all_snippets": [{"quote": "I'm part of the lmr department, large molecule discovery, which is part of research tech if you've worked with them.", "date": "2025-11-05", "callId": "2025-11-05_17f31f16cfe5", "gongUrl": "https://app.gong.io/call?id=17f31f16cfe5d1ef54c008abb1f341614523b8aa17670098bc16e866349710f0", "speakerId": "5476356920226236898", "customerName": "Paige Fenn", "internalName": "Michelle Jang", "customerEmail": "paige.g.fenn@gsk.com", "internalEmail": "michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_pcs_fa8cd72c", "company": "gsk", "gong_entity": "PCS", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "Yeah, for sure. It's PCS.", "snippet_date": "2025-11-05", "person_name": "Paige Fenn", "person_email": "paige.g.fenn@gsk.com", "internal_name": "Michelle Jang", "internal_email": "michelle.jang@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=17f31f16cfe5d1ef54c008abb1f341614523b8aa17670098bc16e866349710f0", "call_id": "2025-11-05_17f31f16cfe5", "call_count": 1, "all_snippets": [{"quote": "Yeah, for sure. It's PCS.", "date": "2025-11-05", "callId": "2025-11-05_17f31f16cfe5", "gongUrl": "https://app.gong.io/call?id=17f31f16cfe5d1ef54c008abb1f341614523b8aa17670098bc16e866349710f0", "speakerId": "5476356920226236898", "customerName": "Paige Fenn", "internalName": "Michelle Jang", "customerEmail": "paige.g.fenn@gsk.com", "internalEmail": "michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_rocks_f15897ba", "company": "gsk", "gong_entity": "ROCKS", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "that Guy Anthony virtue, he's in a group called rocks which also, they're like a service group for research operations", "snippet_date": "2025-10-24", "person_name": "Kim Reese; Kim Reese", "person_email": "kim.x.reese@gsk.com; kim.x.reese@gsk.com", "internal_name": "Michael Long", "internal_email": "michael.long@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=ec055767f572aba9448a7dee23cec923234e76be145b40af151ba488cad520c7", "call_id": "2025-10-24_ec055767f572", "call_count": 1, "all_snippets": [{"quote": "that Guy Anthony virtue, he's in a group called rocks which also, they're like a service group for research operations", "date": "2025-10-24", "callId": "2025-10-24_ec055767f572", "gongUrl": "https://app.gong.io/call?id=ec055767f572aba9448a7dee23cec923234e76be145b40af151ba488cad520c7", "speakerId": "8469599798533541880", "customerName": "Kim Reese; Kim Reese", "internalName": "Michael Long", "customerEmail": "kim.x.reese@gsk.com; kim.x.reese@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}]}, {"id": "gsk_research_and_development_2f792548", "company": "gsk", "gong_entity": "Research and Development", "gong_parent": "GSK R&D", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "we are part of research and development", "snippet_date": "2025-10-24", "person_name": "Kim Reese; Kim Reese", "person_email": "kim.x.reese@gsk.com; kim.x.reese@gsk.com", "internal_name": "Michael Long", "internal_email": "michael.long@biorender.com", "llm_suggested_match": {"manual_node_id": "gsk-rd", "manual_node_name": "GSK Research & Development", "manual_node_path": "GSK Research & Development", "confidence": "high", "reasoning": "Exact match - entity matches the top-level company division name exactly"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=ec055767f572aba9448a7dee23cec923234e76be145b40af151ba488cad520c7", "call_id": "2025-10-24_ec055767f572", "call_count": 1, "all_snippets": [{"quote": "we are part of research and development", "date": "2025-10-24", "callId": "2025-10-24_ec055767f572", "gongUrl": "https://app.gong.io/call?id=ec055767f572aba9448a7dee23cec923234e76be145b40af151ba488cad520c7", "speakerId": "8469599798533541880", "customerName": "Kim Reese; Kim Reese", "internalName": "Michael Long", "customerEmail": "kim.x.reese@gsk.com; kim.x.reese@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}]}, {"id": "gsk_vaccines_and_infectious_disease_group_27760846", "company": "gsk", "gong_entity": "Vaccines and Infectious Disease Group", "gong_parent": "Research and Development", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 2, "snippet": "Groups in vaccines and id specifically", "snippet_date": "2025-11-06", "person_name": "Sam Rowe; Sam Rowe", "person_email": "sam.m.rowe@gsk.com; sam.m.rowe@gsk.com", "internal_name": "Michelle Jang", "internal_email": "michelle.jang@biorender.com", "llm_suggested_match": {"manual_node_id": "vaccines-infectious-diseases-research", "manual_node_name": "Vaccines & Infectious Diseases Research", "manual_node_path": "GSK Research & Development > Research > Vaccines & Infectious Diseases Research", "confidence": "high", "reasoning": "Strong semantic match - entity refers to vaccines and infectious diseases group, which aligns with the Vaccines & Infectious Diseases Research therapeutic area"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=afda494ecd0c139472f54cfe3634d3a4d05c6d7d68456ba5e4509023706ba78b", "call_id": "2025-11-06_afda494ecd0c", "call_count": 2, "all_snippets": [{"quote": "Groups in vaccines and id specifically", "date": "2025-11-06", "callId": "2025-11-06_afda494ecd0c", "gongUrl": "https://app.gong.io/call?id=afda494ecd0c139472f54cfe3634d3a4d05c6d7d68456ba5e4509023706ba78b", "speakerId": "4596687062783714805", "customerName": "Sam Rowe; Sam Rowe", "internalName": "Michelle Jang", "customerEmail": "sam.m.rowe@gsk.com; sam.m.rowe@gsk.com", "internalEmail": "michelle.jang@biorender.com", "sizeMentions": []}, {"quote": "we are part of the vaccine and I guess it's now called vaccines and infectious disease group", "date": "2025-10-15", "callId": "2025-10-15_04d1807e1dcd", "gongUrl": "https://app.gong.io/call?id=04d1807e1dcda3877d1cb617083a2fa0ecad7a97e6b37e1bc1b322f236c38893", "speakerId": "2855433903326779045", "customerName": "Cory Knudson; Cory Knudson", "internalName": "Michael Long; Michelle Jang", "customerEmail": "cory.j.knudson@gsk.com; cory.j.knudson@gsk.com", "internalEmail": "michael.long@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_vaccines_r&d_organization_d1c1adce", "company": "gsk", "gong_entity": "Vaccines R&D Organization", "gong_parent": "Vaccines and Infectious Disease Group", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 2, "snippet": "we started this project to consolidate all GSK licenses for the vaccines RD portfolio", "snippet_date": "2025-10-14", "person_name": "Gunasundari Veerapandian; Prashant Waiker; Raffaele Tiezzi", "person_email": "gunasundari.x.veerapandian@gsk.com; prashant.x.waiker@gsk.com; raffaele.x.tiezzi@gsk.com; john.x.jonesjr@gsk.com; fabrice.x.godart@gsk.com", "internal_name": "Michael Long", "internal_email": "michael.long@biorender.com", "llm_suggested_match": {"manual_node_id": "vaccines-development", "manual_node_name": "Vaccines Development", "manual_node_path": "GSK Research & Development > Development > Vaccines Development", "confidence": "high", "reasoning": "Direct match - entity specifically mentions vaccines R&D organization, which maps to the Vaccines Development therapeutic area"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=8fa4f3232c29fb999967ce828dd3d90d405fbb20e3e24fdfafdacac2bed9aee1", "call_id": "2025-10-14_8fa4f3232c29", "call_count": 2, "all_snippets": [{"quote": "we started this project to consolidate all GSK licenses for the vaccines RD portfolio", "date": "2025-10-14", "callId": "2025-10-14_8fa4f3232c29", "gongUrl": "https://app.gong.io/call?id=8fa4f3232c29fb999967ce828dd3d90d405fbb20e3e24fdfafdacac2bed9aee1", "speakerId": "307459476772530615", "customerName": "Gunasundari Veerapandian; Prashant Waiker; Raffaele Tiezzi", "internalName": "Michael Long", "customerEmail": "gunasundari.x.veerapandian@gsk.com; prashant.x.waiker@gsk.com; raffaele.x.tiezzi@gsk.com; john.x.jonesjr@gsk.com; fabrice.x.godart@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}, {"quote": "I need to talk to a singular shape from our vaccines ird organization", "date": "2025-09-18", "callId": "2025-09-18_cdb277517a69", "gongUrl": "https://app.gong.io/call?id=cdb277517a69d645ec2adf455e162352afec003646a9d73d6f0d037a5a3b991f", "speakerId": "4157251372340494941", "customerName": "Avijit Ray", "internalName": "Michelle Jang; Ross Proudfoot", "customerEmail": "avijit.r.ray@gsk.com", "internalEmail": "michelle.jang@biorender.com; ross@biorender.com", "sizeMentions": []}]}, {"id": "gsk_ribo_group_ed3efd53", "company": "gsk", "gong_entity": "Ribo Group", "gong_parent": "Vaccines and Infectious Disease Group", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "within vaccines within the ribo group", "snippet_date": "2025-10-24", "person_name": "Kim Reese; Kim Reese", "person_email": "kim.x.reese@gsk.com; kim.x.reese@gsk.com", "internal_name": "Michael Long", "internal_email": "michael.long@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=ec055767f572aba9448a7dee23cec923234e76be145b40af151ba488cad520c7", "call_id": "2025-10-24_ec055767f572", "call_count": 1, "all_snippets": [{"quote": "within vaccines within the ribo group", "date": "2025-10-24", "callId": "2025-10-24_ec055767f572", "gongUrl": "https://app.gong.io/call?id=ec055767f572aba9448a7dee23cec923234e76be145b40af151ba488cad520c7", "speakerId": "4608000112955777667", "customerName": "Kim Reese; Kim Reese", "internalName": "Michael Long", "customerEmail": "kim.x.reese@gsk.com; kim.x.reese@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}]}, {"id": "gsk_global_health_f172a0dc", "company": "gsk", "gong_entity": "Global Health", "gong_parent": "Research and Development", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "but as we are global health", "snippet_date": "2025-10-16", "person_name": "Celia Presmanes; Sara Leal", "person_email": "celia.x.presmanes@gsk.com; sara.x.leal@gsk.com", "internal_name": "Michael Long", "internal_email": "michael.long@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=aa822b21b950bd1adf88a50373d844c2ffee7df499714e180d14d5e519dea999", "call_id": "2025-10-16_aa822b21b950", "call_count": 1, "all_snippets": [{"quote": "but as we are global health", "date": "2025-10-16", "callId": "2025-10-16_aa822b21b950", "gongUrl": "https://app.gong.io/call?id=aa822b21b950bd1adf88a50373d844c2ffee7df499714e180d14d5e519dea999", "speakerId": "9221547802177080151", "customerName": "Celia Presmanes; Sara Leal", "internalName": "Michael Long", "customerEmail": "celia.x.presmanes@gsk.com; sara.x.leal@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}]}, {"id": "gsk_global_health_medicine_r&d_b98a534d", "company": "gsk", "gong_entity": "Global Health Medicine R&D", "gong_parent": "Global Health", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "it's global health R\u2026 D, is that the group, your group?", "snippet_date": "2025-10-16", "person_name": "Celia Presmanes; Sara Leal", "person_email": "celia.x.presmanes@gsk.com; sara.x.leal@gsk.com", "internal_name": "Michael Long", "internal_email": "michael.long@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=aa822b21b950bd1adf88a50373d844c2ffee7df499714e180d14d5e519dea999", "call_id": "2025-10-16_aa822b21b950", "call_count": 1, "all_snippets": [{"quote": "it's global health R\u2026 D, is that the group, your group?", "date": "2025-10-16", "callId": "2025-10-16_aa822b21b950", "gongUrl": "https://app.gong.io/call?id=aa822b21b950bd1adf88a50373d844c2ffee7df499714e180d14d5e519dea999", "speakerId": "1262197883725469268", "customerName": "Celia Presmanes; Sara Leal", "internalName": "Michael Long", "customerEmail": "celia.x.presmanes@gsk.com; sara.x.leal@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}]}, {"id": "gsk_vaccine_development_for_global_health_42b4c5a4", "company": "gsk", "gong_entity": "Vaccine Development for Global Health", "gong_parent": "Global Health Medicine R&D", "entity_type": "team", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "the vaccine\u2026 development for global health", "snippet_date": "2025-10-15", "person_name": "Cory Knudson; Cory Knudson", "person_email": "cory.j.knudson@gsk.com; cory.j.knudson@gsk.com", "internal_name": "Michael Long; Michelle Jang", "internal_email": "michael.long@biorender.com; michelle.jang@biorender.com", "llm_suggested_match": {"manual_node_id": "vaccines-development", "manual_node_name": "Vaccines Development", "manual_node_path": "GSK Research & Development > Development > Vaccines Development", "confidence": "medium", "reasoning": "Partial match - the vaccine development aspect aligns with Vaccines Development, though the 'Global Health' qualifier is not specifically represented"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=04d1807e1dcda3877d1cb617083a2fa0ecad7a97e6b37e1bc1b322f236c38893", "call_id": "2025-10-15_04d1807e1dcd", "call_count": 1, "all_snippets": [{"quote": "the vaccine\u2026 development for global health", "date": "2025-10-15", "callId": "2025-10-15_04d1807e1dcd", "gongUrl": "https://app.gong.io/call?id=04d1807e1dcda3877d1cb617083a2fa0ecad7a97e6b37e1bc1b322f236c38893", "speakerId": "3197867211852301234", "customerName": "Cory Knudson; Cory Knudson", "internalName": "Michael Long; Michelle Jang", "customerEmail": "cory.j.knudson@gsk.com; cory.j.knudson@gsk.com", "internalEmail": "michael.long@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_boston_1dc119bd", "company": "gsk", "gong_entity": "Boston", "gong_parent": "GSK R&D", "entity_type": "site", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "three sites up in Boston", "snippet_date": "2025-10-14", "person_name": "Gunasundari Veerapandian; Prashant Waiker; Raffaele Tiezzi", "person_email": "gunasundari.x.veerapandian@gsk.com; prashant.x.waiker@gsk.com; raffaele.x.tiezzi@gsk.com; john.x.jonesjr@gsk.com; fabrice.x.godart@gsk.com", "internal_name": "Michael Long", "internal_email": "michael.long@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=8fa4f3232c29fb999967ce828dd3d90d405fbb20e3e24fdfafdacac2bed9aee1", "call_id": "2025-10-14_8fa4f3232c29", "call_count": 1, "all_snippets": [{"quote": "three sites up in Boston", "date": "2025-10-14", "callId": "2025-10-14_8fa4f3232c29", "gongUrl": "https://app.gong.io/call?id=8fa4f3232c29fb999967ce828dd3d90d405fbb20e3e24fdfafdacac2bed9aee1", "speakerId": "307459476772530615", "customerName": "Gunasundari Veerapandian; Prashant Waiker; Raffaele Tiezzi", "internalName": "Michael Long", "customerEmail": "gunasundari.x.veerapandian@gsk.com; prashant.x.waiker@gsk.com; raffaele.x.tiezzi@gsk.com; john.x.jonesjr@gsk.com; fabrice.x.godart@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}]}, {"id": "gsk_gvgh_56c9dd0f", "company": "gsk", "gong_entity": "GVGH", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "yesterday, there was another exception that came for gvgh as well, which is in Belgium and Italy", "snippet_date": "2025-10-14", "person_name": "Gunasundari Veerapandian; Prashant Waiker; Raffaele Tiezzi", "person_email": "gunasundari.x.veerapandian@gsk.com; prashant.x.waiker@gsk.com; raffaele.x.tiezzi@gsk.com; john.x.jonesjr@gsk.com; fabrice.x.godart@gsk.com", "internal_name": "Michael Long", "internal_email": "michael.long@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=8fa4f3232c29fb999967ce828dd3d90d405fbb20e3e24fdfafdacac2bed9aee1", "call_id": "2025-10-14_8fa4f3232c29", "call_count": 1, "all_snippets": [{"quote": "yesterday, there was another exception that came for gvgh as well, which is in Belgium and Italy", "date": "2025-10-14", "callId": "2025-10-14_8fa4f3232c29", "gongUrl": "https://app.gong.io/call?id=8fa4f3232c29fb999967ce828dd3d90d405fbb20e3e24fdfafdacac2bed9aee1", "speakerId": "8781652897651607371", "customerName": "Gunasundari Veerapandian; Prashant Waiker; Raffaele Tiezzi", "internalName": "Michael Long", "customerEmail": "gunasundari.x.veerapandian@gsk.com; prashant.x.waiker@gsk.com; raffaele.x.tiezzi@gsk.com; john.x.jonesjr@gsk.com; fabrice.x.godart@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}]}, {"id": "gsk_infectious_disease_id_portfolio_63adf4d9", "company": "gsk", "gong_entity": "Infectious Disease ID Portfolio", "gong_parent": "GSK R&D", "entity_type": "therapeutic_area", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I think it's infectious disease id portfolio", "snippet_date": "2025-10-14", "person_name": "Gunasundari Veerapandian; Prashant Waiker; Raffaele Tiezzi", "person_email": "gunasundari.x.veerapandian@gsk.com; prashant.x.waiker@gsk.com; raffaele.x.tiezzi@gsk.com; john.x.jonesjr@gsk.com; fabrice.x.godart@gsk.com", "internal_name": "Michael Long", "internal_email": "michael.long@biorender.com", "llm_suggested_match": {"manual_node_id": "infectious-diseases-development", "manual_node_name": "Infectious Diseases Development", "manual_node_path": "GSK Research & Development > Development > Infectious Diseases Development", "confidence": "high", "reasoning": "Strong match - entity refers to infectious disease portfolio which directly aligns with Infectious Diseases Development therapeutic area"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=8fa4f3232c29fb999967ce828dd3d90d405fbb20e3e24fdfafdacac2bed9aee1", "call_id": "2025-10-14_8fa4f3232c29", "call_count": 1, "all_snippets": [{"quote": "I think it's infectious disease id portfolio", "date": "2025-10-14", "callId": "2025-10-14_8fa4f3232c29", "gongUrl": "https://app.gong.io/call?id=8fa4f3232c29fb999967ce828dd3d90d405fbb20e3e24fdfafdacac2bed9aee1", "speakerId": "307459476772530615", "customerName": "Gunasundari Veerapandian; Prashant Waiker; Raffaele Tiezzi", "internalName": "Michael Long", "customerEmail": "gunasundari.x.veerapandian@gsk.com; prashant.x.waiker@gsk.com; raffaele.x.tiezzi@gsk.com; john.x.jonesjr@gsk.com; fabrice.x.godart@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}]}, {"id": "gsk_cmc_3647fee8", "company": "gsk", "gong_entity": "CMC", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "We are in the CMC space.", "snippet_date": "2025-10-06", "person_name": "Sara Porfirio; Sara Porfirio", "person_email": "sara.p.porfirio@gsk.com; sara.p.porfirio@gsk.com", "internal_name": "Michelle Jang", "internal_email": "michelle.jang@biorender.com", "llm_suggested_match": {"manual_node_id": "cmc-pharmaceutical-sciences", "manual_node_name": "CMC & Pharmaceutical Sciences", "manual_node_path": "GSK Research & Development > CMC & Pharmaceutical Sciences", "confidence": "high", "reasoning": "Exact acronym match - CMC clearly refers to Chemistry, Manufacturing & Controls which matches the CMC & Pharmaceutical Sciences division"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=b7e0aea127322d14222dc881075e90e7887c28a937366ee461c8c76425a2551d", "call_id": "2025-10-06_b7e0aea12732", "call_count": 1, "all_snippets": [{"quote": "We are in the CMC space.", "date": "2025-10-06", "callId": "2025-10-06_b7e0aea12732", "gongUrl": "https://app.gong.io/call?id=b7e0aea127322d14222dc881075e90e7887c28a937366ee461c8c76425a2551d", "speakerId": "1079118745217509530", "customerName": "Sara Porfirio; Sara Porfirio", "internalName": "Michelle Jang", "customerEmail": "sara.p.porfirio@gsk.com; sara.p.porfirio@gsk.com", "internalEmail": "michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_structure_and_function_characterization_f996dd70", "company": "gsk", "gong_entity": "Structure and Function Characterization", "gong_parent": "Analytical Development", "entity_type": "department", "team_size": "100", "confidence": "high", "mention_count": 1, "snippet": "If\u2026 we were to go up to structure and function characterization level. So that's like, the overarching department\u2026 how can I put this the bottom like the lowest level overarching department? That would be probably like 200 something with 203 100 people between us and UK employees.", "snippet_date": "2025-10-06", "person_name": "Sara Porfirio; Sara Porfirio", "person_email": "sara.p.porfirio@gsk.com; sara.p.porfirio@gsk.com", "internal_name": "Michelle Jang", "internal_email": "michelle.jang@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=b7e0aea127322d14222dc881075e90e7887c28a937366ee461c8c76425a2551d", "call_id": "2025-10-06_b7e0aea12732", "call_count": 1, "all_snippets": [{"quote": "If\u2026 we were to go up to structure and function characterization level. So that's like, the overarching department\u2026 how can I put this the bottom like the lowest level overarching department? That would be probably like 200 something with 203 100 people between us and UK employees.", "date": "2025-10-06", "callId": "2025-10-06_b7e0aea12732", "gongUrl": "https://app.gong.io/call?id=b7e0aea127322d14222dc881075e90e7887c28a937366ee461c8c76425a2551d", "speakerId": "1079118745217509530", "customerName": "Sara Porfirio; Sara Porfirio", "internalName": "Michelle Jang", "customerEmail": "sara.p.porfirio@gsk.com; sara.p.porfirio@gsk.com", "internalEmail": "michelle.jang@biorender.com", "sizeMentions": [{"value": "100", "snippetIndex": 0, "source": {"callDate": "2025-10-06", "customerName": "Sara Porfirio; Sara Porfirio"}}]}]}, {"id": "gsk_cpd_b3df9d77", "company": "gsk", "gong_entity": "CPD", "gong_parent": "GSK R&D", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "so my team is the oligobiology team at CPD in Boston", "snippet_date": "2025-10-03", "person_name": "Amy Lancaster; Amy Lancaster", "person_email": "amy.b.lancaster@gsk.com; amy.b.lancaster@gsk.com", "internal_name": "Michael Long; Michelle Jang", "internal_email": "michael.long@biorender.com; michelle.jang@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=d2bd514f48f515072d570d5f538c52ae788f6e547a64618266eea85d840cfc8c", "call_id": "2025-10-03_d2bd514f48f5", "call_count": 1, "all_snippets": [{"quote": "so my team is the oligobiology team at CPD in Boston", "date": "2025-10-03", "callId": "2025-10-03_d2bd514f48f5", "gongUrl": "https://app.gong.io/call?id=d2bd514f48f515072d570d5f538c52ae788f6e547a64618266eea85d840cfc8c", "speakerId": "8622183118565525883", "customerName": "Amy Lancaster; Amy Lancaster", "internalName": "Michael Long; Michelle Jang", "customerEmail": "amy.b.lancaster@gsk.com; amy.b.lancaster@gsk.com", "internalEmail": "michael.long@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_oligobiology_team_5d8b45e9", "company": "gsk", "gong_entity": "Oligobiology Team", "gong_parent": "CPD", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So my, I'm part of, so my team is the oligobiology team at CPD in Boston", "snippet_date": "2025-10-03", "person_name": "Amy Lancaster; Amy Lancaster", "person_email": "amy.b.lancaster@gsk.com; amy.b.lancaster@gsk.com", "internal_name": "Michael Long; Michelle Jang", "internal_email": "michael.long@biorender.com; michelle.jang@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=d2bd514f48f515072d570d5f538c52ae788f6e547a64618266eea85d840cfc8c", "call_id": "2025-10-03_d2bd514f48f5", "call_count": 1, "all_snippets": [{"quote": "So my, I'm part of, so my team is the oligobiology team at CPD in Boston", "date": "2025-10-03", "callId": "2025-10-03_d2bd514f48f5", "gongUrl": "https://app.gong.io/call?id=d2bd514f48f515072d570d5f538c52ae788f6e547a64618266eea85d840cfc8c", "speakerId": "8622183118565525883", "customerName": "Amy Lancaster; Amy Lancaster", "internalName": "Michael Long; Michelle Jang", "customerEmail": "amy.b.lancaster@gsk.com; amy.b.lancaster@gsk.com", "internalEmail": "michael.long@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_ribu_group_aad73ca3", "company": "gsk", "gong_entity": "RIBU Group", "gong_parent": "GSK R&D", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "We have a lot of users within a ribu group out of collegeville and I think it's new provincetown or new", "snippet_date": "2025-10-03", "person_name": "Amy Lancaster; Amy Lancaster", "person_email": "amy.b.lancaster@gsk.com; amy.b.lancaster@gsk.com", "internal_name": "Michael Long; Michelle Jang", "internal_email": "michael.long@biorender.com; michelle.jang@biorender.com", "llm_suggested_match": {"manual_node_id": "respiratory-immunology-research", "manual_node_name": "Respiratory, Immunology & Inflammation Research", "manual_node_path": "GSK Research & Development > Research > Respiratory, Immunology & Inflammation Research", "confidence": "medium", "reasoning": "RIBU likely stands for Respiratory, Immunology Business Unit, which aligns with the Respiratory, Immunology & Inflammation Research therapeutic area."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=d2bd514f48f515072d570d5f538c52ae788f6e547a64618266eea85d840cfc8c", "call_id": "2025-10-03_d2bd514f48f5", "call_count": 1, "all_snippets": [{"quote": "We have a lot of users within a ribu group out of collegeville and I think it's new provincetown or new", "date": "2025-10-03", "callId": "2025-10-03_d2bd514f48f5", "gongUrl": "https://app.gong.io/call?id=d2bd514f48f515072d570d5f538c52ae788f6e547a64618266eea85d840cfc8c", "speakerId": "4756729082506714629", "customerName": "Amy Lancaster; Amy Lancaster", "internalName": "Michael Long; Michelle Jang", "customerEmail": "amy.b.lancaster@gsk.com; amy.b.lancaster@gsk.com", "internalEmail": "michael.long@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_ribu_collegeville_562644f7", "company": "gsk", "gong_entity": "RIBU Collegeville", "gong_parent": "RIBU Group", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "Jamie actually has a full premium license through the ribu collegeville.", "snippet_date": "2025-10-03", "person_name": "Jay Spampanato; Jay Spampanato", "person_email": "jay.g.spampanato@gsk.com; jay.g.spampanato@gsk.com", "internal_name": "Michael Long; Michelle Jang", "internal_email": "michael.long@biorender.com; michelle.jang@biorender.com", "llm_suggested_match": {"manual_node_id": "respiratory-immunology-research", "manual_node_name": "Respiratory, Immunology & Inflammation Research", "manual_node_path": "GSK Research & Development > Research > Respiratory, Immunology & Inflammation Research", "confidence": "medium", "reasoning": "RIBU likely refers to Respiratory, Immunology Business Unit. Collegeville appears to be a site location not explicitly listed in the manual chart."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=64384a023319e8832d3ea6cc50594c12a75fdfa30094be78097a1ca0c5898b54", "call_id": "2025-10-03_64384a023319", "call_count": 1, "all_snippets": [{"quote": "Jamie actually has a full premium license through the ribu collegeville.", "date": "2025-10-03", "callId": "2025-10-03_64384a023319", "gongUrl": "https://app.gong.io/call?id=64384a023319e8832d3ea6cc50594c12a75fdfa30094be78097a1ca0c5898b54", "speakerId": "6170124378915175397", "customerName": "Jay Spampanato; Jay Spampanato", "internalName": "Michael Long; Michelle Jang", "customerEmail": "jay.g.spampanato@gsk.com; jay.g.spampanato@gsk.com", "internalEmail": "michael.long@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_molecular_modalities_98ce8b88", "company": "gsk", "gong_entity": "Molecular Modalities", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "There's molecular modalities, which is small molecule, large molecule and then oligosciences", "snippet_date": "2025-10-03", "person_name": "Amy Lancaster; Amy Lancaster", "person_email": "amy.b.lancaster@gsk.com; amy.b.lancaster@gsk.com", "internal_name": "Michael Long; Michelle Jang", "internal_email": "michael.long@biorender.com; michelle.jang@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=d2bd514f48f515072d570d5f538c52ae788f6e547a64618266eea85d840cfc8c", "call_id": "2025-10-03_d2bd514f48f5", "call_count": 1, "all_snippets": [{"quote": "There's molecular modalities, which is small molecule, large molecule and then oligosciences", "date": "2025-10-03", "callId": "2025-10-03_d2bd514f48f5", "gongUrl": "https://app.gong.io/call?id=d2bd514f48f515072d570d5f538c52ae788f6e547a64618266eea85d840cfc8c", "speakerId": "8622183118565525883", "customerName": "Amy Lancaster; Amy Lancaster", "internalName": "Michael Long; Michelle Jang", "customerEmail": "amy.b.lancaster@gsk.com; amy.b.lancaster@gsk.com", "internalEmail": "michael.long@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_neurodegeneration_53602ac4", "company": "gsk", "gong_entity": "Neurodegeneration", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "Department neurodegeneration?", "snippet_date": "2025-10-03", "person_name": "Jay Spampanato; Jay Spampanato", "person_email": "jay.g.spampanato@gsk.com; jay.g.spampanato@gsk.com", "internal_name": "Michael Long; Michelle Jang", "internal_email": "michael.long@biorender.com; michelle.jang@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=64384a023319e8832d3ea6cc50594c12a75fdfa30094be78097a1ca0c5898b54", "call_id": "2025-10-03_64384a023319", "call_count": 1, "all_snippets": [{"quote": "Department neurodegeneration?", "date": "2025-10-03", "callId": "2025-10-03_64384a023319", "gongUrl": "https://app.gong.io/call?id=64384a023319e8832d3ea6cc50594c12a75fdfa30094be78097a1ca0c5898b54", "speakerId": "8317628498761682714", "customerName": "Jay Spampanato; Jay Spampanato", "internalName": "Michael Long; Michelle Jang", "customerEmail": "jay.g.spampanato@gsk.com; jay.g.spampanato@gsk.com", "internalEmail": "michael.long@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_oncology_department_5dafc6bc", "company": "gsk", "gong_entity": "Oncology Department", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "we're all within the oncology department", "snippet_date": "2025-10-02", "person_name": "Emily Cook; Michael Bond; Shane O'Brien", "person_email": "emily.k.cook@gsk.com; michael.j.bond@gsk.com; shane.w.obrien@gsk.com", "internal_name": "Michael Long", "internal_email": "michael.long@biorender.com", "llm_suggested_match": {"manual_node_id": "oncology-research", "manual_node_name": "Oncology Research", "manual_node_path": "GSK Research & Development > Research > Oncology Research", "confidence": "high", "reasoning": "Strong semantic match with Oncology Research therapeutic area. The entity refers to 'oncology department' which aligns with the oncology research division."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=d8834ee1bf4dbbcf204921eedf6383a7075ebea2af71b19c14c6a0ce69809cd5", "call_id": "2025-10-02_d8834ee1bf4d", "call_count": 1, "all_snippets": [{"quote": "we're all within the oncology department", "date": "2025-10-02", "callId": "2025-10-02_d8834ee1bf4d", "gongUrl": "https://app.gong.io/call?id=d8834ee1bf4dbbcf204921eedf6383a7075ebea2af71b19c14c6a0ce69809cd5", "speakerId": "2477068419797917184", "customerName": "Emily Cook; Michael Bond; Shane O'Brien", "internalName": "Michael Long", "customerEmail": "emily.k.cook@gsk.com; michael.j.bond@gsk.com; shane.w.obrien@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}]}, {"id": "gsk_innovation_team_8fc7271a", "company": "gsk", "gong_entity": "Innovation Team", "gong_parent": "Oncology Department", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "we're both on the, in the innovation team within oncology", "snippet_date": "2025-10-02", "person_name": "Emily Cook; Michael Bond; Shane O'Brien", "person_email": "emily.k.cook@gsk.com; michael.j.bond@gsk.com; shane.w.obrien@gsk.com", "internal_name": "Michael Long", "internal_email": "michael.long@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=d8834ee1bf4dbbcf204921eedf6383a7075ebea2af71b19c14c6a0ce69809cd5", "call_id": "2025-10-02_d8834ee1bf4d", "call_count": 1, "all_snippets": [{"quote": "we're both on the, in the innovation team within oncology", "date": "2025-10-02", "callId": "2025-10-02_d8834ee1bf4d", "gongUrl": "https://app.gong.io/call?id=d8834ee1bf4dbbcf204921eedf6383a7075ebea2af71b19c14c6a0ce69809cd5", "speakerId": "2998628159313808982", "customerName": "Emily Cook; Michael Bond; Shane O'Brien", "internalName": "Michael Long", "customerEmail": "emily.k.cook@gsk.com; michael.j.bond@gsk.com; shane.w.obrien@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}]}, {"id": "gsk_raibu_group_3633b725", "company": "gsk", "gong_entity": "RAIBU Group", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "raibu, group, which is our main point of contact and head is Anthony virtue", "snippet_date": "2025-10-02", "person_name": "Emily Cook; Michael Bond; Shane O'Brien", "person_email": "emily.k.cook@gsk.com; michael.j.bond@gsk.com; shane.w.obrien@gsk.com", "internal_name": "Michael Long", "internal_email": "michael.long@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=d8834ee1bf4dbbcf204921eedf6383a7075ebea2af71b19c14c6a0ce69809cd5", "call_id": "2025-10-02_d8834ee1bf4d", "call_count": 1, "all_snippets": [{"quote": "raibu, group, which is our main point of contact and head is Anthony virtue", "date": "2025-10-02", "callId": "2025-10-02_d8834ee1bf4d", "gongUrl": "https://app.gong.io/call?id=d8834ee1bf4dbbcf204921eedf6383a7075ebea2af71b19c14c6a0ce69809cd5", "speakerId": "688751584058716562", "customerName": "Emily Cook; Michael Bond; Shane O'Brien", "internalName": "Michael Long", "customerEmail": "emily.k.cook@gsk.com; michael.j.bond@gsk.com; shane.w.obrien@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}]}, {"id": "gsk_cambridge_252e6bbf", "company": "gsk", "gong_entity": "Cambridge", "gong_parent": "GSK R&D", "entity_type": "site", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I'm in cambridge", "snippet_date": "2025-10-02", "person_name": "Emily Cook; Michael Bond; Shane O'Brien", "person_email": "emily.k.cook@gsk.com; michael.j.bond@gsk.com; shane.w.obrien@gsk.com", "internal_name": "Michael Long", "internal_email": "michael.long@biorender.com", "llm_suggested_match": {"manual_node_id": "cambridge-ma-binney", "manual_node_name": "Cambridge Binney Street, MA, USA", "manual_node_path": "GSK Research & Development > Global R&D Sites > Cambridge Binney Street, MA, USA", "confidence": "medium", "reasoning": "Cambridge matches multiple GSK sites in Cambridge, MA. Selected Binney Street as it's the first Cambridge location, but could be any of the three Cambridge sites (Binney Street, Park Drive, or Tech Square)."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=d8834ee1bf4dbbcf204921eedf6383a7075ebea2af71b19c14c6a0ce69809cd5", "call_id": "2025-10-02_d8834ee1bf4d", "call_count": 1, "all_snippets": [{"quote": "I'm in cambridge", "date": "2025-10-02", "callId": "2025-10-02_d8834ee1bf4d", "gongUrl": "https://app.gong.io/call?id=d8834ee1bf4dbbcf204921eedf6383a7075ebea2af71b19c14c6a0ce69809cd5", "speakerId": "2998628159313808982", "customerName": "Emily Cook; Michael Bond; Shane O'Brien", "internalName": "Michael Long", "customerEmail": "emily.k.cook@gsk.com; michael.j.bond@gsk.com; shane.w.obrien@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}]}, {"id": "gsk_stevenage_office_f076b9f5", "company": "gsk", "gong_entity": "Stevenage Office", "gong_parent": "GSK R&D", "entity_type": "site", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "we went to the, stevanage office", "snippet_date": "2025-10-02", "person_name": "Emily Cook; Michael Bond; Shane O'Brien", "person_email": "emily.k.cook@gsk.com; michael.j.bond@gsk.com; shane.w.obrien@gsk.com", "internal_name": "Michael Long", "internal_email": "michael.long@biorender.com", "llm_suggested_match": {"manual_node_id": "stevenage-uk", "manual_node_name": "Stevenage, UK (Global R&D Hub)", "manual_node_path": "GSK Research & Development > Global R&D Sites > Stevenage, UK (Global R&D Hub)", "confidence": "high", "reasoning": "Exact location match - 'Stevenage Office' clearly refers to the Stevenage, UK site which is GSK's Global R&D Hub."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=d8834ee1bf4dbbcf204921eedf6383a7075ebea2af71b19c14c6a0ce69809cd5", "call_id": "2025-10-02_d8834ee1bf4d", "call_count": 1, "all_snippets": [{"quote": "we went to the, stevanage office", "date": "2025-10-02", "callId": "2025-10-02_d8834ee1bf4d", "gongUrl": "https://app.gong.io/call?id=d8834ee1bf4dbbcf204921eedf6383a7075ebea2af71b19c14c6a0ce69809cd5", "speakerId": "688751584058716562", "customerName": "Emily Cook; Michael Bond; Shane O'Brien", "internalName": "Michael Long", "customerEmail": "emily.k.cook@gsk.com; michael.j.bond@gsk.com; shane.w.obrien@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}]}, {"id": "gsk_bbp_team_87be906d", "company": "gsk", "gong_entity": "BBP Team", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "I know that the last time we spoke, I kind of sent over that webinar flyer for you to gauge interest within the bbp team.", "snippet_date": "2025-09-19", "person_name": "Kim Reese; Kim Reese", "person_email": "kim.x.reese@gsk.com; kim.x.reese@gsk.com", "internal_name": "Michelle Jang; Walid Habboub", "internal_email": "michelle.jang@biorender.com; walid@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=6aeea9d3a0417f56957e00b7c8de09f1017b1188e263f6d31ba6550d574311b1", "call_id": "2025-09-19_6aeea9d3a041", "call_count": 1, "all_snippets": [{"quote": "I know that the last time we spoke, I kind of sent over that webinar flyer for you to gauge interest within the bbp team.", "date": "2025-09-19", "callId": "2025-09-19_6aeea9d3a041", "gongUrl": "https://app.gong.io/call?id=6aeea9d3a0417f56957e00b7c8de09f1017b1188e263f6d31ba6550d574311b1", "speakerId": "2369921625698132635", "customerName": "Kim Reese; Kim Reese", "internalName": "Michelle Jang; Walid Habboub", "customerEmail": "kim.x.reese@gsk.com; kim.x.reese@gsk.com", "internalEmail": "michelle.jang@biorender.com; walid@biorender.com", "sizeMentions": []}]}, {"id": "gsk_clinical_pharmacology_modeling_and_simulation_76533750", "company": "gsk", "gong_entity": "Clinical Pharmacology Modeling and Simulation", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "our broader team is now called clinical, pharmacology, modeling and simulation", "snippet_date": "2025-09-18", "person_name": "Brett Howell; Brett Howell", "person_email": "brett.a.howell@gsk.com; brett.a.howell@gsk.com", "internal_name": "Jacqueline McCoskey; Michelle Jang", "internal_email": "jacqueline@biorender.com; michelle.jang@biorender.com", "llm_suggested_match": {"manual_node_id": "clinical-pharmacology", "manual_node_name": "Clinical Pharmacology", "manual_node_path": "GSK Research & Development > Development > Clinical Pharmacology", "confidence": "high", "reasoning": "Strong match - the entity includes 'Clinical Pharmacology' and mentions 'Modeling and Simulation' which exists as a team under Clinical Pharmacology department."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=d402ad3f64bbaf948742e0cdc7340b6225fef23b59d465a2c3417220269fd562", "call_id": "2025-09-18_d402ad3f64bb", "call_count": 1, "all_snippets": [{"quote": "our broader team is now called clinical, pharmacology, modeling and simulation", "date": "2025-09-18", "callId": "2025-09-18_d402ad3f64bb", "gongUrl": "https://app.gong.io/call?id=d402ad3f64bbaf948742e0cdc7340b6225fef23b59d465a2c3417220269fd562", "speakerId": "1739148489330104977", "customerName": "Brett Howell; Brett Howell", "internalName": "Jacqueline McCoskey; Michelle Jang", "customerEmail": "brett.a.howell@gsk.com; brett.a.howell@gsk.com", "internalEmail": "jacqueline@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_cpms_oncology_942e7b53", "company": "gsk", "gong_entity": "CPMS Oncology", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So, CP, we call it cpms oncology", "snippet_date": "2025-09-18", "person_name": "Brett Howell; Brett Howell", "person_email": "brett.a.howell@gsk.com; brett.a.howell@gsk.com", "internal_name": "Jacqueline McCoskey; Michelle Jang", "internal_email": "jacqueline@biorender.com; michelle.jang@biorender.com", "llm_suggested_match": {"manual_node_id": "modeling-simulation", "manual_node_name": "Modeling & Simulation", "manual_node_path": "GSK Research & Development > Development > Clinical Pharmacology > Modeling & Simulation", "confidence": "medium", "reasoning": "CPMS likely stands for 'Clinical Pharmacology Modeling and Simulation' with oncology focus. Best match is the Modeling & Simulation team under Clinical Pharmacology."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=d402ad3f64bbaf948742e0cdc7340b6225fef23b59d465a2c3417220269fd562", "call_id": "2025-09-18_d402ad3f64bb", "call_count": 1, "all_snippets": [{"quote": "So, CP, we call it cpms oncology", "date": "2025-09-18", "callId": "2025-09-18_d402ad3f64bb", "gongUrl": "https://app.gong.io/call?id=d402ad3f64bbaf948742e0cdc7340b6225fef23b59d465a2c3417220269fd562", "speakerId": "1739148489330104977", "customerName": "Brett Howell; Brett Howell", "internalName": "Jacqueline McCoskey; Michelle Jang", "customerEmail": "brett.a.howell@gsk.com; brett.a.howell@gsk.com", "internalEmail": "jacqueline@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_qsp_team_69ffd1a0", "company": "gsk", "gong_entity": "QSP Team", "gong_parent": "CPMS Oncology", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So I lead the, what's called the qsp team", "snippet_date": "2025-09-18", "person_name": "Brett Howell; Brett Howell", "person_email": "brett.a.howell@gsk.com; brett.a.howell@gsk.com", "internal_name": "Jacqueline McCoskey; Michelle Jang", "internal_email": "jacqueline@biorender.com; michelle.jang@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=d402ad3f64bbaf948742e0cdc7340b6225fef23b59d465a2c3417220269fd562", "call_id": "2025-09-18_d402ad3f64bb", "call_count": 1, "all_snippets": [{"quote": "So I lead the, what's called the qsp team", "date": "2025-09-18", "callId": "2025-09-18_d402ad3f64bb", "gongUrl": "https://app.gong.io/call?id=d402ad3f64bbaf948742e0cdc7340b6225fef23b59d465a2c3417220269fd562", "speakerId": "1739148489330104977", "customerName": "Brett Howell; Brett Howell", "internalName": "Jacqueline McCoskey; Michelle Jang", "customerEmail": "brett.a.howell@gsk.com; brett.a.howell@gsk.com", "internalEmail": "jacqueline@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_durham_47c2fab2", "company": "gsk", "gong_entity": "Durham", "gong_parent": "GSK R&D", "entity_type": "site", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "But we have an office in Durham as well", "snippet_date": "2025-09-18", "person_name": "Brett Howell; Brett Howell", "person_email": "brett.a.howell@gsk.com; brett.a.howell@gsk.com", "internal_name": "Jacqueline McCoskey; Michelle Jang", "internal_email": "jacqueline@biorender.com; michelle.jang@biorender.com", "llm_suggested_match": {"manual_node_id": "durham-nc", "manual_node_name": "Durham, NC, USA", "manual_node_path": "GSK Research & Development > Global R&D Sites > Durham, NC, USA", "confidence": "high", "reasoning": "Exact location match - 'Durham' refers to the Durham, NC, USA site listed in the Global R&D Sites."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=d402ad3f64bbaf948742e0cdc7340b6225fef23b59d465a2c3417220269fd562", "call_id": "2025-09-18_d402ad3f64bb", "call_count": 1, "all_snippets": [{"quote": "But we have an office in Durham as well", "date": "2025-09-18", "callId": "2025-09-18_d402ad3f64bb", "gongUrl": "https://app.gong.io/call?id=d402ad3f64bbaf948742e0cdc7340b6225fef23b59d465a2c3417220269fd562", "speakerId": "1739148489330104977", "customerName": "Brett Howell; Brett Howell", "internalName": "Jacqueline McCoskey; Michelle Jang", "customerEmail": "brett.a.howell@gsk.com; brett.a.howell@gsk.com", "internalEmail": "jacqueline@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_large_molecule_research_team_832fbd98", "company": "gsk", "gong_entity": "Large Molecule Research Team", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So Michelle had noted you're in the large molecule research team.", "snippet_date": "2025-09-17", "person_name": "Rajesh Sundaresan; Rajesh Sundaresan", "person_email": "rajesh.a.sundaresan@gsk.com; rajesh.a.sundaresan@gsk.com", "internal_name": "Jacqueline McCoskey; Michelle Jang", "internal_email": "jacqueline@biorender.com; michelle.jang@biorender.com", "llm_suggested_match": {"manual_node_id": "biologics-discovery", "manual_node_name": "Biologics Discovery", "manual_node_path": "GSK Research & Development > Medicinal Science & Technology > Biologics Discovery", "confidence": "medium", "reasoning": "Large molecules typically refer to biologics. The Biologics Discovery department is the best match for a large molecule research team."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=2360901185648fdba0e5a4273010b74cec0ad73754ddd7100e4791cf2a9be46b", "call_id": "2025-09-17_236090118564", "call_count": 1, "all_snippets": [{"quote": "So Michelle had noted you're in the large molecule research team.", "date": "2025-09-17", "callId": "2025-09-17_236090118564", "gongUrl": "https://app.gong.io/call?id=2360901185648fdba0e5a4273010b74cec0ad73754ddd7100e4791cf2a9be46b", "speakerId": "194383144458794459", "customerName": "Rajesh Sundaresan; Rajesh Sundaresan", "internalName": "Jacqueline McCoskey; Michelle Jang", "customerEmail": "rajesh.a.sundaresan@gsk.com; rajesh.a.sundaresan@gsk.com", "internalEmail": "jacqueline@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_early_discovery_team_3505efcf", "company": "gsk", "gong_entity": "Early Discovery Team", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So we were part of the early discovery team.", "snippet_date": "2025-09-17", "person_name": "Rajesh Sundaresan; Rajesh Sundaresan", "person_email": "rajesh.a.sundaresan@gsk.com; rajesh.a.sundaresan@gsk.com", "internal_name": "Jacqueline McCoskey; Michelle Jang", "internal_email": "jacqueline@biorender.com; michelle.jang@biorender.com", "llm_suggested_match": {"manual_node_id": "research", "manual_node_name": "Research", "manual_node_path": "GSK Research & Development > Research", "confidence": "medium", "reasoning": "Early discovery activities typically fall under the Research division. While not an exact match, Research is the most appropriate high-level division for early discovery work."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=2360901185648fdba0e5a4273010b74cec0ad73754ddd7100e4791cf2a9be46b", "call_id": "2025-09-17_236090118564", "call_count": 1, "all_snippets": [{"quote": "So we were part of the early discovery team.", "date": "2025-09-17", "callId": "2025-09-17_236090118564", "gongUrl": "https://app.gong.io/call?id=2360901185648fdba0e5a4273010b74cec0ad73754ddd7100e4791cf2a9be46b", "speakerId": "7124197286904339622", "customerName": "Rajesh Sundaresan; Rajesh Sundaresan", "internalName": "Jacqueline McCoskey; Michelle Jang", "customerEmail": "rajesh.a.sundaresan@gsk.com; rajesh.a.sundaresan@gsk.com", "internalEmail": "jacqueline@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_wat_team_cdbecbcf", "company": "gsk", "gong_entity": "WAT Team", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So we have the wat team. So the wat team, WH a T team.", "snippet_date": "2025-09-17", "person_name": "Rajesh Sundaresan; Rajesh Sundaresan", "person_email": "rajesh.a.sundaresan@gsk.com; rajesh.a.sundaresan@gsk.com", "internal_name": "Jacqueline McCoskey; Michelle Jang", "internal_email": "jacqueline@biorender.com; michelle.jang@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=2360901185648fdba0e5a4273010b74cec0ad73754ddd7100e4791cf2a9be46b", "call_id": "2025-09-17_236090118564", "call_count": 1, "all_snippets": [{"quote": "So we have the wat team. So the wat team, WH a T team.", "date": "2025-09-17", "callId": "2025-09-17_236090118564", "gongUrl": "https://app.gong.io/call?id=2360901185648fdba0e5a4273010b74cec0ad73754ddd7100e4791cf2a9be46b", "speakerId": "7124197286904339622", "customerName": "Rajesh Sundaresan; Rajesh Sundaresan", "internalName": "Jacqueline McCoskey; Michelle Jang", "customerEmail": "rajesh.a.sundaresan@gsk.com; rajesh.a.sundaresan@gsk.com", "internalEmail": "jacqueline@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_research_units_638cf8e1", "company": "gsk", "gong_entity": "Research Units", "gong_parent": "GSK R&D", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So we call them the research units.", "snippet_date": "2025-09-17", "person_name": "Rajesh Sundaresan; Rajesh Sundaresan", "person_email": "rajesh.a.sundaresan@gsk.com; rajesh.a.sundaresan@gsk.com", "internal_name": "Jacqueline McCoskey; Michelle Jang", "internal_email": "jacqueline@biorender.com; michelle.jang@biorender.com", "llm_suggested_match": {"manual_node_id": "research", "manual_node_name": "Research", "manual_node_path": "GSK Research & Development > Research", "confidence": "medium", "reasoning": "Generic reference to research units likely refers to the main Research division which contains multiple therapeutic area units"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=2360901185648fdba0e5a4273010b74cec0ad73754ddd7100e4791cf2a9be46b", "call_id": "2025-09-17_236090118564", "call_count": 1, "all_snippets": [{"quote": "So we call them the research units.", "date": "2025-09-17", "callId": "2025-09-17_236090118564", "gongUrl": "https://app.gong.io/call?id=2360901185648fdba0e5a4273010b74cec0ad73754ddd7100e4791cf2a9be46b", "speakerId": "7124197286904339622", "customerName": "Rajesh Sundaresan; Rajesh Sundaresan", "internalName": "Jacqueline McCoskey; Michelle Jang", "customerEmail": "rajesh.a.sundaresan@gsk.com; rajesh.a.sundaresan@gsk.com", "internalEmail": "jacqueline@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_how_team_5f722a7f", "company": "gsk", "gong_entity": "HOW Team", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "And then we come, we are part of the, how team.", "snippet_date": "2025-09-17", "person_name": "Rajesh Sundaresan; Rajesh Sundaresan", "person_email": "rajesh.a.sundaresan@gsk.com; rajesh.a.sundaresan@gsk.com", "internal_name": "Jacqueline McCoskey; Michelle Jang", "internal_email": "jacqueline@biorender.com; michelle.jang@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=2360901185648fdba0e5a4273010b74cec0ad73754ddd7100e4791cf2a9be46b", "call_id": "2025-09-17_236090118564", "call_count": 1, "all_snippets": [{"quote": "And then we come, we are part of the, how team.", "date": "2025-09-17", "callId": "2025-09-17_236090118564", "gongUrl": "https://app.gong.io/call?id=2360901185648fdba0e5a4273010b74cec0ad73754ddd7100e4791cf2a9be46b", "speakerId": "7124197286904339622", "customerName": "Rajesh Sundaresan; Rajesh Sundaresan", "internalName": "Jacqueline McCoskey; Michelle Jang", "customerEmail": "rajesh.a.sundaresan@gsk.com; rajesh.a.sundaresan@gsk.com", "internalEmail": "jacqueline@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_when_team_825d4652", "company": "gsk", "gong_entity": "WHEN Team", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "And then the, when team is a commercial team, right?", "snippet_date": "2025-09-17", "person_name": "Rajesh Sundaresan; Rajesh Sundaresan", "person_email": "rajesh.a.sundaresan@gsk.com; rajesh.a.sundaresan@gsk.com", "internal_name": "Jacqueline McCoskey; Michelle Jang", "internal_email": "jacqueline@biorender.com; michelle.jang@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=2360901185648fdba0e5a4273010b74cec0ad73754ddd7100e4791cf2a9be46b", "call_id": "2025-09-17_236090118564", "call_count": 1, "all_snippets": [{"quote": "And then the, when team is a commercial team, right?", "date": "2025-09-17", "callId": "2025-09-17_236090118564", "gongUrl": "https://app.gong.io/call?id=2360901185648fdba0e5a4273010b74cec0ad73754ddd7100e4791cf2a9be46b", "speakerId": "7124197286904339622", "customerName": "Rajesh Sundaresan; Rajesh Sundaresan", "internalName": "Jacqueline McCoskey; Michelle Jang", "customerEmail": "rajesh.a.sundaresan@gsk.com; rajesh.a.sundaresan@gsk.com", "internalEmail": "jacqueline@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_immunology_and_inflammation_therapeutic_unit_43a867e9", "company": "gsk", "gong_entity": "Immunology and Inflammation Therapeutic Unit", "gong_parent": "GSK R&D", "entity_type": "therapeutic_area", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "it's the it's\u2026 immunology and inflammation therapeutic unit that's what it's I believe that's what it's currently called", "snippet_date": "2025-09-16", "person_name": "David Lipshutz", "person_email": "david.b.lipshutz@gsk.com", "internal_name": "Michelle Jang", "internal_email": "michelle.jang@biorender.com", "llm_suggested_match": {"manual_node_id": "respiratory-immunology-research", "manual_node_name": "Respiratory, Immunology & Inflammation Research", "manual_node_path": "GSK Research & Development > Research > Respiratory, Immunology & Inflammation Research", "confidence": "high", "reasoning": "Strong semantic match - 'Immunology and Inflammation' maps directly to 'Respiratory, Immunology & Inflammation Research' therapeutic area"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=cdd66f55adb2418bbc8ad438fe78804b882597dea669f5a52f1ced5cfcd25a8a", "call_id": "2025-09-16_cdd66f55adb2", "call_count": 1, "all_snippets": [{"quote": "it's the it's\u2026 immunology and inflammation therapeutic unit that's what it's I believe that's what it's currently called", "date": "2025-09-16", "callId": "2025-09-16_cdd66f55adb2", "gongUrl": "https://app.gong.io/call?id=cdd66f55adb2418bbc8ad438fe78804b882597dea669f5a52f1ced5cfcd25a8a", "speakerId": "9120475520023842770", "customerName": "David Lipshutz", "internalName": "Michelle Jang", "customerEmail": "david.b.lipshutz@gsk.com", "internalEmail": "michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_business_development_2d8c0229", "company": "gsk", "gong_entity": "Business Development", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "but like now, if it comes from, you know, digital marketing or like business development side", "snippet_date": "2025-09-16", "person_name": "Bhasker Radaram", "person_email": "bhasker.x.radaram@gsk.com", "internal_name": "Michelle Jang", "internal_email": "michelle.jang@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=1366b7cc0516b72ec6d90dc4e01493ccdd6036eb21b68bf9b1e2932bf6653086", "call_id": "2025-09-16_1366b7cc0516", "call_count": 1, "all_snippets": [{"quote": "but like now, if it comes from, you know, digital marketing or like business development side", "date": "2025-09-16", "callId": "2025-09-16_1366b7cc0516", "gongUrl": "https://app.gong.io/call?id=1366b7cc0516b72ec6d90dc4e01493ccdd6036eb21b68bf9b1e2932bf6653086", "speakerId": "6359003338091271041", "customerName": "Bhasker Radaram", "internalName": "Michelle Jang", "customerEmail": "bhasker.x.radaram@gsk.com", "internalEmail": "michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_digital_marketing_82bf6810", "company": "gsk", "gong_entity": "Digital Marketing", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "but like now, if it comes from, you know, digital marketing or like business development side", "snippet_date": "2025-09-16", "person_name": "Bhasker Radaram", "person_email": "bhasker.x.radaram@gsk.com", "internal_name": "Michelle Jang", "internal_email": "michelle.jang@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=1366b7cc0516b72ec6d90dc4e01493ccdd6036eb21b68bf9b1e2932bf6653086", "call_id": "2025-09-16_1366b7cc0516", "call_count": 1, "all_snippets": [{"quote": "but like now, if it comes from, you know, digital marketing or like business development side", "date": "2025-09-16", "callId": "2025-09-16_1366b7cc0516", "gongUrl": "https://app.gong.io/call?id=1366b7cc0516b72ec6d90dc4e01493ccdd6036eb21b68bf9b1e2932bf6653086", "speakerId": "6359003338091271041", "customerName": "Bhasker Radaram", "internalName": "Michelle Jang", "customerEmail": "bhasker.x.radaram@gsk.com", "internalEmail": "michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_riiru_d86840f7", "company": "gsk", "gong_entity": "RIIRU", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "we met with, I don't know if I should pronounce it riiroo. But it's the RIIRU team.", "snippet_date": "2025-09-16", "person_name": "Tim Hamerly; Tim Hamerly; Tim Hamerly; Tim Hamerly", "person_email": "tim.k.hamerly@gsk.com; tim.k.hamerly@gsk.com; tim.k.hamerly@gsk.com; tim.k.hamerly@gsk.com", "internal_name": "Walid Habboub", "internal_email": "walid@biorender.com", "llm_suggested_match": {"manual_node_id": "respiratory-immunology-research", "manual_node_name": "Respiratory, Immunology & Inflammation Research", "manual_node_path": "GSK Research & Development > Research > Respiratory, Immunology & Inflammation Research", "confidence": "high", "reasoning": "RIIRU appears to be an acronym for 'Respiratory, Immunology & Inflammation Research Unit' - matches the therapeutic area exactly"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=67c3826736f835724dd0e4da51c7f1f5c3aa5b84de5b8d66186437cfeaaf7b33", "call_id": "2025-09-16_67c3826736f8", "call_count": 1, "all_snippets": [{"quote": "we met with, I don't know if I should pronounce it riiroo. But it's the RIIRU team.", "date": "2025-09-16", "callId": "2025-09-16_67c3826736f8", "gongUrl": "https://app.gong.io/call?id=67c3826736f835724dd0e4da51c7f1f5c3aa5b84de5b8d66186437cfeaaf7b33", "speakerId": "5355256015715604085", "customerName": "Tim Hamerly; Tim Hamerly; Tim Hamerly; Tim Hamerly", "internalName": "Walid Habboub", "customerEmail": "tim.k.hamerly@gsk.com; tim.k.hamerly@gsk.com; tim.k.hamerly@gsk.com; tim.k.hamerly@gsk.com", "internalEmail": "walid@biorender.com", "sizeMentions": []}]}, {"id": "gsk_atct_4896d6a4", "company": "gsk", "gong_entity": "ATCT", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So we are in atct, so the research unit.", "snippet_date": "2025-09-15", "person_name": "Natacha Steinckwich-Besancon", "person_email": "natacha.x.steinckwich-besancon@gsk.com", "internal_name": "Michelle Jang", "internal_email": "michelle.jang@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=f3479b8f25850f3b96859ffe9ad38c626cdc729fb5ee10e2bb6a951891bd47f9", "call_id": "2025-09-15_f3479b8f2585", "call_count": 1, "all_snippets": [{"quote": "So we are in atct, so the research unit.", "date": "2025-09-15", "callId": "2025-09-15_f3479b8f2585", "gongUrl": "https://app.gong.io/call?id=f3479b8f25850f3b96859ffe9ad38c626cdc729fb5ee10e2bb6a951891bd47f9", "speakerId": "974860769058339397", "customerName": "Natacha Steinckwich-Besancon", "internalName": "Michelle Jang", "customerEmail": "natacha.x.steinckwich-besancon@gsk.com", "internalEmail": "michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_molecular_modalities_and_discovery_e9003f96", "company": "gsk", "gong_entity": "Molecular Modalities and Discovery", "gong_parent": "GSK R&D", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "Department or it's like molecular modalities and discovery like they're that's like the greater org, gotcha under pharma", "snippet_date": "2025-09-15", "person_name": "Brett Estes; Brett Estes", "person_email": "brett.j.estes@gsk.com; brett.j.estes@gsk.com", "internal_name": "Michelle Jang", "internal_email": "michelle.jang@biorender.com", "llm_suggested_match": {"manual_node_id": "medicinal-science-technology", "manual_node_name": "Medicinal Science & Technology", "manual_node_path": "GSK Research & Development > Medicinal Science & Technology", "confidence": "medium", "reasoning": "Semantic match - 'Molecular Modalities and Discovery' aligns with drug discovery activities under Medicinal Science & Technology division"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=5540535c969ad20650657c3cbd7009d1feddff907ffcdd3474a78635904c8ac9", "call_id": "2025-09-15_5540535c969a", "call_count": 1, "all_snippets": [{"quote": "Department or it's like molecular modalities and discovery like they're that's like the greater org, gotcha under pharma", "date": "2025-09-15", "callId": "2025-09-15_5540535c969a", "gongUrl": "https://app.gong.io/call?id=5540535c969ad20650657c3cbd7009d1feddff907ffcdd3474a78635904c8ac9", "speakerId": "6191335738950966226", "customerName": "Brett Estes; Brett Estes", "internalName": "Michelle Jang", "customerEmail": "brett.j.estes@gsk.com; brett.j.estes@gsk.com", "internalEmail": "michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_oligosciences_department_211ee17a", "company": "gsk", "gong_entity": "Oligosciences Department", "gong_parent": "Molecular Modalities and Discovery", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I'm in the oligosciences department", "snippet_date": "2025-09-15", "person_name": "Brett Estes; Brett Estes", "person_email": "brett.j.estes@gsk.com; brett.j.estes@gsk.com", "internal_name": "Michelle Jang", "internal_email": "michelle.jang@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=5540535c969ad20650657c3cbd7009d1feddff907ffcdd3474a78635904c8ac9", "call_id": "2025-09-15_5540535c969a", "call_count": 1, "all_snippets": [{"quote": "I'm in the oligosciences department", "date": "2025-09-15", "callId": "2025-09-15_5540535c969a", "gongUrl": "https://app.gong.io/call?id=5540535c969ad20650657c3cbd7009d1feddff907ffcdd3474a78635904c8ac9", "speakerId": "6191335738950966226", "customerName": "Brett Estes; Brett Estes", "internalName": "Michelle Jang", "customerEmail": "brett.j.estes@gsk.com; brett.j.estes@gsk.com", "internalEmail": "michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_htcl_bd98c684", "company": "gsk", "gong_entity": "HTCL", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So, I'm in the department for htcl, it's running a clinical\u2026 trial for the rxv vaccine.", "snippet_date": "2025-09-15", "person_name": "Mathilde Galais; Mathilde Galais", "person_email": "mathilde.x.galais@gsk.com; mathilde.x.galais@gsk.com", "internal_name": "Michelle Jang", "internal_email": "michelle.jang@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=0931d68138afd328336b57332a4aab9063137b2265f51320a916137bbf84a4d2", "call_id": "2025-09-15_0931d68138af", "call_count": 1, "all_snippets": [{"quote": "So, I'm in the department for htcl, it's running a clinical\u2026 trial for the rxv vaccine.", "date": "2025-09-15", "callId": "2025-09-15_0931d68138af", "gongUrl": "https://app.gong.io/call?id=0931d68138afd328336b57332a4aab9063137b2265f51320a916137bbf84a4d2", "speakerId": "1677354052943189611", "customerName": "Mathilde Galais; Mathilde Galais", "internalName": "Michelle Jang", "customerEmail": "mathilde.x.galais@gsk.com; mathilde.x.galais@gsk.com", "internalEmail": "michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_id_organization_68759998", "company": "gsk", "gong_entity": "ID Organization", "gong_parent": "GSK R&D", "entity_type": "business_unit", "team_size": "50", "confidence": "high", "mention_count": 1, "snippet": "when the whole id organization is more than seven to 50 to 60", "snippet_date": "2025-09-12", "person_name": "Avijit Ray; Avijit Ray", "person_email": "avijit.r.ray@gsk.com; avijit.r.ray@gsk.com", "internal_name": "Michelle Jang", "internal_email": "michelle.jang@biorender.com", "llm_suggested_match": {"manual_node_id": "infectious-diseases-development", "manual_node_name": "Infectious Diseases Development", "manual_node_path": "GSK Research & Development > Development > Infectious Diseases Development", "confidence": "medium", "reasoning": "ID likely stands for Infectious Diseases, matching the Infectious Diseases Development therapeutic area, though entity type differs (business_unit vs therapeutic_area)"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=edbf5121af36c0cd11ee5baf0b933463de64565f2262067f8df7f0ef5a29ac8b", "call_id": "2025-09-12_edbf5121af36", "call_count": 1, "all_snippets": [{"quote": "when the whole id organization is more than seven to 50 to 60", "date": "2025-09-12", "callId": "2025-09-12_edbf5121af36", "gongUrl": "https://app.gong.io/call?id=edbf5121af36c0cd11ee5baf0b933463de64565f2262067f8df7f0ef5a29ac8b", "speakerId": "6986996972425148019", "customerName": "Avijit Ray; Avijit Ray", "internalName": "Michelle Jang", "customerEmail": "avijit.r.ray@gsk.com; avijit.r.ray@gsk.com", "internalEmail": "michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_vaccines_and_id_department_aec71cc8", "company": "gsk", "gong_entity": "Vaccines and ID Department", "gong_parent": "ID Organization", "entity_type": "department", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "I'm in the vaccine and id department", "snippet_date": "2025-09-12", "person_name": "Avijit Ray; Avijit Ray", "person_email": "avijit.r.ray@gsk.com; avijit.r.ray@gsk.com", "internal_name": "Michelle Jang", "internal_email": "michelle.jang@biorender.com", "llm_suggested_match": {"manual_node_id": "vaccines-infectious-diseases-research", "manual_node_name": "Vaccines & Infectious Diseases Research", "manual_node_path": "GSK Research & Development > Research > Vaccines & Infectious Diseases Research", "confidence": "high", "reasoning": "Strong semantic match - 'Vaccines and ID' aligns well with 'Vaccines & Infectious Diseases Research' therapeutic area"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=edbf5121af36c0cd11ee5baf0b933463de64565f2262067f8df7f0ef5a29ac8b", "call_id": "2025-09-12_edbf5121af36", "call_count": 1, "all_snippets": [{"quote": "I'm in the vaccine and id department", "date": "2025-09-12", "callId": "2025-09-12_edbf5121af36", "gongUrl": "https://app.gong.io/call?id=edbf5121af36c0cd11ee5baf0b933463de64565f2262067f8df7f0ef5a29ac8b", "speakerId": "6986996972425148019", "customerName": "Avijit Ray; Avijit Ray", "internalName": "Michelle Jang", "customerEmail": "avijit.r.ray@gsk.com; avijit.r.ray@gsk.com", "internalEmail": "michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_mbv_group_adf49a8d", "company": "gsk", "gong_entity": "MBV Group", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "but in the mbv group, there were four, I think there's four lab heads that are, you know, in charge of the different groups of scientists", "snippet_date": "2025-09-12", "person_name": "Laura Lessen", "person_email": "laura.n.lessen@gsk.com", "internal_name": "Michelle Jang", "internal_email": "michelle.jang@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=902bd3a5f20d8844ef4b15ad60f4252dcc62a04ed66b00777bb367ece5d9e10e", "call_id": "2025-09-12_902bd3a5f20d", "call_count": 1, "all_snippets": [{"quote": "but in the mbv group, there were four, I think there's four lab heads that are, you know, in charge of the different groups of scientists", "date": "2025-09-12", "callId": "2025-09-12_902bd3a5f20d", "gongUrl": "https://app.gong.io/call?id=902bd3a5f20d8844ef4b15ad60f4252dcc62a04ed66b00777bb367ece5d9e10e", "speakerId": "7040570900781563444", "customerName": "Laura Lessen", "internalName": "Michelle Jang", "customerEmail": "laura.n.lessen@gsk.com", "internalEmail": "michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_large_molecule_research_b463ef35", "company": "gsk", "gong_entity": "Large Molecule Research", "gong_parent": "GSK R&D", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So large molecule research.", "snippet_date": "2025-09-12", "person_name": "Sandeep Talapatra", "person_email": "sandeep.k.talapatra@gsk.com", "internal_name": "Michelle Jang", "internal_email": "michelle.jang@biorender.com", "llm_suggested_match": {"manual_node_id": "biologics-discovery", "manual_node_name": "Biologics Discovery", "manual_node_path": "GSK Research & Development > Medicinal Science & Technology > Biologics Discovery", "confidence": "medium", "reasoning": "Large molecules typically refer to biologics in pharmaceutical context, making Biologics Discovery a reasonable semantic match"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=15e032aa78b9280b2df0ee2f70cb87273437574fffd29e48ff4d2fa6f3b38ed4", "call_id": "2025-09-12_15e032aa78b9", "call_count": 1, "all_snippets": [{"quote": "So large molecule research.", "date": "2025-09-12", "callId": "2025-09-12_15e032aa78b9", "gongUrl": "https://app.gong.io/call?id=15e032aa78b9280b2df0ee2f70cb87273437574fffd29e48ff4d2fa6f3b38ed4", "speakerId": "671417595239033477", "customerName": "Sandeep Talapatra", "internalName": "Michelle Jang", "customerEmail": "sandeep.k.talapatra@gsk.com", "internalEmail": "michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_lsa_group_71a32f5c", "company": "gsk", "gong_entity": "LSA Group", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "we do have existing licenses with the lsa group, a smaller group in organoids, stem cells, ribu, viral, vaccines", "snippet_date": "2025-09-10", "person_name": "Prajna Behera", "person_email": "prajna.x.behera@gsk.com", "internal_name": "Michelle Jang", "internal_email": "michelle.jang@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=530ae118a98960354a5e3c5b9f6d7f7c5bd3c01b80cfc9e1d437ffde1d3c3f8c", "call_id": "2025-09-10_530ae118a989", "call_count": 1, "all_snippets": [{"quote": "we do have existing licenses with the lsa group, a smaller group in organoids, stem cells, ribu, viral, vaccines", "date": "2025-09-10", "callId": "2025-09-10_530ae118a989", "gongUrl": "https://app.gong.io/call?id=530ae118a98960354a5e3c5b9f6d7f7c5bd3c01b80cfc9e1d437ffde1d3c3f8c", "speakerId": "1993373116859830080", "customerName": "Prajna Behera", "internalName": "Michelle Jang", "customerEmail": "prajna.x.behera@gsk.com", "internalEmail": "michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_etct_892c712d", "company": "gsk", "gong_entity": "ETCT", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "It should be either etct or itct?", "snippet_date": "2025-09-10", "person_name": "Prajna Behera", "person_email": "prajna.x.behera@gsk.com", "internal_name": "Michelle Jang", "internal_email": "michelle.jang@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=530ae118a98960354a5e3c5b9f6d7f7c5bd3c01b80cfc9e1d437ffde1d3c3f8c", "call_id": "2025-09-10_530ae118a989", "call_count": 1, "all_snippets": [{"quote": "It should be either etct or itct?", "date": "2025-09-10", "callId": "2025-09-10_530ae118a989", "gongUrl": "https://app.gong.io/call?id=530ae118a98960354a5e3c5b9f6d7f7c5bd3c01b80cfc9e1d437ffde1d3c3f8c", "speakerId": "2590160092166618127", "customerName": "Prajna Behera", "internalName": "Michelle Jang", "customerEmail": "prajna.x.behera@gsk.com", "internalEmail": "michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_itct_c3487ce1", "company": "gsk", "gong_entity": "ITCT", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "It should be either etct or itct?", "snippet_date": "2025-09-10", "person_name": "Prajna Behera", "person_email": "prajna.x.behera@gsk.com", "internal_name": "Michelle Jang", "internal_email": "michelle.jang@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=530ae118a98960354a5e3c5b9f6d7f7c5bd3c01b80cfc9e1d437ffde1d3c3f8c", "call_id": "2025-09-10_530ae118a989", "call_count": 1, "all_snippets": [{"quote": "It should be either etct or itct?", "date": "2025-09-10", "callId": "2025-09-10_530ae118a989", "gongUrl": "https://app.gong.io/call?id=530ae118a98960354a5e3c5b9f6d7f7c5bd3c01b80cfc9e1d437ffde1d3c3f8c", "speakerId": "2590160092166618127", "customerName": "Prajna Behera", "internalName": "Michelle Jang", "customerEmail": "prajna.x.behera@gsk.com", "internalEmail": "michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_bioanalysis_and_biomarker_platforms_e6f59281", "company": "gsk", "gong_entity": "Bioanalysis and Biomarker Platforms", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So, I guess our department people that I would speak to is called bioanalysis\u2026 and biomarker platforms. I can't remember if it's biomarkers and bioanalysis, or biomarkers, like if they're switched, but we call it bbp.", "snippet_date": "2025-09-03", "person_name": "Kim Reese; Kim Reese; Kim Reese", "person_email": "kim.x.reese@gsk.com; kim.x.reese@gsk.com; kim.x.reese@gsk.com", "internal_name": "Michelle Jang", "internal_email": "michelle.jang@biorender.com", "llm_suggested_match": {"manual_node_id": "biomarker-development", "manual_node_name": "Biomarker Development", "manual_node_path": "GSK Research & Development > Development > Translational Medicine > Biomarker Development", "confidence": "medium", "reasoning": "Partial semantic match - the biomarker component aligns with Biomarker Development team, though the full name suggests a broader analytical platform"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=765229881bc41cbbe72aa77176d37901c5dc7203ee313002b13587d3b47ff8bb", "call_id": "2025-09-03_765229881bc4", "call_count": 1, "all_snippets": [{"quote": "So, I guess our department people that I would speak to is called bioanalysis\u2026 and biomarker platforms. I can't remember if it's biomarkers and bioanalysis, or biomarkers, like if they're switched, but we call it bbp.", "date": "2025-09-03", "callId": "2025-09-03_765229881bc4", "gongUrl": "https://app.gong.io/call?id=765229881bc41cbbe72aa77176d37901c5dc7203ee313002b13587d3b47ff8bb", "speakerId": "1217104218013791246", "customerName": "Kim Reese; Kim Reese; Kim Reese", "internalName": "Michelle Jang", "customerEmail": "kim.x.reese@gsk.com; kim.x.reese@gsk.com; kim.x.reese@gsk.com", "internalEmail": "michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_respiratory_group_269e2f0f", "company": "gsk", "gong_entity": "Respiratory Group", "gong_parent": "GSK R&D", "entity_type": "therapeutic_area", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "if you engage with the respiratory group, whether that's Anthony virtue sort of or, you know, a different contact", "snippet_date": "2025-08-06", "person_name": "Neil Garton", "person_email": "neil.s.garton@gsk.com", "internal_name": "Michael Long", "internal_email": "michael.long@biorender.com", "llm_suggested_match": {"manual_node_id": "respiratory-immunology-research", "manual_node_name": "Respiratory, Immunology & Inflammation Research", "manual_node_path": "GSK Research & Development > Research > Respiratory, Immunology & Inflammation Research", "confidence": "medium", "reasoning": "Entity refers to respiratory group which aligns with the respiratory therapeutic area in research, though the exact name differs slightly"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=11af0262f179c9ac8387e6625b64d00ff94c4535d86edaa188ce22b99db6b978", "call_id": "2025-08-06_11af0262f179", "call_count": 1, "all_snippets": [{"quote": "if you engage with the respiratory group, whether that's Anthony virtue sort of or, you know, a different contact", "date": "2025-08-06", "callId": "2025-08-06_11af0262f179", "gongUrl": "https://app.gong.io/call?id=11af0262f179c9ac8387e6625b64d00ff94c4535d86edaa188ce22b99db6b978", "speakerId": "920261568244958462", "customerName": "Neil Garton", "internalName": "Michael Long", "customerEmail": "neil.s.garton@gsk.com", "internalEmail": "michael.long@biorender.com", "sizeMentions": []}]}, {"id": "gsk_preclinical_discovery_sciences_67d0f59d", "company": "gsk", "gong_entity": "Preclinical Discovery Sciences", "gong_parent": "GSK R&D", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "Buy for us, actually, we are in preclinical discovery sciences.", "snippet_date": "2025-07-24", "person_name": "Muhmmad Maqbool", "person_email": "muhammad.x.maqbool@gsk.com", "internal_name": "Michael Long; Michelle Jang", "internal_email": "michael.long@biorender.com; michelle.jang@biorender.com", "llm_suggested_match": {"manual_node_id": "medicinal-science-technology", "manual_node_name": "Medicinal Science & Technology", "manual_node_path": "GSK Research & Development > Medicinal Science & Technology", "confidence": "medium", "reasoning": "Preclinical discovery sciences aligns with medicinal science & technology division which encompasses discovery activities"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=9b7e9ddca3aadad1c5f46e2224d385615ab48148c7bba49b34e976b5480e664f", "call_id": "2025-07-24_9b7e9ddca3aa", "call_count": 1, "all_snippets": [{"quote": "Buy for us, actually, we are in preclinical discovery sciences.", "date": "2025-07-24", "callId": "2025-07-24_9b7e9ddca3aa", "gongUrl": "https://app.gong.io/call?id=9b7e9ddca3aadad1c5f46e2224d385615ab48148c7bba49b34e976b5480e664f", "speakerId": "1933768169700736814", "customerName": "Muhmmad Maqbool", "internalName": "Michael Long; Michelle Jang", "customerEmail": "muhammad.x.maqbool@gsk.com", "internalEmail": "michael.long@biorender.com; michelle.jang@biorender.com", "sizeMentions": []}]}, {"id": "gsk_discovery_genomics_d7055833", "company": "gsk", "gong_entity": "Discovery Genomics", "gong_parent": "Preclinical Discovery Sciences", "entity_type": "team", "team_size": "35", "confidence": "high", "mention_count": 1, "snippet": "So if I talk about really my team, we are called discovery genomics within like omics sciences department. So the discovery genomics team overall, this is about like almost 35 people.", "snippet_date": "2025-07-24", "person_name": "Muhmmad Maqbool", "person_email": "muhammad.x.maqbool@gsk.com", "internal_name": "Michael Long; Michelle Jang", "internal_email": "michael.long@biorender.com; michelle.jang@biorender.com", "llm_suggested_match": {"manual_node_id": "functional-genomics", "manual_node_name": "Functional Genomics", "manual_node_path": "GSK Research & Development > Human Genetics & Genomics > Functional Genomics", "confidence": "medium", "reasoning": "Discovery genomics team closely matches functional genomics department, both focused on genomics work in discovery context"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=9b7e9ddca3aadad1c5f46e2224d385615ab48148c7bba49b34e976b5480e664f", "call_id": "2025-07-24_9b7e9ddca3aa", "call_count": 1, "all_snippets": [{"quote": "So if I talk about really my team, we are called discovery genomics within like omics sciences department. So the discovery genomics team overall, this is about like almost 35 people.", "date": "2025-07-24", "callId": "2025-07-24_9b7e9ddca3aa", "gongUrl": "https://app.gong.io/call?id=9b7e9ddca3aadad1c5f46e2224d385615ab48148c7bba49b34e976b5480e664f", "speakerId": "1933768169700736814", "customerName": "Muhmmad Maqbool", "internalName": "Michael Long; Michelle Jang", "customerEmail": "muhammad.x.maqbool@gsk.com", "internalEmail": "michael.long@biorender.com; michelle.jang@biorender.com", "sizeMentions": [{"value": "35", "snippetIndex": 0, "source": {"callDate": "2025-07-24", "customerName": "Muhmmad Maqbool"}}]}]}, {"id": "gsk_heidelberg_e86d3cf1", "company": "gsk", "gong_entity": "Heidelberg", "gong_parent": "GSK R&D", "entity_type": "site", "team_size": "14", "confidence": "high", "mention_count": 1, "snippet": "about like 13, 14 people in heidelberg in Germany", "snippet_date": "2025-07-24", "person_name": "Muhmmad Maqbool", "person_email": "muhammad.x.maqbool@gsk.com", "internal_name": "Michael Long; Michelle Jang", "internal_email": "michael.long@biorender.com; michelle.jang@biorender.com", "llm_suggested_match": {"manual_node_id": "heidelberg-germany", "manual_node_name": "Heidelberg, Germany", "manual_node_path": "GSK Research & Development > Global R&D Sites > Heidelberg, Germany", "confidence": "high", "reasoning": "Exact match for the Heidelberg site location mentioned in the snippet"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=9b7e9ddca3aadad1c5f46e2224d385615ab48148c7bba49b34e976b5480e664f", "call_id": "2025-07-24_9b7e9ddca3aa", "call_count": 1, "all_snippets": [{"quote": "about like 13, 14 people in heidelberg in Germany", "date": "2025-07-24", "callId": "2025-07-24_9b7e9ddca3aa", "gongUrl": "https://app.gong.io/call?id=9b7e9ddca3aadad1c5f46e2224d385615ab48148c7bba49b34e976b5480e664f", "speakerId": "1933768169700736814", "customerName": "Muhmmad Maqbool", "internalName": "Michael Long; Michelle Jang", "customerEmail": "muhammad.x.maqbool@gsk.com", "internalEmail": "michael.long@biorender.com; michelle.jang@biorender.com", "sizeMentions": [{"value": "14", "snippetIndex": 0, "source": {"callDate": "2025-07-24", "customerName": "Muhmmad Maqbool"}}]}]}, {"id": "gsk_purification_department_9b93ec49", "company": "gsk", "gong_entity": "Purification Department", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So I'm currently, I'm in a purification department.", "snippet_date": "2025-04-15", "person_name": "Jenna Sumey; Jenna Sumey", "person_email": "jenna.l.sumey@gsk.com; jenna.l.sumey@gsk.com", "internal_name": "Adrian Rizos", "internal_email": "adrian.rizos@biorender.com", "llm_suggested_match": {"manual_node_id": "upstream-downstream", "manual_node_name": "Upstream & Downstream Processing", "manual_node_path": "GSK Research & Development > CMC & Pharmaceutical Sciences > Biologics CMC > Upstream & Downstream Processing", "confidence": "medium", "reasoning": "Purification activities are part of downstream processing in biologics manufacturing, which includes protein purification"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=a4f1ae6fa22dfa3ec50d22e3e991b85fa7d23a9bbec23d4c29b90a64c6db44e6", "call_id": "2025-04-15_a4f1ae6fa22d", "call_count": 1, "all_snippets": [{"quote": "So I'm currently, I'm in a purification department.", "date": "2025-04-15", "callId": "2025-04-15_a4f1ae6fa22d", "gongUrl": "https://app.gong.io/call?id=a4f1ae6fa22dfa3ec50d22e3e991b85fa7d23a9bbec23d4c29b90a64c6db44e6", "speakerId": "6926483137994405218", "customerName": "Jenna Sumey; Jenna Sumey", "internalName": "Adrian Rizos", "customerEmail": "jenna.l.sumey@gsk.com; jenna.l.sumey@gsk.com", "internalEmail": "adrian.rizos@biorender.com", "sizeMentions": []}]}, {"id": "gsk_upstream_4e2849c5", "company": "gsk", "gong_entity": "Upstream", "gong_parent": "Purification Department", "entity_type": "team", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "So our department's kind of split between there's some upstream people that are definitely more cell culture heavy would use biorender a lot more.", "snippet_date": "2025-04-15", "person_name": "Jenna Sumey; Jenna Sumey", "person_email": "jenna.l.sumey@gsk.com; jenna.l.sumey@gsk.com", "internal_name": "Adrian Rizos", "internal_email": "adrian.rizos@biorender.com", "llm_suggested_match": {"manual_node_id": "upstream-downstream", "manual_node_name": "Upstream & Downstream Processing", "manual_node_path": "GSK Research & Development > CMC & Pharmaceutical Sciences > Biologics CMC > Upstream & Downstream Processing", "confidence": "high", "reasoning": "Direct match - upstream is explicitly part of the 'Upstream & Downstream Processing' team name"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=a4f1ae6fa22dfa3ec50d22e3e991b85fa7d23a9bbec23d4c29b90a64c6db44e6", "call_id": "2025-04-15_a4f1ae6fa22d", "call_count": 1, "all_snippets": [{"quote": "So our department's kind of split between there's some upstream people that are definitely more cell culture heavy would use biorender a lot more.", "date": "2025-04-15", "callId": "2025-04-15_a4f1ae6fa22d", "gongUrl": "https://app.gong.io/call?id=a4f1ae6fa22dfa3ec50d22e3e991b85fa7d23a9bbec23d4c29b90a64c6db44e6", "speakerId": "6926483137994405218", "customerName": "Jenna Sumey; Jenna Sumey", "internalName": "Adrian Rizos", "customerEmail": "jenna.l.sumey@gsk.com; jenna.l.sumey@gsk.com", "internalEmail": "adrian.rizos@biorender.com", "sizeMentions": []}]}, {"id": "gsk_downstream_cb1b0cbd", "company": "gsk", "gong_entity": "Downstream", "gong_parent": "Purification Department", "entity_type": "team", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "And then I'm currently in more of a it's called the downstream position where it's a lot more figuring out how to like purify our proteins, antibody based.", "snippet_date": "2025-04-15", "person_name": "Jenna Sumey; Jenna Sumey", "person_email": "jenna.l.sumey@gsk.com; jenna.l.sumey@gsk.com", "internal_name": "Adrian Rizos", "internal_email": "adrian.rizos@biorender.com", "llm_suggested_match": {"manual_node_id": "upstream-downstream", "manual_node_name": "Upstream & Downstream Processing", "manual_node_path": "GSK Research & Development > CMC & Pharmaceutical Sciences > Biologics CMC > Upstream & Downstream Processing", "confidence": "high", "reasoning": "Direct match - downstream is explicitly part of the 'Upstream & Downstream Processing' team name, and context matches protein purification"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=a4f1ae6fa22dfa3ec50d22e3e991b85fa7d23a9bbec23d4c29b90a64c6db44e6", "call_id": "2025-04-15_a4f1ae6fa22d", "call_count": 1, "all_snippets": [{"quote": "And then I'm currently in more of a it's called the downstream position where it's a lot more figuring out how to like purify our proteins, antibody based.", "date": "2025-04-15", "callId": "2025-04-15_a4f1ae6fa22d", "gongUrl": "https://app.gong.io/call?id=a4f1ae6fa22dfa3ec50d22e3e991b85fa7d23a9bbec23d4c29b90a64c6db44e6", "speakerId": "6926483137994405218", "customerName": "Jenna Sumey; Jenna Sumey", "internalName": "Adrian Rizos", "customerEmail": "jenna.l.sumey@gsk.com; jenna.l.sumey@gsk.com", "internalEmail": "adrian.rizos@biorender.com", "sizeMentions": []}]}, {"id": "gsk_early_phase_511069eb", "company": "gsk", "gong_entity": "Early Phase", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "We do have people in early phase who we'll talk to. So say we have a molecule that's been targeted. So they'll do a lot of like very initial high level development and then they'll pass it off to us.", "snippet_date": "2025-04-15", "person_name": "Jenna Sumey; Jenna Sumey", "person_email": "jenna.l.sumey@gsk.com; jenna.l.sumey@gsk.com", "internal_name": "Adrian Rizos", "internal_email": "adrian.rizos@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=a4f1ae6fa22dfa3ec50d22e3e991b85fa7d23a9bbec23d4c29b90a64c6db44e6", "call_id": "2025-04-15_a4f1ae6fa22d", "call_count": 1, "all_snippets": [{"quote": "We do have people in early phase who we'll talk to. So say we have a molecule that's been targeted. So they'll do a lot of like very initial high level development and then they'll pass it off to us.", "date": "2025-04-15", "callId": "2025-04-15_a4f1ae6fa22d", "gongUrl": "https://app.gong.io/call?id=a4f1ae6fa22dfa3ec50d22e3e991b85fa7d23a9bbec23d4c29b90a64c6db44e6", "speakerId": "6926483137994405218", "customerName": "Jenna Sumey; Jenna Sumey", "internalName": "Adrian Rizos", "customerEmail": "jenna.l.sumey@gsk.com; jenna.l.sumey@gsk.com", "internalEmail": "adrian.rizos@biorender.com", "sizeMentions": []}]}, {"id": "gsk_drug_product_91c87e1f", "company": "gsk", "gong_entity": "Drug Product", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "And then we have a different department focused on the product, drug product and they work a lot with the final like fill and finish design of packaging it into syringes or vials or however that final form is gonna look like.", "snippet_date": "2025-04-15", "person_name": "Jenna Sumey; Jenna Sumey", "person_email": "jenna.l.sumey@gsk.com; jenna.l.sumey@gsk.com", "internal_name": "Adrian Rizos", "internal_email": "adrian.rizos@biorender.com", "llm_suggested_match": {"manual_node_id": "drug-product-development", "manual_node_name": "Drug Product Development", "manual_node_path": null, "confidence": "high", "reasoning": "Exact match for drug product development team, which handles final formulation, fill and finish activities as described"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=a4f1ae6fa22dfa3ec50d22e3e991b85fa7d23a9bbec23d4c29b90a64c6db44e6", "call_id": "2025-04-15_a4f1ae6fa22d", "call_count": 1, "all_snippets": [{"quote": "And then we have a different department focused on the product, drug product and they work a lot with the final like fill and finish design of packaging it into syringes or vials or however that final form is gonna look like.", "date": "2025-04-15", "callId": "2025-04-15_a4f1ae6fa22d", "gongUrl": "https://app.gong.io/call?id=a4f1ae6fa22dfa3ec50d22e3e991b85fa7d23a9bbec23d4c29b90a64c6db44e6", "speakerId": "6926483137994405218", "customerName": "Jenna Sumey; Jenna Sumey", "internalName": "Adrian Rizos", "customerEmail": "jenna.l.sumey@gsk.com; jenna.l.sumey@gsk.com", "internalEmail": "adrian.rizos@biorender.com", "sizeMentions": []}]}, {"id": "gsk_vaccine_r&d_center_4780af97", "company": "gsk", "gong_entity": "Vaccine R&D Center", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I'm in charge of the immunology research lab in our vaccine RD center in Belgium", "snippet_date": "2025-02-13", "person_name": "Arpita P.; Tessa Lincoln; Yannick Vanloubbeeck; Yannick Vanloubbeeck", "person_email": "arpita.p.bose@gsk.com; ambertessa.c.lincoln@gsk.com; yannick.f.vanloubbeeck@gsk.com; yannick.f.vanloubbeeck@gsk.com", "internal_name": "Adrian Rizos; James Lee; Sydney Burniston; Walid Habboub", "internal_email": "adrian.rizos@biorender.com; james@biorender.com; sydney.b@biorender.com; walid@biorender.com", "llm_suggested_match": {"manual_node_id": "rixensart-belgium", "manual_node_name": "Rixensart & Wavre, Belgium (Vaccines R&D Hub)", "manual_node_path": "GSK Research & Development > Global R&D Sites > Rixensart & Wavre, Belgium (Vaccines R&D Hub)", "confidence": "high", "reasoning": "Context mentions Belgium vaccine R&D center, which matches the Rixensart & Wavre Belgium vaccines R&D hub site"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=80dc32ad641324c1b5e7d63d8dd5e894cf6b6bd0d84960e1ac9ad614776f5b83", "call_id": "2025-02-13_80dc32ad6413", "call_count": 1, "all_snippets": [{"quote": "I'm in charge of the immunology research lab in our vaccine RD center in Belgium", "date": "2025-02-13", "callId": "2025-02-13_80dc32ad6413", "gongUrl": "https://app.gong.io/call?id=80dc32ad641324c1b5e7d63d8dd5e894cf6b6bd0d84960e1ac9ad614776f5b83", "speakerId": "4183780971210248231", "customerName": "Arpita P.; Tessa Lincoln; Yannick Vanloubbeeck; Yannick Vanloubbeeck", "internalName": "Adrian Rizos; James Lee; Sydney Burniston; Walid Habboub", "customerEmail": "arpita.p.bose@gsk.com; ambertessa.c.lincoln@gsk.com; yannick.f.vanloubbeeck@gsk.com; yannick.f.vanloubbeeck@gsk.com", "internalEmail": "adrian.rizos@biorender.com; james@biorender.com; sydney.b@biorender.com; walid@biorender.com", "sizeMentions": []}]}, {"id": "gsk_immunology_research_lab_3e4e29e5", "company": "gsk", "gong_entity": "Immunology Research Lab", "gong_parent": "Vaccine R&D Center", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I'm Jan, Ivan lubeck, I'm in charge of the immunology research lab in our vaccine RD center in Belgium", "snippet_date": "2025-02-13", "person_name": "Arpita P.; Tessa Lincoln; Yannick Vanloubbeeck; Yannick Vanloubbeeck", "person_email": "arpita.p.bose@gsk.com; ambertessa.c.lincoln@gsk.com; yannick.f.vanloubbeeck@gsk.com; yannick.f.vanloubbeeck@gsk.com", "internal_name": "Adrian Rizos; James Lee; Sydney Burniston; Walid Habboub", "internal_email": "adrian.rizos@biorender.com; james@biorender.com; sydney.b@biorender.com; walid@biorender.com", "llm_suggested_match": {"manual_node_id": "respiratory-immunology-research", "manual_node_name": "Respiratory, Immunology & Inflammation Research", "manual_node_path": "GSK Research & Development > Research > Respiratory, Immunology & Inflammation Research", "confidence": "medium", "reasoning": "Entity mentions immunology research and is located in Belgium vaccine R&D center. Best match is the immunology research therapeutic area, though the entity appears more vaccine-focused."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=80dc32ad641324c1b5e7d63d8dd5e894cf6b6bd0d84960e1ac9ad614776f5b83", "call_id": "2025-02-13_80dc32ad6413", "call_count": 1, "all_snippets": [{"quote": "I'm Jan, Ivan lubeck, I'm in charge of the immunology research lab in our vaccine RD center in Belgium", "date": "2025-02-13", "callId": "2025-02-13_80dc32ad6413", "gongUrl": "https://app.gong.io/call?id=80dc32ad641324c1b5e7d63d8dd5e894cf6b6bd0d84960e1ac9ad614776f5b83", "speakerId": "4183780971210248231", "customerName": "Arpita P.; Tessa Lincoln; Yannick Vanloubbeeck; Yannick Vanloubbeeck", "internalName": "Adrian Rizos; James Lee; Sydney Burniston; Walid Habboub", "customerEmail": "arpita.p.bose@gsk.com; ambertessa.c.lincoln@gsk.com; yannick.f.vanloubbeeck@gsk.com; yannick.f.vanloubbeeck@gsk.com", "internalEmail": "adrian.rizos@biorender.com; james@biorender.com; sydney.b@biorender.com; walid@biorender.com", "sizeMentions": []}]}, {"id": "gsk_assay_development_and_innovation_group_1f8b45e4", "company": "gsk", "gong_entity": "Assay Development and Innovation Group", "gong_parent": "Vaccine R&D Center", "entity_type": "team", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "So the group is called essay development and innovation group. So it's under the vaccine umbrella, let's say and the r d department", "snippet_date": "2024-12-19", "person_name": "Rossella Cuffaro; Rossella Cuffaro", "person_email": "rossella.x.cuffaro@gsk.com; rossella.x.cuffaro@gsk.com", "internal_name": "Adrian Rizos", "internal_email": "adrian.rizos@biorender.com", "llm_suggested_match": {"manual_node_id": "vaccine-analytics", "manual_node_name": "Vaccine Analytics", "manual_node_path": "GSK Research & Development > CMC & Pharmaceutical Sciences > Vaccine CMC > Vaccine Analytics", "confidence": "medium", "reasoning": "Entity is described as under vaccine umbrella doing assay development. Vaccine Analytics team likely handles assay development and analytical innovation for vaccines."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=3eab6711ee749bdab92955a7d6f83f6c2b1f967bab5572b3c0e664e32f1ef1a8", "call_id": "2024-12-19_3eab6711ee74", "call_count": 1, "all_snippets": [{"quote": "So the group is called essay development and innovation group. So it's under the vaccine umbrella, let's say and the r d department", "date": "2024-12-19", "callId": "2024-12-19_3eab6711ee74", "gongUrl": "https://app.gong.io/call?id=3eab6711ee749bdab92955a7d6f83f6c2b1f967bab5572b3c0e664e32f1ef1a8", "speakerId": "7040791890700399135", "customerName": "Rossella Cuffaro; Rossella Cuffaro", "internalName": "Adrian Rizos", "customerEmail": "rossella.x.cuffaro@gsk.com; rossella.x.cuffaro@gsk.com", "internalEmail": "adrian.rizos@biorender.com", "sizeMentions": []}]}, {"id": "gsk_legal_department_89aa823f", "company": "gsk", "gong_entity": "Legal Department", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "if Arpita, you're in\u2026 legal department, how are you using biorender?", "snippet_date": "2025-02-13", "person_name": "Arpita P.; Tessa Lincoln; Yannick Vanloubbeeck; Yannick Vanloubbeeck", "person_email": "arpita.p.bose@gsk.com; ambertessa.c.lincoln@gsk.com; yannick.f.vanloubbeeck@gsk.com; yannick.f.vanloubbeeck@gsk.com", "internal_name": "Adrian Rizos; James Lee; Sydney Burniston; Walid Habboub", "internal_email": "adrian.rizos@biorender.com; james@biorender.com; sydney.b@biorender.com; walid@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=80dc32ad641324c1b5e7d63d8dd5e894cf6b6bd0d84960e1ac9ad614776f5b83", "call_id": "2025-02-13_80dc32ad6413", "call_count": 1, "all_snippets": [{"quote": "if Arpita, you're in\u2026 legal department, how are you using biorender?", "date": "2025-02-13", "callId": "2025-02-13_80dc32ad6413", "gongUrl": "https://app.gong.io/call?id=80dc32ad641324c1b5e7d63d8dd5e894cf6b6bd0d84960e1ac9ad614776f5b83", "speakerId": "40043153506698517", "customerName": "Arpita P.; Tessa Lincoln; Yannick Vanloubbeeck; Yannick Vanloubbeeck", "internalName": "Adrian Rizos; James Lee; Sydney Burniston; Walid Habboub", "customerEmail": "arpita.p.bose@gsk.com; ambertessa.c.lincoln@gsk.com; yannick.f.vanloubbeeck@gsk.com; yannick.f.vanloubbeeck@gsk.com", "internalEmail": "adrian.rizos@biorender.com; james@biorender.com; sydney.b@biorender.com; walid@biorender.com", "sizeMentions": []}]}, {"id": "gsk_tech_legal_team_1a9ca275", "company": "gsk", "gong_entity": "Tech Legal Team", "gong_parent": "Legal Department", "entity_type": "team", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "Fortunately the contract did get fairly quickly reassigned to somebody else within our tech legal team", "snippet_date": "2024-10-30", "person_name": "Tessa Lincoln", "person_email": "ambertessa.c.lincoln@gsk.com", "internal_name": "Adrian Rizos; Madison Knock", "internal_email": "adrian.rizos@biorender.com; madison@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=bbb91e448568fdc9be4bc0b740cb9aa2621977588ce974c1b5729756983089db", "call_id": "2024-10-30_bbb91e448568", "call_count": 1, "all_snippets": [{"quote": "Fortunately the contract did get fairly quickly reassigned to somebody else within our tech legal team", "date": "2024-10-30", "callId": "2024-10-30_bbb91e448568", "gongUrl": "https://app.gong.io/call?id=bbb91e448568fdc9be4bc0b740cb9aa2621977588ce974c1b5729756983089db", "speakerId": "2098640847695153322", "customerName": "Tessa Lincoln", "internalName": "Adrian Rizos; Madison Knock", "customerEmail": "ambertessa.c.lincoln@gsk.com", "internalEmail": "adrian.rizos@biorender.com; madison@biorender.com", "sizeMentions": []}]}, {"id": "gsk_clinical_science_group_3a244956", "company": "gsk", "gong_entity": "Clinical Science Group", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I'm a scientist in the boxing club group. So clinical science", "snippet_date": "2024-12-19", "person_name": "Rossella Cuffaro; Rossella Cuffaro", "person_email": "rossella.x.cuffaro@gsk.com; rossella.x.cuffaro@gsk.com", "internal_name": "Adrian Rizos", "internal_email": "adrian.rizos@biorender.com", "llm_suggested_match": {"manual_node_id": "clinical-operations", "manual_node_name": "Clinical Operations", "manual_node_path": "GSK Research & Development > Development > Clinical Operations", "confidence": "medium", "reasoning": "Clinical Science Group likely aligns with Clinical Operations department, which manages clinical trial activities and clinical science functions."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=3eab6711ee749bdab92955a7d6f83f6c2b1f967bab5572b3c0e664e32f1ef1a8", "call_id": "2024-12-19_3eab6711ee74", "call_count": 1, "all_snippets": [{"quote": "I'm a scientist in the boxing club group. So clinical science", "date": "2024-12-19", "callId": "2024-12-19_3eab6711ee74", "gongUrl": "https://app.gong.io/call?id=3eab6711ee749bdab92955a7d6f83f6c2b1f967bab5572b3c0e664e32f1ef1a8", "speakerId": "7040791890700399135", "customerName": "Rossella Cuffaro; Rossella Cuffaro", "internalName": "Adrian Rizos", "customerEmail": "rossella.x.cuffaro@gsk.com; rossella.x.cuffaro@gsk.com", "internalEmail": "adrian.rizos@biorender.com", "sizeMentions": []}]}, {"id": "gsk_tdr_b8b8fdb0", "company": "gsk", "gong_entity": "TDR", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "theyre for a team internally called TDR", "snippet_date": "2024-10-30", "person_name": "Tessa Lincoln", "person_email": "ambertessa.c.lincoln@gsk.com", "internal_name": "Adrian Rizos; Madison Knock", "internal_email": "adrian.rizos@biorender.com; madison@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=bbb91e448568fdc9be4bc0b740cb9aa2621977588ce974c1b5729756983089db", "call_id": "2024-10-30_bbb91e448568", "call_count": 1, "all_snippets": [{"quote": "theyre for a team internally called TDR", "date": "2024-10-30", "callId": "2024-10-30_bbb91e448568", "gongUrl": "https://app.gong.io/call?id=bbb91e448568fdc9be4bc0b740cb9aa2621977588ce974c1b5729756983089db", "speakerId": "2098640847695153322", "customerName": "Tessa Lincoln", "internalName": "Adrian Rizos; Madison Knock", "customerEmail": "ambertessa.c.lincoln@gsk.com", "internalEmail": "adrian.rizos@biorender.com; madison@biorender.com", "sizeMentions": []}]}, {"id": "gsk_viral_team_b886139f", "company": "gsk", "gong_entity": "Viral Team", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "he was kind of speaking on behalf of the viral team who decided not to extend well, not to continue their licenses", "snippet_date": "2024-10-30", "person_name": "Tessa Lincoln", "person_email": "ambertessa.c.lincoln@gsk.com", "internal_name": "Adrian Rizos; Madison Knock", "internal_email": "adrian.rizos@biorender.com; madison@biorender.com", "llm_suggested_match": {"manual_node_id": "vaccines-infectious-diseases-research", "manual_node_name": "Vaccines & Infectious Diseases Research", "manual_node_path": "GSK Research & Development > Research > Vaccines & Infectious Diseases Research", "confidence": "medium", "reasoning": "Viral Team likely works on viral research, which would fall under the Vaccines & Infectious Diseases Research therapeutic area that covers viral pathogens."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=bbb91e448568fdc9be4bc0b740cb9aa2621977588ce974c1b5729756983089db", "call_id": "2024-10-30_bbb91e448568", "call_count": 1, "all_snippets": [{"quote": "he was kind of speaking on behalf of the viral team who decided not to extend well, not to continue their licenses", "date": "2024-10-30", "callId": "2024-10-30_bbb91e448568", "gongUrl": "https://app.gong.io/call?id=bbb91e448568fdc9be4bc0b740cb9aa2621977588ce974c1b5729756983089db", "speakerId": "2098640847695153322", "customerName": "Tessa Lincoln", "internalName": "Adrian Rizos; Madison Knock", "customerEmail": "ambertessa.c.lincoln@gsk.com", "internalEmail": "adrian.rizos@biorender.com; madison@biorender.com", "sizeMentions": []}]}, {"id": "gsk_ai_compliance_team_0b1c4c90", "company": "gsk", "gong_entity": "AI Compliance Team", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "our AI compliance team are fully aware of how were using the product", "snippet_date": "2024-10-30", "person_name": "Tessa Lincoln", "person_email": "ambertessa.c.lincoln@gsk.com", "internal_name": "Adrian Rizos; Madison Knock", "internal_email": "adrian.rizos@biorender.com; madison@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=bbb91e448568fdc9be4bc0b740cb9aa2621977588ce974c1b5729756983089db", "call_id": "2024-10-30_bbb91e448568", "call_count": 1, "all_snippets": [{"quote": "our AI compliance team are fully aware of how were using the product", "date": "2024-10-30", "callId": "2024-10-30_bbb91e448568", "gongUrl": "https://app.gong.io/call?id=bbb91e448568fdc9be4bc0b740cb9aa2621977588ce974c1b5729756983089db", "speakerId": "2098640847695153322", "customerName": "Tessa Lincoln", "internalName": "Adrian Rizos; Madison Knock", "customerEmail": "ambertessa.c.lincoln@gsk.com", "internalEmail": "adrian.rizos@biorender.com; madison@biorender.com", "sizeMentions": []}]}, {"id": "gsk_tac_22887667", "company": "gsk", "gong_entity": "TAC", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "Osama, who is our legal counsel and is the head of legal counsel for TAC", "snippet_date": "2024-10-17", "person_name": "Tessa Lincoln", "person_email": "ambertessa.c.lincoln@gsk.com", "internal_name": "Adrian Rizos; Madison Knock; Mark Erbele", "internal_email": "adrian.rizos@biorender.com; madison@biorender.com; mark@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=64ecd023c8da4c083bfeb99a73c265b3939df52e6a304d60ff5bc20c2c5a8586", "call_id": "2024-10-17_64ecd023c8da", "call_count": 1, "all_snippets": [{"quote": "Osama, who is our legal counsel and is the head of legal counsel for TAC", "date": "2024-10-17", "callId": "2024-10-17_64ecd023c8da", "gongUrl": "https://app.gong.io/call?id=64ecd023c8da4c083bfeb99a73c265b3939df52e6a304d60ff5bc20c2c5a8586", "speakerId": "4126133769471087775", "customerName": "Tessa Lincoln", "internalName": "Adrian Rizos; Madison Knock; Mark Erbele", "customerEmail": "ambertessa.c.lincoln@gsk.com", "internalEmail": "adrian.rizos@biorender.com; madison@biorender.com; mark@biorender.com", "sizeMentions": []}]}, {"id": "gsk_immunology_for_vaccines_r&d_f01ced23", "company": "gsk", "gong_entity": "Immunology for Vaccines R&D", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "he is actually the head of immunology for vaccines R&D, therapeutic vaccines R&D", "snippet_date": "2024-10-17", "person_name": "Tessa Lincoln", "person_email": "ambertessa.c.lincoln@gsk.com", "internal_name": "Adrian Rizos; Madison Knock; Mark Erbele", "internal_email": "adrian.rizos@biorender.com; madison@biorender.com; mark@biorender.com", "llm_suggested_match": {"manual_node_id": "vaccines-infectious-diseases-research", "manual_node_name": "Vaccines & Infectious Diseases Research", "manual_node_path": "GSK Research & Development > Research > Vaccines & Infectious Diseases Research", "confidence": "high", "reasoning": "Entity specifically mentions immunology for vaccines R&D and therapeutic vaccines R&D, which directly aligns with the Vaccines & Infectious Diseases Research therapeutic area."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=64ecd023c8da4c083bfeb99a73c265b3939df52e6a304d60ff5bc20c2c5a8586", "call_id": "2024-10-17_64ecd023c8da", "call_count": 1, "all_snippets": [{"quote": "he is actually the head of immunology for vaccines R&D, therapeutic vaccines R&D", "date": "2024-10-17", "callId": "2024-10-17_64ecd023c8da", "gongUrl": "https://app.gong.io/call?id=64ecd023c8da4c083bfeb99a73c265b3939df52e6a304d60ff5bc20c2c5a8586", "speakerId": "4126133769471087775", "customerName": "Tessa Lincoln", "internalName": "Adrian Rizos; Madison Knock; Mark Erbele", "customerEmail": "ambertessa.c.lincoln@gsk.com", "internalEmail": "adrian.rizos@biorender.com; madison@biorender.com; mark@biorender.com", "sizeMentions": []}]}, {"id": "gsk_wavre_c633281e", "company": "gsk", "gong_entity": "Wavre", "gong_parent": "GSK R&D", "entity_type": "site", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "but based out of Wavre? I want to say is where our Belgium site is", "snippet_date": "2024-10-17", "person_name": "Tessa Lincoln", "person_email": "ambertessa.c.lincoln@gsk.com", "internal_name": "Adrian Rizos; Madison Knock; Mark Erbele", "internal_email": "adrian.rizos@biorender.com; madison@biorender.com; mark@biorender.com", "llm_suggested_match": {"manual_node_id": "rixensart-belgium", "manual_node_name": "Rixensart & Wavre, Belgium (Vaccines R&D Hub)", "manual_node_path": "GSK Research & Development > Global R&D Sites > Rixensart & Wavre, Belgium (Vaccines R&D Hub)", "confidence": "high", "reasoning": "Exact match - Wavre is explicitly mentioned in the manual node name for the Belgium vaccines R&D site"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=64ecd023c8da4c083bfeb99a73c265b3939df52e6a304d60ff5bc20c2c5a8586", "call_id": "2024-10-17_64ecd023c8da", "call_count": 1, "all_snippets": [{"quote": "but based out of Wavre? I want to say is where our Belgium site is", "date": "2024-10-17", "callId": "2024-10-17_64ecd023c8da", "gongUrl": "https://app.gong.io/call?id=64ecd023c8da4c083bfeb99a73c265b3939df52e6a304d60ff5bc20c2c5a8586", "speakerId": "4126133769471087775", "customerName": "Tessa Lincoln", "internalName": "Adrian Rizos; Madison Knock; Mark Erbele", "customerEmail": "ambertessa.c.lincoln@gsk.com", "internalEmail": "adrian.rizos@biorender.com; madison@biorender.com; mark@biorender.com", "sizeMentions": []}]}, {"id": "gsk_respiratory_immunology_dc690bcb", "company": "gsk", "gong_entity": "Respiratory Immunology", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "Anthony Virtuo he's part of the respiratory immunology something unit", "snippet_date": "2024-09-26", "person_name": "Tessa Lincoln", "person_email": "ambertessa.c.lincoln@gsk.com", "internal_name": "Adrian Rizos; Madison Knock", "internal_email": "adrian.rizos@biorender.com; madison@biorender.com", "llm_suggested_match": {"manual_node_id": "respiratory-immunology-research", "manual_node_name": "Respiratory, Immunology & Inflammation Research", "manual_node_path": "GSK Research & Development > Research > Respiratory, Immunology & Inflammation Research", "confidence": "high", "reasoning": "Strong fuzzy match - 'Respiratory Immunology' closely matches 'Respiratory, Immunology & Inflammation Research' therapeutic area"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=fb29d3402fba855e29ed25a7029784e284b8b5ea46d8fa8be210b732789c6b4d", "call_id": "2024-09-26_fb29d3402fba", "call_count": 1, "all_snippets": [{"quote": "Anthony Virtuo he's part of the respiratory immunology something unit", "date": "2024-09-26", "callId": "2024-09-26_fb29d3402fba", "gongUrl": "https://app.gong.io/call?id=fb29d3402fba855e29ed25a7029784e284b8b5ea46d8fa8be210b732789c6b4d", "speakerId": "4659266201076121295", "customerName": "Tessa Lincoln", "internalName": "Adrian Rizos; Madison Knock", "customerEmail": "ambertessa.c.lincoln@gsk.com", "internalEmail": "adrian.rizos@biorender.com; madison@biorender.com", "sizeMentions": []}]}, {"id": "gsk_immunology_in_collegeville_3e7e3acd", "company": "gsk", "gong_entity": "Immunology in Collegeville", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "John Lish is from the immunology in Collegeville that's the 30 license", "snippet_date": "2024-09-26", "person_name": "Tessa Lincoln", "person_email": "ambertessa.c.lincoln@gsk.com", "internal_name": "Adrian Rizos; Madison Knock", "internal_email": "adrian.rizos@biorender.com; madison@biorender.com", "llm_suggested_match": {"manual_node_id": "upper-providence-pa", "manual_node_name": "Upper Providence, PA, USA (R&D Hub)", "manual_node_path": "GSK Research & Development > Global R&D Sites > Upper Providence, PA, USA (R&D Hub)", "confidence": "medium", "reasoning": "Geographic match - Collegeville is adjacent to Upper Providence, PA, and this appears to be referencing immunology work at the PA R&D hub"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=fb29d3402fba855e29ed25a7029784e284b8b5ea46d8fa8be210b732789c6b4d", "call_id": "2024-09-26_fb29d3402fba", "call_count": 1, "all_snippets": [{"quote": "John Lish is from the immunology in Collegeville that's the 30 license", "date": "2024-09-26", "callId": "2024-09-26_fb29d3402fba", "gongUrl": "https://app.gong.io/call?id=fb29d3402fba855e29ed25a7029784e284b8b5ea46d8fa8be210b732789c6b4d", "speakerId": "1153909625369851789", "customerName": "Tessa Lincoln", "internalName": "Adrian Rizos; Madison Knock", "customerEmail": "ambertessa.c.lincoln@gsk.com", "internalEmail": "adrian.rizos@biorender.com; madison@biorender.com", "sizeMentions": []}]}, {"id": "gsk_procurement_team_5e724fc7", "company": "gsk", "gong_entity": "Procurement Team", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I've been with GSK for, gosh, almost two and a half years, I think now, always within the procurement team.", "snippet_date": "2024-09-10", "person_name": "Tessa Lincoln", "person_email": "ambertessa.c.lincoln@gsk.com", "internal_name": "Derek Fitting; Madison Knock", "internal_email": "derek.fitting@biorender.com; madison@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=bdeb980229bf249722cd1e207256e8487e5d4818b79c5748f1e4c66f2572c171", "call_id": "2024-09-10_bdeb980229bf", "call_count": 1, "all_snippets": [{"quote": "I've been with GSK for, gosh, almost two and a half years, I think now, always within the procurement team.", "date": "2024-09-10", "callId": "2024-09-10_bdeb980229bf", "gongUrl": "https://app.gong.io/call?id=bdeb980229bf249722cd1e207256e8487e5d4818b79c5748f1e4c66f2572c171", "speakerId": "1018109843767271699", "customerName": "Tessa Lincoln", "internalName": "Derek Fitting; Madison Knock", "customerEmail": "ambertessa.c.lincoln@gsk.com", "internalEmail": "derek.fitting@biorender.com; madison@biorender.com", "sizeMentions": []}]}, {"id": "gsk_tech_team_487cf6ad", "company": "gsk", "gong_entity": "Tech Team", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "And I've actually recently transitioned to the tech team.", "snippet_date": "2024-09-10", "person_name": "Tessa Lincoln", "person_email": "ambertessa.c.lincoln@gsk.com", "internal_name": "Derek Fitting; Madison Knock", "internal_email": "derek.fitting@biorender.com; madison@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=bdeb980229bf249722cd1e207256e8487e5d4818b79c5748f1e4c66f2572c171", "call_id": "2024-09-10_bdeb980229bf", "call_count": 1, "all_snippets": [{"quote": "And I've actually recently transitioned to the tech team.", "date": "2024-09-10", "callId": "2024-09-10_bdeb980229bf", "gongUrl": "https://app.gong.io/call?id=bdeb980229bf249722cd1e207256e8487e5d4818b79c5748f1e4c66f2572c171", "speakerId": "1018109843767271699", "customerName": "Tessa Lincoln", "internalName": "Derek Fitting; Madison Knock", "customerEmail": "ambertessa.c.lincoln@gsk.com", "internalEmail": "derek.fitting@biorender.com; madison@biorender.com", "sizeMentions": []}]}, {"id": "gsk_medicine_development_and_supply_9371208e", "company": "gsk", "gong_entity": "Medicine Development and Supply", "gong_parent": "GSK R&D", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So the Biopharm Process Research team falls under what's known as the Medicine Development, the MDS team, the Medicine Development and Supply team.", "snippet_date": "2024-08-14", "person_name": "Holly Corrigall; Shoumo Chatterjee", "person_email": "holly.l.corrigall@gsk.com; shoumo.k.chatterjee@gsk.com", "internal_name": "Jacqueline McCoskey; Madison Knock", "internal_email": "jacqueline@biorender.com; madison@biorender.com", "llm_suggested_match": {"manual_node_id": "development", "manual_node_name": "Development", "manual_node_path": "GSK Research & Development > Development", "confidence": "medium", "reasoning": "Semantic match - 'Medicine Development and Supply' aligns with the Development division, though supply aspects may extend beyond R&D"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=198127ea884392e62e06166535fd4bf000fc814f59d6279c6db0fe29b71aae23", "call_id": "2024-08-14_198127ea8843", "call_count": 1, "all_snippets": [{"quote": "So the Biopharm Process Research team falls under what's known as the Medicine Development, the MDS team, the Medicine Development and Supply team.", "date": "2024-08-14", "callId": "2024-08-14_198127ea8843", "gongUrl": "https://app.gong.io/call?id=198127ea884392e62e06166535fd4bf000fc814f59d6279c6db0fe29b71aae23", "speakerId": "4627793280013784240", "customerName": "Holly Corrigall; Shoumo Chatterjee", "internalName": "Jacqueline McCoskey; Madison Knock", "customerEmail": "holly.l.corrigall@gsk.com; shoumo.k.chatterjee@gsk.com", "internalEmail": "jacqueline@biorender.com; madison@biorender.com", "sizeMentions": []}]}, {"id": "gsk_genetic_toxicology_253ec48b", "company": "gsk", "gong_entity": "Genetic Toxicology", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": "10", "confidence": "high", "mention_count": 1, "snippet": "So I work in genetic toxicology, so it's very early stages of drug development. And I'm in a team that was a team of 10 going into a team of 25", "snippet_date": "2024-07-31", "person_name": "Ruby Buckley", "person_email": "ruby.x.buckley@gsk.com", "internal_name": "Jaden Dankevy", "internal_email": "jaden.dankevy@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=9664f1b1ce292cafa39a985dfd060f24fb81d89556fd6d3b88e47e6acea0900d", "call_id": "2024-07-31_9664f1b1ce29", "call_count": 1, "all_snippets": [{"quote": "So I work in genetic toxicology, so it's very early stages of drug development. And I'm in a team that was a team of 10 going into a team of 25", "date": "2024-07-31", "callId": "2024-07-31_9664f1b1ce29", "gongUrl": "https://app.gong.io/call?id=9664f1b1ce292cafa39a985dfd060f24fb81d89556fd6d3b88e47e6acea0900d", "speakerId": "1473869484882034679", "customerName": "Ruby Buckley", "internalName": "Jaden Dankevy", "customerEmail": "ruby.x.buckley@gsk.com", "internalEmail": "jaden.dankevy@biorender.com", "sizeMentions": [{"value": "10", "snippetIndex": 0, "source": {"callDate": "2024-07-31", "customerName": "Ruby Buckley"}}]}]}, {"id": "gsk_process_development_560a332a", "company": "gsk", "gong_entity": "Process Development", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So my department is in more process development.", "snippet_date": "2024-07-23", "person_name": "Jenna Sumey; Jenna Sumey", "person_email": "jenna.l.sumey@gsk.com; jenna.l.sumey@gsk.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": {"manual_node_id": "vaccine-process-development", "manual_node_name": "Vaccine Process Development", "manual_node_path": "GSK Research & Development > CMC & Pharmaceutical Sciences > Vaccine CMC > Vaccine Process Development", "confidence": "low", "reasoning": "Partial match - could refer to vaccine process development or other process development areas not specifically mapped"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=03bd29b420ab75e49adf9c37efc4d105d224830df1fd2436eeb67477983e4b0c", "call_id": "2024-07-23_03bd29b420ab", "call_count": 1, "all_snippets": [{"quote": "So my department is in more process development.", "date": "2024-07-23", "callId": "2024-07-23_03bd29b420ab", "gongUrl": "https://app.gong.io/call?id=03bd29b420ab75e49adf9c37efc4d105d224830df1fd2436eeb67477983e4b0c", "speakerId": "1661437798478689558", "customerName": "Jenna Sumey; Jenna Sumey", "internalName": "Jacqueline McCoskey", "customerEmail": "jenna.l.sumey@gsk.com; jenna.l.sumey@gsk.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": []}]}, {"id": "gsk_biopharm_discovery_a2b2f980", "company": "gsk", "gong_entity": "Biopharm Discovery", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So they're biopharm discovery.", "snippet_date": "2024-07-23", "person_name": "Jenna Sumey; Jenna Sumey", "person_email": "jenna.l.sumey@gsk.com; jenna.l.sumey@gsk.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": {"manual_node_id": "biologics-discovery", "manual_node_name": "Biologics Discovery", "manual_node_path": "GSK Research & Development > Medicinal Science & Technology > Biologics Discovery", "confidence": "medium", "reasoning": "Semantic match - 'Biopharm Discovery' likely refers to biologics/biopharmaceutical discovery activities"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=03bd29b420ab75e49adf9c37efc4d105d224830df1fd2436eeb67477983e4b0c", "call_id": "2024-07-23_03bd29b420ab", "call_count": 1, "all_snippets": [{"quote": "So they're biopharm discovery.", "date": "2024-07-23", "callId": "2024-07-23_03bd29b420ab", "gongUrl": "https://app.gong.io/call?id=03bd29b420ab75e49adf9c37efc4d105d224830df1fd2436eeb67477983e4b0c", "speakerId": "1661437798478689558", "customerName": "Jenna Sumey; Jenna Sumey", "internalName": "Jacqueline McCoskey", "customerEmail": "jenna.l.sumey@gsk.com; jenna.l.sumey@gsk.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": []}]}, {"id": "gsk_ben_street,_cambridge_ebff1cde", "company": "gsk", "gong_entity": "Ben Street, Cambridge", "gong_parent": "GSK R&D", "entity_type": "site", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "one is in Ben street, cambridge", "snippet_date": "2024-07-16", "person_name": "Mark Richardson; Mark Richardson; Mark Richardson; Zakaria Mahmud", "person_email": "mark.8.richardson@gsk.com; mark.8.richardson@gsk.com; mark.8.richardson@gsk.com; zakaria.x.mahmud@gsk.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": {"manual_node_id": "cambridge-ma-binney", "manual_node_name": "Cambridge Binney Street, MA, USA", "manual_node_path": "GSK Research & Development > Global R&D Sites > Cambridge Binney Street, MA, USA", "confidence": "medium", "reasoning": "Ben Street likely refers to Binney Street in Cambridge, MA - common abbreviation/mishearing of street name"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=ffeb57b81c8e39ea8fde253ea726ecab2169ec61ffaa044a4f35652278e75751", "call_id": "2024-07-16_ffeb57b81c8e", "call_count": 1, "all_snippets": [{"quote": "one is in Ben street, cambridge", "date": "2024-07-16", "callId": "2024-07-16_ffeb57b81c8e", "gongUrl": "https://app.gong.io/call?id=ffeb57b81c8e39ea8fde253ea726ecab2169ec61ffaa044a4f35652278e75751", "speakerId": "2425925482248274804", "customerName": "Mark Richardson; Mark Richardson; Mark Richardson; Zakaria Mahmud", "internalName": "Jacqueline McCoskey", "customerEmail": "mark.8.richardson@gsk.com; mark.8.richardson@gsk.com; mark.8.richardson@gsk.com; zakaria.x.mahmud@gsk.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": []}]}, {"id": "gsk_italy_9261a53a", "company": "gsk", "gong_entity": "Italy", "gong_parent": "GSK R&D", "entity_type": "site", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "another one is italy", "snippet_date": "2024-07-16", "person_name": "Mark Richardson; Mark Richardson; Mark Richardson; Zakaria Mahmud", "person_email": "mark.8.richardson@gsk.com; mark.8.richardson@gsk.com; mark.8.richardson@gsk.com; zakaria.x.mahmud@gsk.com", "internal_name": "Jacqueline McCoskey", "internal_email": "jacqueline@biorender.com", "llm_suggested_match": {"manual_node_id": "siena-italy", "manual_node_name": "Siena, Italy (Vaccines R&D Hub)", "manual_node_path": "GSK Research & Development > Global R&D Sites > Siena, Italy (Vaccines R&D Hub)", "confidence": "high", "reasoning": "Italy matches the Siena, Italy site which is GSK's only Italian R&D location in the org chart"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=ffeb57b81c8e39ea8fde253ea726ecab2169ec61ffaa044a4f35652278e75751", "call_id": "2024-07-16_ffeb57b81c8e", "call_count": 1, "all_snippets": [{"quote": "another one is italy", "date": "2024-07-16", "callId": "2024-07-16_ffeb57b81c8e", "gongUrl": "https://app.gong.io/call?id=ffeb57b81c8e39ea8fde253ea726ecab2169ec61ffaa044a4f35652278e75751", "speakerId": "2425925482248274804", "customerName": "Mark Richardson; Mark Richardson; Mark Richardson; Zakaria Mahmud", "internalName": "Jacqueline McCoskey", "customerEmail": "mark.8.richardson@gsk.com; mark.8.richardson@gsk.com; mark.8.richardson@gsk.com; zakaria.x.mahmud@gsk.com", "internalEmail": "jacqueline@biorender.com", "sizeMentions": []}]}, {"id": "gsk_sienna_site_864b5af9", "company": "gsk", "gong_entity": "Sienna Site", "gong_parent": "GSK R&D", "entity_type": "site", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So he's based at the sienna site.", "snippet_date": "2024-05-30", "person_name": "Breda Rogulj; Tessa Lincoln", "person_email": "breda.x.rogulj@gsk.com; ambertessa.c.lincoln@gsk.com", "internal_name": "Derek Fitting; Madison Knock; Rich Lee", "internal_email": "derek.fitting@biorender.com; madison@biorender.com; rich@biorender.com", "llm_suggested_match": {"manual_node_id": "siena-italy", "manual_node_name": "Siena, Italy (Vaccines R&D Hub)", "manual_node_path": "GSK Research & Development > Global R&D Sites > Siena, Italy (Vaccines R&D Hub)", "confidence": "high", "reasoning": "Sienna is a common misspelling of Siena - exact match to the Italian vaccines R&D hub"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=f48501c94e990cf7e54c1421991cebe6f095560a36ba438c3628c278d935c0e7", "call_id": "2024-05-30_f48501c94e99", "call_count": 1, "all_snippets": [{"quote": "So he's based at the sienna site.", "date": "2024-05-30", "callId": "2024-05-30_f48501c94e99", "gongUrl": "https://app.gong.io/call?id=f48501c94e990cf7e54c1421991cebe6f095560a36ba438c3628c278d935c0e7", "speakerId": "4947416887802317457", "customerName": "Breda Rogulj; Tessa Lincoln", "internalName": "Derek Fitting; Madison Knock; Rich Lee", "customerEmail": "breda.x.rogulj@gsk.com; ambertessa.c.lincoln@gsk.com", "internalEmail": "derek.fitting@biorender.com; madison@biorender.com; rich@biorender.com", "sizeMentions": []}]}, {"id": "gsk_lab_services_team_86113408", "company": "gsk", "gong_entity": "Lab Services Team", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I worked within the lab services team like similar to Breda", "snippet_date": "2024-02-23", "person_name": "Breda Rogulj; Tessa Lincoln", "person_email": "breda.x.rogulj@gsk.com; ambertessa.c.lincoln@gsk.com", "internal_name": "Rich Lee; Sydney Burniston", "internal_email": "rich@biorender.com; sydney.b@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=e10c2dfb876ce01ec90746386e619fa972ba5a9c4b6883be813affbc7a7b5144", "call_id": "2024-02-23_e10c2dfb876c", "call_count": 1, "all_snippets": [{"quote": "I worked within the lab services team like similar to Breda", "date": "2024-02-23", "callId": "2024-02-23_e10c2dfb876c", "gongUrl": "https://app.gong.io/call?id=e10c2dfb876ce01ec90746386e619fa972ba5a9c4b6883be813affbc7a7b5144", "speakerId": "7775052794332009420", "customerName": "Breda Rogulj; Tessa Lincoln", "internalName": "Rich Lee; Sydney Burniston", "customerEmail": "breda.x.rogulj@gsk.com; ambertessa.c.lincoln@gsk.com", "internalEmail": "rich@biorender.com; sydney.b@biorender.com", "sizeMentions": []}]}, {"id": "gsk_safety_department_5aaba30d", "company": "gsk", "gong_entity": "Safety Department", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So I'm so I'm a medical director at GSK within the safety department.", "snippet_date": "2024-01-17", "person_name": "Lucy Walker", "person_email": "lucy.j.walker@gsk.com", "internal_name": "Rich Lee; Sydney Burniston", "internal_email": "rich@biorender.com; sydney.b@biorender.com", "llm_suggested_match": {"manual_node_id": "patient-safety", "manual_node_name": "Patient Safety & Pharmacovigilance", "manual_node_path": "GSK Research & Development > Medical, Regulatory & Quality > Patient Safety & Pharmacovigilance", "confidence": "high", "reasoning": "Safety department clearly maps to Patient Safety & Pharmacovigilance department"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=ab9569a335f6106b8793ef73c2e042ced8865f0aa6546e09abe7128b17410c39", "call_id": "2024-01-17_ab9569a335f6", "call_count": 1, "all_snippets": [{"quote": "So I'm so I'm a medical director at GSK within the safety department.", "date": "2024-01-17", "callId": "2024-01-17_ab9569a335f6", "gongUrl": "https://app.gong.io/call?id=ab9569a335f6106b8793ef73c2e042ced8865f0aa6546e09abe7128b17410c39", "speakerId": "8941229749871462674", "customerName": "Lucy Walker", "internalName": "Rich Lee; Sydney Burniston", "customerEmail": "lucy.j.walker@gsk.com", "internalEmail": "rich@biorender.com; sydney.b@biorender.com", "sizeMentions": []}]}, {"id": "gsk_immunology_group_eca2f6dc", "company": "gsk", "gong_entity": "Immunology Group", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "We are in the munology group.", "snippet_date": "2023-12-14", "person_name": "Breda Rogulj; Fabiana Spensieri; Raffaele Tiezzi", "person_email": "breda.x.rogulj@gsk.com; fabiana.x.spensieri@gsk.com; raffaele.x.tiezzi@gsk.com", "internal_name": "Rich Lee; Sydney Burniston", "internal_email": "rich@biorender.com; sydney.b@biorender.com", "llm_suggested_match": {"manual_node_id": "respiratory-immunology-research", "manual_node_name": "Respiratory, Immunology & Inflammation Research", "manual_node_path": "GSK Research & Development > Research > Respiratory, Immunology & Inflammation Research", "confidence": "medium", "reasoning": "Immunology group likely refers to the immunology portion of the respiratory/immunology research therapeutic area"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=b1ffc24e479ce7233193fda5e74985a0cab248e19b2a7ff75b51c02db505a70b", "call_id": "2023-12-14_b1ffc24e479c", "call_count": 1, "all_snippets": [{"quote": "We are in the munology group.", "date": "2023-12-14", "callId": "2023-12-14_b1ffc24e479c", "gongUrl": "https://app.gong.io/call?id=b1ffc24e479ce7233193fda5e74985a0cab248e19b2a7ff75b51c02db505a70b", "speakerId": "2750901220975667109", "customerName": "Breda Rogulj; Fabiana Spensieri; Raffaele Tiezzi", "internalName": "Rich Lee; Sydney Burniston", "customerEmail": "breda.x.rogulj@gsk.com; fabiana.x.spensieri@gsk.com; raffaele.x.tiezzi@gsk.com", "internalEmail": "rich@biorender.com; sydney.b@biorender.com", "sizeMentions": []}]}, {"id": "gsk_vaccine_group_46c1a48c", "company": "gsk", "gong_entity": "Vaccine Group", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So the vaccine group wouldn't qualify?", "snippet_date": "2023-12-14", "person_name": "Breda Rogulj; Fabiana Spensieri; Raffaele Tiezzi", "person_email": "breda.x.rogulj@gsk.com; fabiana.x.spensieri@gsk.com; raffaele.x.tiezzi@gsk.com", "internal_name": "Rich Lee; Sydney Burniston", "internal_email": "rich@biorender.com; sydney.b@biorender.com", "llm_suggested_match": {"manual_node_id": "vaccines-infectious-diseases-research", "manual_node_name": "Vaccines & Infectious Diseases Research", "manual_node_path": "GSK Research & Development > Research > Vaccines & Infectious Diseases Research", "confidence": "high", "reasoning": "Vaccine group directly matches the vaccines research therapeutic area"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=b1ffc24e479ce7233193fda5e74985a0cab248e19b2a7ff75b51c02db505a70b", "call_id": "2023-12-14_b1ffc24e479c", "call_count": 1, "all_snippets": [{"quote": "So the vaccine group wouldn't qualify?", "date": "2023-12-14", "callId": "2023-12-14_b1ffc24e479c", "gongUrl": "https://app.gong.io/call?id=b1ffc24e479ce7233193fda5e74985a0cab248e19b2a7ff75b51c02db505a70b", "speakerId": "7016314231623551404", "customerName": "Breda Rogulj; Fabiana Spensieri; Raffaele Tiezzi", "internalName": "Rich Lee; Sydney Burniston", "customerEmail": "breda.x.rogulj@gsk.com; fabiana.x.spensieri@gsk.com; raffaele.x.tiezzi@gsk.com", "internalEmail": "rich@biorender.com; sydney.b@biorender.com", "sizeMentions": []}]}, {"id": "gsk_immunology_research_unit_8892371c", "company": "gsk", "gong_entity": "Immunology Research Unit", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I'm from the immunology research unit?", "snippet_date": "2023-12-08", "person_name": "Victoria Fenstermaker; Victoria Fenstermaker", "person_email": "victoria.r.fenstermaker@gsk.com; victoria.r.fenstermaker@gsk.com", "internal_name": "Rich Lee", "internal_email": "rich@biorender.com", "llm_suggested_match": {"manual_node_id": "respiratory-immunology-research", "manual_node_name": "Respiratory, Immunology & Inflammation Research", "manual_node_path": "GSK Research & Development > Research > Respiratory, Immunology & Inflammation Research", "confidence": "medium", "reasoning": "Immunology research unit maps to the immunology portion of the respiratory/immunology therapeutic area"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=861eeca42685191489f22d720ca1bf80aa2900ca4f2a14c3eb4edce54804b3d6", "call_id": "2023-12-08_861eeca42685", "call_count": 1, "all_snippets": [{"quote": "I'm from the immunology research unit?", "date": "2023-12-08", "callId": "2023-12-08_861eeca42685", "gongUrl": "https://app.gong.io/call?id=861eeca42685191489f22d720ca1bf80aa2900ca4f2a14c3eb4edce54804b3d6", "speakerId": "1014562985380537944", "customerName": "Victoria Fenstermaker; Victoria Fenstermaker", "internalName": "Rich Lee", "customerEmail": "victoria.r.fenstermaker@gsk.com; victoria.r.fenstermaker@gsk.com", "internalEmail": "rich@biorender.com", "sizeMentions": []}]}, {"id": "gsk_ppr_ade344e5", "company": "gsk", "gong_entity": "PPR", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": "50", "confidence": "high", "mention_count": 1, "snippet": "we have a basically the whole PPR team is split between the UK and the U. S. So the UK team is around about 50 people, but I think we got about like 50 to 75 people who are within the us up at pro.", "snippet_date": "2023-11-15", "person_name": "Shoumo Chattergee", "person_email": "shoumo.k.chatterjee@gsk.com", "internal_name": "Rich Lee", "internal_email": "rich@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=74abd88ac57b7875b609b4bbc3edf3a5d3ba82594ec3058dc6187cb265bb3a14", "call_id": "2023-11-15_74abd88ac57b", "call_count": 1, "all_snippets": [{"quote": "we have a basically the whole PPR team is split between the UK and the U. S. So the UK team is around about 50 people, but I think we got about like 50 to 75 people who are within the us up at pro.", "date": "2023-11-15", "callId": "2023-11-15_74abd88ac57b", "gongUrl": "https://app.gong.io/call?id=74abd88ac57b7875b609b4bbc3edf3a5d3ba82594ec3058dc6187cb265bb3a14", "speakerId": "3293505899689536693", "customerName": "Shoumo Chattergee", "internalName": "Rich Lee", "customerEmail": "shoumo.k.chatterjee@gsk.com", "internalEmail": "rich@biorender.com", "sizeMentions": [{"value": "50", "snippetIndex": 0, "source": {"callDate": "2023-11-15", "customerName": "Shoumo Chattergee"}}]}]}, {"id": "gsk_genomics_sciences_5a08b370", "company": "gsk", "gong_entity": "Genomics Sciences", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": "400", "confidence": "high", "mention_count": 1, "snippet": "I sit in the genomics sciences that's about 400 people, a mix of lab and competitional people", "snippet_date": "2023-11-09", "person_name": "Tokuwa Kanno", "person_email": "tokuwa.x.kanno@gsk.com", "internal_name": "Rich Lee", "internal_email": "rich@biorender.com", "llm_suggested_match": {"manual_node_id": "human-genetics-genomics", "manual_node_name": "Human Genetics & Genomics", "manual_node_path": "GSK Research & Development > Human Genetics & Genomics", "confidence": "high", "reasoning": "Genomics Sciences directly maps to the Human Genetics & Genomics division"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=71b36b12d3476e89b91a2a5c5f3afe9e26eedf853e9bf1e6eb428b06b655e1ee", "call_id": "2023-11-09_71b36b12d347", "call_count": 1, "all_snippets": [{"quote": "I sit in the genomics sciences that's about 400 people, a mix of lab and competitional people", "date": "2023-11-09", "callId": "2023-11-09_71b36b12d347", "gongUrl": "https://app.gong.io/call?id=71b36b12d3476e89b91a2a5c5f3afe9e26eedf853e9bf1e6eb428b06b655e1ee", "speakerId": "354087791523643735", "customerName": "Tokuwa Kanno", "internalName": "Rich Lee", "customerEmail": "tokuwa.x.kanno@gsk.com", "internalEmail": "rich@biorender.com", "sizeMentions": [{"value": "400", "snippetIndex": 0, "source": {"callDate": "2023-11-09", "customerName": "Tokuwa Kanno"}}]}]}, {"id": "gsk_cyber_security_team_593362ee", "company": "gsk", "gong_entity": "Cyber Security Team", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "we maybe I don't know we also have to get in the, I think cyber security team or legal or I don't know to clarify how the, that are stored and table there.", "snippet_date": "2023-11-09", "person_name": "Raffaele Tiezzi", "person_email": "raffaele.x.tiezzi@gsk.com", "internal_name": "Rich Lee", "internal_email": "rich@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=b35fc13ea87e4414b10dbcd88212cee9053ac02917f7331308adf409270911ba", "call_id": "2023-11-09_b35fc13ea87e", "call_count": 1, "all_snippets": [{"quote": "we maybe I don't know we also have to get in the, I think cyber security team or legal or I don't know to clarify how the, that are stored and table there.", "date": "2023-11-09", "callId": "2023-11-09_b35fc13ea87e", "gongUrl": "https://app.gong.io/call?id=b35fc13ea87e4414b10dbcd88212cee9053ac02917f7331308adf409270911ba", "speakerId": "6886108149542803438", "customerName": "Raffaele Tiezzi", "internalName": "Rich Lee", "customerEmail": "raffaele.x.tiezzi@gsk.com", "internalEmail": "rich@biorender.com", "sizeMentions": []}]}, {"id": "gsk_novel_human_genetics_6bf83a19", "company": "gsk", "gong_entity": "Novel Human Genetics", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "we're actually running trials in complex in vitro med, Cam, monology, novel human genetics, new chemical entity at the upper providence site", "snippet_date": "2023-11-08", "person_name": "Kashappa-Goud Desai", "person_email": "kashappa-goud.x.desai@gsk.com", "internal_name": "Rich Lee", "internal_email": "rich@biorender.com", "llm_suggested_match": {"manual_node_id": "human-genetics", "manual_node_name": "Human Genetics", "manual_node_path": "GSK Research & Development > Human Genetics & Genomics > Human Genetics", "confidence": "medium", "reasoning": "Strong semantic match - 'Novel Human Genetics' likely refers to the Human Genetics department, with 'novel' being descriptive rather than part of the formal name"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=32901e504b4b4280296134091d8a2c98e4d720452805d63826edfbbaef8f402c", "call_id": "2023-11-08_32901e504b4b", "call_count": 1, "all_snippets": [{"quote": "we're actually running trials in complex in vitro med, Cam, monology, novel human genetics, new chemical entity at the upper providence site", "date": "2023-11-08", "callId": "2023-11-08_32901e504b4b", "gongUrl": "https://app.gong.io/call?id=32901e504b4b4280296134091d8a2c98e4d720452805d63826edfbbaef8f402c", "speakerId": "5258701633084091090", "customerName": "Kashappa-Goud Desai", "internalName": "Rich Lee", "customerEmail": "kashappa-goud.x.desai@gsk.com", "internalEmail": "rich@biorender.com", "sizeMentions": []}]}, {"id": "gsk_drug_development_sterile_26cebe56", "company": "gsk", "gong_entity": "Drug Development Sterile", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "Just you, but what about in drug, product development, sterile?", "snippet_date": "2023-11-08", "person_name": "Kashappa-Goud Desai", "person_email": "kashappa-goud.x.desai@gsk.com", "internal_name": "Rich Lee", "internal_email": "rich@biorender.com", "llm_suggested_match": {"manual_node_id": "drug-product-development", "manual_node_name": "Drug Product Development", "manual_node_path": "GSK Research & Development > CMC & Pharmaceutical Sciences > Small Molecule CMC > Drug Product Development", "confidence": "medium", "reasoning": "Likely refers to sterile drug product development within the Drug Product Development team - 'sterile' appears to be a specialization descriptor"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=32901e504b4b4280296134091d8a2c98e4d720452805d63826edfbbaef8f402c", "call_id": "2023-11-08_32901e504b4b", "call_count": 1, "all_snippets": [{"quote": "Just you, but what about in drug, product development, sterile?", "date": "2023-11-08", "callId": "2023-11-08_32901e504b4b", "gongUrl": "https://app.gong.io/call?id=32901e504b4b4280296134091d8a2c98e4d720452805d63826edfbbaef8f402c", "speakerId": "5258701633084091090", "customerName": "Kashappa-Goud Desai", "internalName": "Rich Lee", "customerEmail": "kashappa-goud.x.desai@gsk.com", "internalEmail": "rich@biorender.com", "sizeMentions": []}]}, {"id": "gsk_gsk_conference_center_c4f52f7d", "company": "gsk", "gong_entity": "GSK Conference Center", "gong_parent": "GSK R&D", "entity_type": "site", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "he put us in touch now with the GSK conference center over there", "snippet_date": "2023-09-29", "person_name": "Alex Hartofelis; Cecilia Shaw; Jessica Reilley; Joanne Reichart; Matthew Brecher", "person_email": "alex.p.hartofelis@gsk.com; cecilia.x.shaw@gsk.com; jessica.r.reilley@gsk.com; joanne.x.reichart@gsk.com; matthew.b.brecher@gsk.com", "internal_name": "Rich Lee; Sydney Burniston", "internal_email": "rich@biorender.com; sydney.b@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=8cc90fde3c9b3888646c1f0b7c2b5af030361f9de8e606ff34e051ef683314b4", "call_id": "2023-09-29_8cc90fde3c9b", "call_count": 1, "all_snippets": [{"quote": "he put us in touch now with the GSK conference center over there", "date": "2023-09-29", "callId": "2023-09-29_8cc90fde3c9b", "gongUrl": "https://app.gong.io/call?id=8cc90fde3c9b3888646c1f0b7c2b5af030361f9de8e606ff34e051ef683314b4", "speakerId": "8181303305939133730", "customerName": "Alex Hartofelis; Cecilia Shaw; Jessica Reilley; Joanne Reichart; Matthew Brecher", "internalName": "Rich Lee; Sydney Burniston", "customerEmail": "alex.p.hartofelis@gsk.com; cecilia.x.shaw@gsk.com; jessica.r.reilley@gsk.com; joanne.x.reichart@gsk.com; matthew.b.brecher@gsk.com", "internalEmail": "rich@biorender.com; sydney.b@biorender.com", "sizeMentions": []}]}, {"id": "gsk_trt_019577bd", "company": "gsk", "gong_entity": "TRT", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "We have, we have three departments, but the, these three departments are divided in a bunch of groups each. So we have for example, the TRT, the TRT plain, the three department sub department, every sub departments has these groups.", "snippet_date": "2023-09-28", "person_name": "Raffaele Tiezzi", "person_email": "raffaele.x.tiezzi@gsk.com", "internal_name": "Rich Lee", "internal_email": "rich@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=618bf1f4a61b98611588526f790ac828485d4e4a3ac7e2f630e6f526028a9553", "call_id": "2023-09-28_618bf1f4a61b", "call_count": 1, "all_snippets": [{"quote": "We have, we have three departments, but the, these three departments are divided in a bunch of groups each. So we have for example, the TRT, the TRT plain, the three department sub department, every sub departments has these groups.", "date": "2023-09-28", "callId": "2023-09-28_618bf1f4a61b", "gongUrl": "https://app.gong.io/call?id=618bf1f4a61b98611588526f790ac828485d4e4a3ac7e2f630e6f526028a9553", "speakerId": "514719409783807592", "customerName": "Raffaele Tiezzi", "internalName": "Rich Lee", "customerEmail": "raffaele.x.tiezzi@gsk.com", "internalEmail": "rich@biorender.com", "sizeMentions": []}]}, {"id": "gsk_elt_0300654e", "company": "gsk", "gong_entity": "ELT", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I work in the ELT so in code technology group", "snippet_date": "2023-08-01", "person_name": "Elizabeth D'ambrosio", "person_email": "elizabeth.a.d'ambrosio@gsk.com", "internal_name": "Hayley Lau; Jorell Izaguirre; Richard Lee", "internal_email": "hayley@biorender.com; jorell.izaguirre@biorender.com; rich@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=37963b03dba5488180bdb7a975fb6f1fb918839f75cdbb3ab7dbd5546deabf9c", "call_id": "2023-08-01_37963b03dba5", "call_count": 1, "all_snippets": [{"quote": "I work in the ELT so in code technology group", "date": "2023-08-01", "callId": "2023-08-01_37963b03dba5", "gongUrl": "https://app.gong.io/call?id=37963b03dba5488180bdb7a975fb6f1fb918839f75cdbb3ab7dbd5546deabf9c", "speakerId": "1304583252827154696", "customerName": "Elizabeth D'ambrosio", "internalName": "Hayley Lau; Jorell Izaguirre; Richard Lee", "customerEmail": "elizabeth.a.d'ambrosio@gsk.com", "internalEmail": "hayley@biorender.com; jorell.izaguirre@biorender.com; rich@biorender.com", "sizeMentions": []}]}, {"id": "gsk_innate_immunity_and_checkpoint_biology_group_497d01bb", "company": "gsk", "gong_entity": "Innate Immunity and Checkpoint Biology Group", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "It's called the innate immunity and checkpoint biology group.", "snippet_date": "2023-07-21", "person_name": "Sissy Easo-Joseph; Sissy Easo-Joseph", "person_email": "sissy.x.easo-joseph@gsk.com; sissy.x.easo-joseph@gsk.com", "internal_name": "Hayley Lau; Richard Lee", "internal_email": "hayley@biorender.com; rich@biorender.com", "llm_suggested_match": {"manual_node_id": "respiratory-immunology-research", "manual_node_name": "Respiratory, Immunology & Inflammation Research", "manual_node_path": "GSK Research & Development > Research > Respiratory, Immunology & Inflammation Research", "confidence": "medium", "reasoning": "Immunology focus suggests this group likely falls under the Respiratory, Immunology & Inflammation Research therapeutic area, though specific group name not found"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=909f63b4232d6cedca4a8bbfdb3ec14d40dd8cc1280e0ede31a30e9de745ddbd", "call_id": "2023-07-21_909f63b4232d", "call_count": 1, "all_snippets": [{"quote": "It's called the innate immunity and checkpoint biology group.", "date": "2023-07-21", "callId": "2023-07-21_909f63b4232d", "gongUrl": "https://app.gong.io/call?id=909f63b4232d6cedca4a8bbfdb3ec14d40dd8cc1280e0ede31a30e9de745ddbd", "speakerId": "1782946702512217361", "customerName": "Sissy Easo-Joseph; Sissy Easo-Joseph", "internalName": "Hayley Lau; Richard Lee", "customerEmail": "sissy.x.easo-joseph@gsk.com; sissy.x.easo-joseph@gsk.com", "internalEmail": "hayley@biorender.com; rich@biorender.com", "sizeMentions": []}]}, {"id": "gsk_scientific_communications_group_2550fbfc", "company": "gsk", "gong_entity": "Scientific Communications Group", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So as part of a scientific communications group", "snippet_date": "2023-07-21", "person_name": "Sissy Easo-Joseph; Sissy Easo-Joseph", "person_email": "sissy.x.easo-joseph@gsk.com; sissy.x.easo-joseph@gsk.com", "internal_name": "Hayley Lau; Richard Lee", "internal_email": "hayley@biorender.com; rich@biorender.com", "llm_suggested_match": {"manual_node_id": "medical-communications", "manual_node_name": "Medical Communications", "manual_node_path": "GSK Research & Development > Medical, Regulatory & Quality > Medical Affairs > Medical Communications", "confidence": "high", "reasoning": "Strong semantic match - Scientific Communications Group is very likely the same as or part of Medical Communications team"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=909f63b4232d6cedca4a8bbfdb3ec14d40dd8cc1280e0ede31a30e9de745ddbd", "call_id": "2023-07-21_909f63b4232d", "call_count": 1, "all_snippets": [{"quote": "So as part of a scientific communications group", "date": "2023-07-21", "callId": "2023-07-21_909f63b4232d", "gongUrl": "https://app.gong.io/call?id=909f63b4232d6cedca4a8bbfdb3ec14d40dd8cc1280e0ede31a30e9de745ddbd", "speakerId": "5327207188246079082", "customerName": "Sissy Easo-Joseph; Sissy Easo-Joseph", "internalName": "Hayley Lau; Richard Lee", "customerEmail": "sissy.x.easo-joseph@gsk.com; sissy.x.easo-joseph@gsk.com", "internalEmail": "hayley@biorender.com; rich@biorender.com", "sizeMentions": []}]}, {"id": "gsk_antibiotics_group_4f64f9b5", "company": "gsk", "gong_entity": "Antibiotics Group", "gong_parent": "Medical Affairs", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "There's six of us under the antibiotics group, under the medical affairs team.", "snippet_date": "2023-07-21", "person_name": "Sissy Easo-Joseph; Sissy Easo-Joseph", "person_email": "sissy.x.easo-joseph@gsk.com; sissy.x.easo-joseph@gsk.com", "internal_name": "Hayley Lau; Richard Lee", "internal_email": "hayley@biorender.com; rich@biorender.com", "llm_suggested_match": {"manual_node_id": "infectious-diseases-development", "manual_node_name": "Infectious Diseases Development", "manual_node_path": "GSK Research & Development > Development > Infectious Diseases Development", "confidence": "medium", "reasoning": "Antibiotics are used to treat infectious diseases, so this group likely falls under Infectious Diseases Development therapeutic area"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=909f63b4232d6cedca4a8bbfdb3ec14d40dd8cc1280e0ede31a30e9de745ddbd", "call_id": "2023-07-21_909f63b4232d", "call_count": 1, "all_snippets": [{"quote": "There's six of us under the antibiotics group, under the medical affairs team.", "date": "2023-07-21", "callId": "2023-07-21_909f63b4232d", "gongUrl": "https://app.gong.io/call?id=909f63b4232d6cedca4a8bbfdb3ec14d40dd8cc1280e0ede31a30e9de745ddbd", "speakerId": "5327207188246079082", "customerName": "Sissy Easo-Joseph; Sissy Easo-Joseph", "internalName": "Hayley Lau; Richard Lee", "customerEmail": "sissy.x.easo-joseph@gsk.com; sissy.x.easo-joseph@gsk.com", "internalEmail": "hayley@biorender.com; rich@biorender.com", "sizeMentions": []}]}, {"id": "gsk_general_medicine_fcb167c7", "company": "gsk", "gong_entity": "General Medicine", "gong_parent": "GSK R&D", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "we're going to be part of a cycon group within general medicine.", "snippet_date": "2023-07-21", "person_name": "Sissy Easo-Joseph; Sissy Easo-Joseph", "person_email": "sissy.x.easo-joseph@gsk.com; sissy.x.easo-joseph@gsk.com", "internal_name": "Hayley Lau; Richard Lee", "internal_email": "hayley@biorender.com; rich@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=909f63b4232d6cedca4a8bbfdb3ec14d40dd8cc1280e0ede31a30e9de745ddbd", "call_id": "2023-07-21_909f63b4232d", "call_count": 1, "all_snippets": [{"quote": "we're going to be part of a cycon group within general medicine.", "date": "2023-07-21", "callId": "2023-07-21_909f63b4232d", "gongUrl": "https://app.gong.io/call?id=909f63b4232d6cedca4a8bbfdb3ec14d40dd8cc1280e0ede31a30e9de745ddbd", "speakerId": "5327207188246079082", "customerName": "Sissy Easo-Joseph; Sissy Easo-Joseph", "internalName": "Hayley Lau; Richard Lee", "customerEmail": "sissy.x.easo-joseph@gsk.com; sissy.x.easo-joseph@gsk.com", "internalEmail": "hayley@biorender.com; rich@biorender.com", "sizeMentions": []}]}, {"id": "gsk_cycon_group_1a4888d0", "company": "gsk", "gong_entity": "Cycon Group", "gong_parent": "General Medicine", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "And eventually there's been a little bit of an organizational change where we're going to be part of a cycon group within general medicine.", "snippet_date": "2023-07-21", "person_name": "Sissy Easo-Joseph; Sissy Easo-Joseph", "person_email": "sissy.x.easo-joseph@gsk.com; sissy.x.easo-joseph@gsk.com", "internal_name": "Hayley Lau; Richard Lee", "internal_email": "hayley@biorender.com; rich@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=909f63b4232d6cedca4a8bbfdb3ec14d40dd8cc1280e0ede31a30e9de745ddbd", "call_id": "2023-07-21_909f63b4232d", "call_count": 1, "all_snippets": [{"quote": "And eventually there's been a little bit of an organizational change where we're going to be part of a cycon group within general medicine.", "date": "2023-07-21", "callId": "2023-07-21_909f63b4232d", "gongUrl": "https://app.gong.io/call?id=909f63b4232d6cedca4a8bbfdb3ec14d40dd8cc1280e0ede31a30e9de745ddbd", "speakerId": "5327207188246079082", "customerName": "Sissy Easo-Joseph; Sissy Easo-Joseph", "internalName": "Hayley Lau; Richard Lee", "customerEmail": "sissy.x.easo-joseph@gsk.com; sissy.x.easo-joseph@gsk.com", "internalEmail": "hayley@biorender.com; rich@biorender.com", "sizeMentions": []}]}, {"id": "gsk_rand_site_e830887d", "company": "gsk", "gong_entity": "Rand Site", "gong_parent": "GSK R&D", "entity_type": "site", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "I helped the rand site in Belgium with 30 licenses last year as well.", "snippet_date": "2023-07-21", "person_name": "Sissy Easo-Joseph; Sissy Easo-Joseph", "person_email": "sissy.x.easo-joseph@gsk.com; sissy.x.easo-joseph@gsk.com", "internal_name": "Hayley Lau; Richard Lee", "internal_email": "hayley@biorender.com; rich@biorender.com", "llm_suggested_match": {"manual_node_id": "rixensart-belgium", "manual_node_name": "Rixensart & Wavre, Belgium (Vaccines R&D Hub)", "manual_node_path": "GSK Research & Development > Global R&D Sites > Rixensart & Wavre, Belgium (Vaccines R&D Hub)", "confidence": "medium", "reasoning": "Likely refers to the Rixensart site in Belgium, which is phonetically similar to 'Rand' and matches the Belgium location context from other entities."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=909f63b4232d6cedca4a8bbfdb3ec14d40dd8cc1280e0ede31a30e9de745ddbd", "call_id": "2023-07-21_909f63b4232d", "call_count": 1, "all_snippets": [{"quote": "I helped the rand site in Belgium with 30 licenses last year as well.", "date": "2023-07-21", "callId": "2023-07-21_909f63b4232d", "gongUrl": "https://app.gong.io/call?id=909f63b4232d6cedca4a8bbfdb3ec14d40dd8cc1280e0ede31a30e9de745ddbd", "speakerId": "1782946702512217361", "customerName": "Sissy Easo-Joseph; Sissy Easo-Joseph", "internalName": "Hayley Lau; Richard Lee", "customerEmail": "sissy.x.easo-joseph@gsk.com; sissy.x.easo-joseph@gsk.com", "internalEmail": "hayley@biorender.com; rich@biorender.com", "sizeMentions": []}]}, {"id": "gsk_rnd_8ff9181e", "company": "gsk", "gong_entity": "RND", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": "2000", "confidence": "high", "mention_count": 1, "snippet": "In RND, we have, I think 2000 people", "snippet_date": "2023-07-13", "person_name": "Jim Janimak", "person_email": "jim.j.janimak@gsk.com", "internal_name": "Rich Lee", "internal_email": "rich@biorender.com", "llm_suggested_match": {"manual_node_id": "gsk-rd", "manual_node_name": "GSK Research & Development", "manual_node_path": "GSK Research & Development", "confidence": "high", "reasoning": "RND is a clear acronym for Research and Development, matching the top-level GSK R&D organization."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=ee58197b7092f81d16e8fc320a609108e69871f803fffcb37b7af9e0e30b692a", "call_id": "2023-07-13_ee58197b7092", "call_count": 1, "all_snippets": [{"quote": "In RND, we have, I think 2000 people", "date": "2023-07-13", "callId": "2023-07-13_ee58197b7092", "gongUrl": "https://app.gong.io/call?id=ee58197b7092f81d16e8fc320a609108e69871f803fffcb37b7af9e0e30b692a", "speakerId": "3824991001065428162", "customerName": "Jim Janimak", "internalName": "Rich Lee", "customerEmail": "jim.j.janimak@gsk.com", "internalEmail": "rich@biorender.com", "sizeMentions": [{"value": "2000", "snippetIndex": 0, "source": {"callDate": "2023-07-13", "customerName": "Jim Janimak"}}]}]}, {"id": "gsk_analytical_research_and_development_cb9274a7", "company": "gsk", "gong_entity": "Analytical Research and Development", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "Analytical research and development. So, so we do sample testing for internal material. We develop methods for batch release, that type of thing that's what we do", "snippet_date": "2023-07-11", "person_name": "Matthew Brecher", "person_email": "matthew.b.brecher@gsk.com", "internal_name": "Rich Lee", "internal_email": "rich@biorender.com", "llm_suggested_match": {"manual_node_id": "analytical-development-sm", "manual_node_name": "Analytical Development", "manual_node_path": "GSK Research & Development > CMC & Pharmaceutical Sciences > Small Molecule CMC > Analytical Development", "confidence": "medium", "reasoning": "Strong semantic match with Analytical Development team. The entity describes sample testing and method development which aligns with analytical development functions, though there are multiple analytical development teams."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=602faffb183e4e4824d3bf1ab28ee115412c31e230677d7ee034801eb4a6fa8c", "call_id": "2023-07-11_602faffb183e", "call_count": 1, "all_snippets": [{"quote": "Analytical research and development. So, so we do sample testing for internal material. We develop methods for batch release, that type of thing that's what we do", "date": "2023-07-11", "callId": "2023-07-11_602faffb183e", "gongUrl": "https://app.gong.io/call?id=602faffb183e4e4824d3bf1ab28ee115412c31e230677d7ee034801eb4a6fa8c", "speakerId": "5882762078687495157", "customerName": "Matthew Brecher", "internalName": "Rich Lee", "customerEmail": "matthew.b.brecher@gsk.com", "internalEmail": "rich@biorender.com", "sizeMentions": []}]}, {"id": "gsk_preclinical_abebe716", "company": "gsk", "gong_entity": "Preclinical", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": "60", "confidence": "high", "mention_count": 1, "snippet": "And then preclinical has like, I don't know maybe they have like\u2026 60 70 something like that", "snippet_date": "2023-07-11", "person_name": "Matthew Brecher", "person_email": "matthew.b.brecher@gsk.com", "internal_name": "Rich Lee", "internal_email": "rich@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=602faffb183e4e4824d3bf1ab28ee115412c31e230677d7ee034801eb4a6fa8c", "call_id": "2023-07-11_602faffb183e", "call_count": 1, "all_snippets": [{"quote": "And then preclinical has like, I don't know maybe they have like\u2026 60 70 something like that", "date": "2023-07-11", "callId": "2023-07-11_602faffb183e", "gongUrl": "https://app.gong.io/call?id=602faffb183e4e4824d3bf1ab28ee115412c31e230677d7ee034801eb4a6fa8c", "speakerId": "5882762078687495157", "customerName": "Matthew Brecher", "internalName": "Rich Lee", "customerEmail": "matthew.b.brecher@gsk.com", "internalEmail": "rich@biorender.com", "sizeMentions": []}]}, {"id": "gsk_gsk_rixensart_1e083f52", "company": "gsk", "gong_entity": "GSK Rixensart", "gong_parent": "GSK R&D", "entity_type": "site", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "Yes, yeah, Rexton sort, Belgium. So GSK recon sort, is very large", "snippet_date": "2023-07-11", "person_name": "Matthew Brecher", "person_email": "matthew.b.brecher@gsk.com", "internal_name": "Rich Lee", "internal_email": "rich@biorender.com", "llm_suggested_match": {"manual_node_id": "rixensart-belgium", "manual_node_name": "Rixensart & Wavre, Belgium (Vaccines R&D Hub)", "manual_node_path": "GSK Research & Development > Global R&D Sites > Rixensart & Wavre, Belgium (Vaccines R&D Hub)", "confidence": "high", "reasoning": "Exact location match - Rixensart is explicitly listed as a major GSK R&D site in Belgium focused on vaccines."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=602faffb183e4e4824d3bf1ab28ee115412c31e230677d7ee034801eb4a6fa8c", "call_id": "2023-07-11_602faffb183e", "call_count": 1, "all_snippets": [{"quote": "Yes, yeah, Rexton sort, Belgium. So GSK recon sort, is very large", "date": "2023-07-11", "callId": "2023-07-11_602faffb183e", "gongUrl": "https://app.gong.io/call?id=602faffb183e4e4824d3bf1ab28ee115412c31e230677d7ee034801eb4a6fa8c", "speakerId": "5882762078687495157", "customerName": "Matthew Brecher", "internalName": "Rich Lee", "customerEmail": "matthew.b.brecher@gsk.com", "internalEmail": "rich@biorender.com", "sizeMentions": []}]}, {"id": "gsk_elt_inquiry_technologies_group_72166209", "company": "gsk", "gong_entity": "ELT Inquiry Technologies Group", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": "60", "confidence": "high", "mention_count": 1, "snippet": "So I said in the ELT inquiry technologies group which is a larger group of 60 people is about let's say 45 Ish of which are chemists.", "snippet_date": "2023-06-29", "person_name": "Karanbir Pahil", "person_email": "karanbir.s.pahil@gsk.com", "internal_name": "Hayley Lau; Richard Lee", "internal_email": "hayley@biorender.com; rich@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=c53828a1ea9ea13b52e16a4647afb62d5db5a4268832101b27b731c8fdfb8c1d", "call_id": "2023-06-29_c53828a1ea9e", "call_count": 1, "all_snippets": [{"quote": "So I said in the ELT inquiry technologies group which is a larger group of 60 people is about let's say 45 Ish of which are chemists.", "date": "2023-06-29", "callId": "2023-06-29_c53828a1ea9e", "gongUrl": "https://app.gong.io/call?id=c53828a1ea9ea13b52e16a4647afb62d5db5a4268832101b27b731c8fdfb8c1d", "speakerId": "4157582843694321151", "customerName": "Karanbir Pahil", "internalName": "Hayley Lau; Richard Lee", "customerEmail": "karanbir.s.pahil@gsk.com", "internalEmail": "hayley@biorender.com; rich@biorender.com", "sizeMentions": [{"value": "60", "snippetIndex": 0, "source": {"callDate": "2023-06-29", "customerName": "Karanbir Pahil"}}]}]}, {"id": "gsk_biophysics_group_ec5d3909", "company": "gsk", "gong_entity": "Biophysics Group", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So I'm in the biophysixs group and a set of a set of people are in the biology group.", "snippet_date": "2023-06-29", "person_name": "Karanbir Pahil", "person_email": "karanbir.s.pahil@gsk.com", "internal_name": "Hayley Lau; Richard Lee", "internal_email": "hayley@biorender.com; rich@biorender.com", "llm_suggested_match": {"manual_node_id": "structural-biology", "manual_node_name": "Structural Biology", "manual_node_path": "GSK Research & Development > Medicinal Science & Technology > Structural Biology", "confidence": "medium", "reasoning": "Biophysics work often overlaps with structural biology activities. While not an exact match, structural biology is the closest related discipline in the org chart."}, "status": "pending", "gong_url": "https://app.gong.io/call?id=c53828a1ea9ea13b52e16a4647afb62d5db5a4268832101b27b731c8fdfb8c1d", "call_id": "2023-06-29_c53828a1ea9e", "call_count": 1, "all_snippets": [{"quote": "So I'm in the biophysixs group and a set of a set of people are in the biology group.", "date": "2023-06-29", "callId": "2023-06-29_c53828a1ea9e", "gongUrl": "https://app.gong.io/call?id=c53828a1ea9ea13b52e16a4647afb62d5db5a4268832101b27b731c8fdfb8c1d", "speakerId": "4157582843694321151", "customerName": "Karanbir Pahil", "internalName": "Hayley Lau; Richard Lee", "customerEmail": "karanbir.s.pahil@gsk.com", "internalEmail": "hayley@biorender.com; rich@biorender.com", "sizeMentions": []}]}, {"id": "gsk_biology_group_c82850c2", "company": "gsk", "gong_entity": "Biology Group", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So I'm in the biophysixs group and a set of a set of people are in the biology group.", "snippet_date": "2023-06-29", "person_name": "Karanbir Pahil", "person_email": "karanbir.s.pahil@gsk.com", "internal_name": "Hayley Lau; Richard Lee", "internal_email": "hayley@biorender.com; rich@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=c53828a1ea9ea13b52e16a4647afb62d5db5a4268832101b27b731c8fdfb8c1d", "call_id": "2023-06-29_c53828a1ea9e", "call_count": 1, "all_snippets": [{"quote": "So I'm in the biophysixs group and a set of a set of people are in the biology group.", "date": "2023-06-29", "callId": "2023-06-29_c53828a1ea9e", "gongUrl": "https://app.gong.io/call?id=c53828a1ea9ea13b52e16a4647afb62d5db5a4268832101b27b731c8fdfb8c1d", "speakerId": "4157582843694321151", "customerName": "Karanbir Pahil", "internalName": "Hayley Lau; Richard Lee", "customerEmail": "karanbir.s.pahil@gsk.com", "internalEmail": "hayley@biorender.com; rich@biorender.com", "sizeMentions": []}]}, {"id": "gsk_cambridge,_massachusetts_bc6249f3", "company": "gsk", "gong_entity": "Cambridge, Massachusetts", "gong_parent": "GSK R&D", "entity_type": "site", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So I'm in cambridge, Massachusetts\u2026 one of the sites there.", "snippet_date": "2023-06-29", "person_name": "Karanbir Pahil", "person_email": "karanbir.s.pahil@gsk.com", "internal_name": "Hayley Lau; Richard Lee", "internal_email": "hayley@biorender.com; rich@biorender.com", "llm_suggested_match": {"manual_node_id": "cambridge-ma-binney", "manual_node_name": "Cambridge Binney Street, MA, USA", "manual_node_path": "GSK Research & Development > Global R&D Sites > Cambridge Binney Street, MA, USA", "confidence": "medium", "reasoning": "Geographic match for Cambridge, Massachusetts. Multiple Cambridge sites exist in org chart, choosing first one as representative match since specific address not mentioned in entity"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=c53828a1ea9ea13b52e16a4647afb62d5db5a4268832101b27b731c8fdfb8c1d", "call_id": "2023-06-29_c53828a1ea9e", "call_count": 1, "all_snippets": [{"quote": "So I'm in cambridge, Massachusetts\u2026 one of the sites there.", "date": "2023-06-29", "callId": "2023-06-29_c53828a1ea9e", "gongUrl": "https://app.gong.io/call?id=c53828a1ea9ea13b52e16a4647afb62d5db5a4268832101b27b731c8fdfb8c1d", "speakerId": "4157582843694321151", "customerName": "Karanbir Pahil", "internalName": "Hayley Lau; Richard Lee", "customerEmail": "karanbir.s.pahil@gsk.com", "internalEmail": "hayley@biorender.com; rich@biorender.com", "sizeMentions": []}]}, {"id": "gsk_gsk_italy_2e619e35", "company": "gsk", "gong_entity": "GSK Italy", "gong_parent": "GSK R&D", "entity_type": "site", "team_size": "200", "confidence": "high", "mention_count": 1, "snippet": "So, I recently, a couple of weeks ago, I did a couple of webinars for a big site in GSK Italy in Seana, about 150 to 200 scientists and they all love it.", "snippet_date": "2023-06-29", "person_name": "Karanbir Pahil", "person_email": "karanbir.s.pahil@gsk.com", "internal_name": "Hayley Lau; Richard Lee", "internal_email": "hayley@biorender.com; rich@biorender.com", "llm_suggested_match": {"manual_node_id": "siena-italy", "manual_node_name": "Siena, Italy (Vaccines R&D Hub)", "manual_node_path": "GSK Research & Development > Global R&D Sites > Siena, Italy (Vaccines R&D Hub)", "confidence": "high", "reasoning": "Exact geographic match - snippet mentions 'GSK Italy in Seana' which matches Siena, Italy site, and context mentions vaccines which aligns with this being a Vaccines R&D Hub"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=c53828a1ea9ea13b52e16a4647afb62d5db5a4268832101b27b731c8fdfb8c1d", "call_id": "2023-06-29_c53828a1ea9e", "call_count": 1, "all_snippets": [{"quote": "So, I recently, a couple of weeks ago, I did a couple of webinars for a big site in GSK Italy in Seana, about 150 to 200 scientists and they all love it.", "date": "2023-06-29", "callId": "2023-06-29_c53828a1ea9e", "gongUrl": "https://app.gong.io/call?id=c53828a1ea9ea13b52e16a4647afb62d5db5a4268832101b27b731c8fdfb8c1d", "speakerId": "6566323918198523305", "customerName": "Karanbir Pahil", "internalName": "Hayley Lau; Richard Lee", "customerEmail": "karanbir.s.pahil@gsk.com", "internalEmail": "hayley@biorender.com; rich@biorender.com", "sizeMentions": [{"value": "200", "snippetIndex": 0, "source": {"callDate": "2023-06-29", "customerName": "Karanbir Pahil"}}]}]}, {"id": "gsk_r_and_d_e55e0c30", "company": "gsk", "gong_entity": "R and D", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "I also work with like a group, I think R and D out in Boston as well.", "snippet_date": "2023-06-29", "person_name": "Karanbir Pahil", "person_email": "karanbir.s.pahil@gsk.com", "internal_name": "Hayley Lau; Richard Lee", "internal_email": "hayley@biorender.com; rich@biorender.com", "llm_suggested_match": {"manual_node_id": "gsk-rd", "manual_node_name": "GSK Research & Development", "manual_node_path": "GSK Research & Development", "confidence": "high", "reasoning": "Exact acronym match - 'R and D' is clearly 'Research & Development', matching the top-level GSK R&D organization"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=c53828a1ea9ea13b52e16a4647afb62d5db5a4268832101b27b731c8fdfb8c1d", "call_id": "2023-06-29_c53828a1ea9e", "call_count": 1, "all_snippets": [{"quote": "I also work with like a group, I think R and D out in Boston as well.", "date": "2023-06-29", "callId": "2023-06-29_c53828a1ea9e", "gongUrl": "https://app.gong.io/call?id=c53828a1ea9ea13b52e16a4647afb62d5db5a4268832101b27b731c8fdfb8c1d", "speakerId": "6566323918198523305", "customerName": "Karanbir Pahil", "internalName": "Hayley Lau; Richard Lee", "customerEmail": "karanbir.s.pahil@gsk.com", "internalEmail": "hayley@biorender.com; rich@biorender.com", "sizeMentions": []}]}, {"id": "gsk_gsk_vaccines_c87464a7", "company": "gsk", "gong_entity": "GSK vaccines", "gong_parent": "GSK R&D", "entity_type": "business_unit", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "So this is GSK vaccines in sienna, Italy.", "snippet_date": "2023-06-27", "person_name": "Sunil Nagpal", "person_email": "sunil.x.nagpal@gsk.com", "internal_name": "Richard Lee", "internal_email": "rich@biorender.com", "llm_suggested_match": {"manual_node_id": "vaccines-infectious-diseases-research", "manual_node_name": "Vaccines & Infectious Diseases Research", "manual_node_path": "GSK Research & Development > Research > Vaccines & Infectious Diseases Research", "confidence": "medium", "reasoning": "Semantic match for vaccines business unit. Context mentions Siena, Italy which is a vaccines hub, suggesting this refers to the vaccines research organization"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=f8c29de04cc378bc43bcbcb80fe22c6db16637f3f6a2a97dac990864f2b61df2", "call_id": "2023-06-27_f8c29de04cc3", "call_count": 1, "all_snippets": [{"quote": "So this is GSK vaccines in sienna, Italy.", "date": "2023-06-27", "callId": "2023-06-27_f8c29de04cc3", "gongUrl": "https://app.gong.io/call?id=f8c29de04cc378bc43bcbcb80fe22c6db16637f3f6a2a97dac990864f2b61df2", "speakerId": "4071680020446326604", "customerName": "Sunil Nagpal", "internalName": "Richard Lee", "customerEmail": "sunil.x.nagpal@gsk.com", "internalEmail": "rich@biorender.com", "sizeMentions": []}]}, {"id": "gsk_vaccine_team_25d86c67", "company": "gsk", "gong_entity": "vaccine team", "gong_parent": "GSK vaccines", "entity_type": "team", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "So there's a vaccine team, there's a BI team.", "snippet_date": "2023-01-12", "person_name": "", "person_email": "james.x.lodge@gsk.com; manjunath.n.hegde@gsk.com", "internal_name": "Hayley Lau; Richard Lee", "internal_email": "hayley@biorender.com; rich@biorender.com", "llm_suggested_match": {"manual_node_id": "vaccines-development", "manual_node_name": "Vaccines Development", "manual_node_path": "GSK Research & Development > Development > Vaccines Development", "confidence": "medium", "reasoning": "Generic vaccine team reference could match multiple vaccine nodes. Choosing development area as it's a major vaccine organizational unit, though specific team unclear"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=879191214155d8be5ee095fc329941ab64bf31ba216733d33adff0cce5ee8bdc", "call_id": "2023-01-12_879191214155", "call_count": 1, "all_snippets": [{"quote": "So there's a vaccine team, there's a BI team.", "date": "2023-01-12", "callId": "2023-01-12_879191214155", "gongUrl": "https://app.gong.io/call?id=879191214155d8be5ee095fc329941ab64bf31ba216733d33adff0cce5ee8bdc", "speakerId": "5207298135856666814", "customerName": "", "internalName": "Hayley Lau; Richard Lee", "customerEmail": "james.x.lodge@gsk.com; manjunath.n.hegde@gsk.com", "internalEmail": "hayley@biorender.com; rich@biorender.com", "sizeMentions": []}]}, {"id": "gsk_immunology_research_team_ad3ebe7f", "company": "gsk", "gong_entity": "immunology research team", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": null, "confidence": "high", "mention_count": 1, "snippet": "Have you talked with our team, immunology research team they are at in san UK?", "snippet_date": "2023-06-27", "person_name": "Sunil Nagpal", "person_email": "sunil.x.nagpal@gsk.com", "internal_name": "Richard Lee", "internal_email": "rich@biorender.com", "llm_suggested_match": {"manual_node_id": "respiratory-immunology-research", "manual_node_name": "Respiratory, Immunology & Inflammation Research", "manual_node_path": "GSK Research & Development > Research > Respiratory, Immunology & Inflammation Research", "confidence": "high", "reasoning": "Strong semantic match - 'immunology research team' aligns well with 'Respiratory, Immunology & Inflammation Research' therapeutic area"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=f8c29de04cc378bc43bcbcb80fe22c6db16637f3f6a2a97dac990864f2b61df2", "call_id": "2023-06-27_f8c29de04cc3", "call_count": 1, "all_snippets": [{"quote": "Have you talked with our team, immunology research team they are at in san UK?", "date": "2023-06-27", "callId": "2023-06-27_f8c29de04cc3", "gongUrl": "https://app.gong.io/call?id=f8c29de04cc378bc43bcbcb80fe22c6db16637f3f6a2a97dac990864f2b61df2", "speakerId": "3217337874125958899", "customerName": "Sunil Nagpal", "internalName": "Richard Lee", "customerEmail": "sunil.x.nagpal@gsk.com", "internalEmail": "rich@biorender.com", "sizeMentions": []}]}, {"id": "gsk_clinical_bio_market_group_39352625", "company": "gsk", "gong_entity": "clinical bio market group", "gong_parent": "GSK R&D", "entity_type": "business_unit", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "The, the discovery medicine, the person is on the senior VP of discovery medicine or clinical bio market group.", "snippet_date": "2023-06-27", "person_name": "Sunil Nagpal", "person_email": "sunil.x.nagpal@gsk.com", "internal_name": "Richard Lee", "internal_email": "rich@biorender.com", "llm_suggested_match": {"manual_node_id": "biomarker-development", "manual_node_name": "Biomarker Development", "manual_node_path": "GSK Research & Development > Development > Translational Medicine > Biomarker Development", "confidence": "low", "reasoning": "Weak match based on 'bio market' potentially referring to biomarkers. The entity seems garbled or unclear, making confident matching difficult"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=f8c29de04cc378bc43bcbcb80fe22c6db16637f3f6a2a97dac990864f2b61df2", "call_id": "2023-06-27_f8c29de04cc3", "call_count": 1, "all_snippets": [{"quote": "The, the discovery medicine, the person is on the senior VP of discovery medicine or clinical bio market group.", "date": "2023-06-27", "callId": "2023-06-27_f8c29de04cc3", "gongUrl": "https://app.gong.io/call?id=f8c29de04cc378bc43bcbcb80fe22c6db16637f3f6a2a97dac990864f2b61df2", "speakerId": "3217337874125958899", "customerName": "Sunil Nagpal", "internalName": "Richard Lee", "customerEmail": "sunil.x.nagpal@gsk.com", "internalEmail": "rich@biorender.com", "sizeMentions": []}]}, {"id": "gsk_cellular_biomarkers_584b0a00", "company": "gsk", "gong_entity": "Cellular Biomarkers", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": null, "confidence": "low", "mention_count": 1, "snippet": "Sell are by Marcus", "snippet_date": "2023-06-19", "person_name": "Eduardo Gomez Castaneda", "person_email": "eduardo.x.gomezcastaneda@gsk.com", "internal_name": "Richard Lee", "internal_email": "rich@biorender.com", "llm_suggested_match": {"manual_node_id": "biomarker-development", "manual_node_name": "Biomarker Development", "manual_node_path": "GSK Research & Development > Development > Translational Medicine > Biomarker Development", "confidence": "medium", "reasoning": "Semantic match - 'Cellular Biomarkers' relates to biomarker development activities, though the manual node is more general"}, "status": "pending", "gong_url": "https://app.gong.io/call?id=dba59ffcded46b48ef33dd10a6a3880e25343d08362ce5456378e1da3d0c84ef", "call_id": "2023-06-19_dba59ffcded4", "call_count": 1, "all_snippets": [{"quote": "Sell are by Marcus", "date": "2023-06-19", "callId": "2023-06-19_dba59ffcded4", "gongUrl": "https://app.gong.io/call?id=dba59ffcded46b48ef33dd10a6a3880e25343d08362ce5456378e1da3d0c84ef", "speakerId": "1620862635613952978", "customerName": "Eduardo Gomez Castaneda", "internalName": "Richard Lee", "customerEmail": "eduardo.x.gomezcastaneda@gsk.com", "internalEmail": "rich@biorender.com", "sizeMentions": []}]}, {"id": "gsk_ibib_b052df29", "company": "gsk", "gong_entity": "IBIB", "gong_parent": "GSK R&D", "entity_type": "department", "team_size": "20", "confidence": "medium", "mention_count": 1, "snippet": "the bigger department that it would be more than 20 people is deep, which is, I always forget", "snippet_date": "2023-06-19", "person_name": "Eduardo Gomez Castaneda", "person_email": "eduardo.x.gomezcastaneda@gsk.com", "internal_name": "Richard Lee", "internal_email": "rich@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=dba59ffcded46b48ef33dd10a6a3880e25343d08362ce5456378e1da3d0c84ef", "call_id": "2023-06-19_dba59ffcded4", "call_count": 1, "all_snippets": [{"quote": "the bigger department that it would be more than 20 people is deep, which is, I always forget", "date": "2023-06-19", "callId": "2023-06-19_dba59ffcded4", "gongUrl": "https://app.gong.io/call?id=dba59ffcded46b48ef33dd10a6a3880e25343d08362ce5456378e1da3d0c84ef", "speakerId": "1620862635613952978", "customerName": "Eduardo Gomez Castaneda", "internalName": "Richard Lee", "customerEmail": "eduardo.x.gomezcastaneda@gsk.com", "internalEmail": "rich@biorender.com", "sizeMentions": [{"value": "20", "snippetIndex": 0, "source": {"callDate": "2023-06-19", "customerName": "Eduardo Gomez Castaneda"}}]}]}, {"id": "gsk_bi_team_ea75682e", "company": "gsk", "gong_entity": "BI team", "gong_parent": "GSK R&D", "entity_type": "team", "team_size": null, "confidence": "medium", "mention_count": 1, "snippet": "So there's a vaccine team, there's a BI team.", "snippet_date": "2023-01-12", "person_name": "", "person_email": "james.x.lodge@gsk.com; manjunath.n.hegde@gsk.com", "internal_name": "Hayley Lau; Richard Lee", "internal_email": "hayley@biorender.com; rich@biorender.com", "llm_suggested_match": null, "status": "pending", "gong_url": "https://app.gong.io/call?id=879191214155d8be5ee095fc329941ab64bf31ba216733d33adff0cce5ee8bdc", "call_id": "2023-01-12_879191214155", "call_count": 1, "all_snippets": [{"quote": "So there's a vaccine team, there's a BI team.", "date": "2023-01-12", "callId": "2023-01-12_879191214155", "gongUrl": "https://app.gong.io/call?id=879191214155d8be5ee095fc329941ab64bf31ba216733d33adff0cce5ee8bdc", "speakerId": "5207298135856666814", "customerName": "", "internalName": "Hayley Lau; Richard Lee", "customerEmail": "james.x.lodge@gsk.com; manjunath.n.hegde@gsk.com", "internalEmail": "hayley@biorender.com; rich@biorender.com", "sizeMentions": []}]}]}